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Abstract 
 
An in vivo evaluation of pulmonary immune response and toxicity following combined 
respiratory exposure to crystalline silica and diesel particulate matter 
Breanne Yingling Farris 
 
Crystalline silica (SIL) and diesel particulate matter (DPM) are each well-recognized for 
their potential to cause pulmonary toxicity following inhalation. However, these particulates have 
also been identified as coexisting in mixtures of respirable aerosols at a variety of industrial 
settings: mining, oil and gas extraction, construction, road construction, tunneling, excavation, 
foundry, and sandblasting. In order to characterize the potential for increased pulmonary health 
effects when these particulates are inhaled in a mixture, a battery of acute and subacute in vivo 
exposure studies were conducted. The current studies examined co-exposure to SIL and DPM 
at doses that were derived from field measures collected during industrial activities. The project 
had three major aims: (1a) Characterize the pulmonary response to an acute co-exposure to 
DPM and SIL at varying doses; (1b) characterize the pulmonary response to a repeated co-
exposure to DPM and SIL in order to determine if subacute exposure vs. acute exposure altered 
the effects observed for 1a; (2) establish if susceptibility to an acute respiratory infection was 
altered following a co-exposure of DPM and SIL; and (3) determine whether clearance of 
particulate in a co-exposure to DPM and SIL was altered compared with the clearance rate of 
either particle individually to assess the effect of particle load in toxicity. Co-exposure of rats to 
SIL and DPM had the capability to enhance indicators of inflammation, injury, oxidant production 
by phagocytes, onset of the initiation of fibrosis, and differentially alter immunological responses 
when administered in combination, compared to either particle individually. In acute infection 
models examining respiratory susceptibility following exposure to particles, the highest dose of 
DPM was shown to suppress bacterial clearance in the innate phase of the immune response 
as compared to SIL. It was determined that although some macrophage functions were reduced 
by the presence of DPM early in the time course (1 to 3 days following infection), all groups 
cleared the infection at a similar rate in the adaptive phase of the immune response. Further, it 
was determined that some effects in the co-exposure group were associated with the presence 
of SIL and the overall particle load over time, particularly tissue remodeling and the 
development of fibrosis; whereas other effects were due to specific characteristics of DPM 
including inflammation, injury, and oxidant production. Overall, the studies indicate that silica-
exposed workers may be at an increased risk for adverse health effects when concomitantly 
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Exposure to airborne particulate occurs in a variety of occupations. Recorded 
observation of respiratory diseases resulting from such exposures date back to prehistoric eras, 
including mining with origins as far back as the Paleolithic and Neolithic eras [1]. It is speculated 
that silicosis, once referred to as “dust phthisis” and “knapper’s rot,” a pneumoconiosis caused 
by the inhalation of crystalline silica dust, may be the oldest known occupationally acquired 
disease, dating back to the flint mining and knapping origins of industry [2]. Silicosis is still 
prevalent to date, associated with a number of different occupations including mining, and data 
from the Coal Worker’s Health Surveillance Program (CWHSP) suggests it is again on the rise 
in coal miners, after a period of decline in the 1980’s [3]. Silica exposure has been shown to 
lead to several health complications, most notably progressive fibrosis and cancer [4]. In 
addition to silica, workers in the oil and gas industry are also at risk for exposure to diesel 
exhaust. The diesel engine, invented in the 1890s, was used mostly for industrial or public-
sector transportation applications until its transformation for private use in the 1980s. 
Combustion exhaust was not recognized as a health hazard until the latter part of the 20th 
century. Pulmonary exposure to diesel exhaust (DE) is now associated with several adverse 
health effects including but not limited to inflammation, decrements in lung function, chronic 
obstructive pulmonary disorder (COPD), bronchitis, asthma, cancer, respiratory infection, 
cardiovascular disease, and stroke [5, 6]. Components of diesel exhaust are complex and 
variable dependent upon many factors including the type of fuel combusted, the age and 
maintenance of the engine, and the temperature and pressure at which the engine is operated 
[5]. Due to the complex nature of diesel exhaust the approach to regulating occupational 
exposure has varied globally.  
Co-exposure to respirable crystalline silica and diesel particulate matter (DPM) may 
occur in occupations in which diesel-powered equipment is primarily utilized for the purposes of 
disturbing the earth’s crust, crushing, grinding, or polishing rock, as well as occupations in which 
the use of sand as a material is prevalent. These occupations include surface and underground 
mining, road paving and construction, tunneling, as well as masonry, ceramics, and 
sandblasting [7]. While the health hazards associated with each of these particles individually 
have been investigated, very few studies have systematically examined the possible risks posed 
by silica and DPM combined. Additionally, many of the in vivo studies examining these particles 
were conducted using doses that exceed real-time measures of particles in the personal 
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breathing zones of workers collected during industrial activities. Because mixing particles may 
result in chemical interactions that alter their toxicological properties compared to the individual 
particles that constitute the mixture, and dose comparison to actual exposure measurements 
are of utmost importance in order to determine the combined risk of silica and DPM exposure in 
the workplace, it is necessary to investigate these two aspects for a better understanding of the 
possible adverse health outcomes that may result due to co-exposure to these materials in 
occupational settings. 
Human Health Effects of Respiratory Exposure to Crystalline Silica 
 
Currently, the Occupational Safety and Health Administration (OSHA) report that 
approximately 2 million workers in the United States are potentially exposed to crystalline silica 
and for many of those workers air levels may exceed recommended exposure limits (RELs) 
depending upon the industry [7, 8]. Millions more are affected in middle-low income countries 
such as India, China, Brazil, and South Africa. In addition to silicosis, exposure to silica is 
related to other respiratory illnesses, which have been extensively reviewed, including COPD, 
emphysema, chronic bronchitis, development of respiratory infection, the overall declination of 
lung function and cancer [9-12].  
Moreover, non-pulmonary effects of silica exposure have also been identified including 
the development of autoimmune diseases, malignancies outside of the respiratory tract [13-16], 
cardiovascular diseases [17, 18] such as cor pulmonale [19] and ischemia [20], and renal 
disease. For the purposes of the current studies, the review will focus on the development of 
respiratory conditions as they relate to silica exposure and particularly to prolonged 
inflammation and alterations in immune function.  
Pulmonary Disease and Lung Cancer 
Pulmonary effects following silica exposure in workers are well-established. Respiratory 
exposure to silica causes pneumoconiosis, more specifically, silicosis, which is a restrictive, 
fibrotic lung disease. Etiology depends upon dose/exposure and duration. The four types are: 
acute, accelerated, chronic, and complicated or conglomerate silicosis, where the latter may 
advance to progressive massive fibrosis (PMF) [4, 21, 22]. Silicotic fibrosis has been well-
studied in humans across several decades by medical survey, retrospective, and case study 
(Table 1), and though it has been recognized in the literature since it was described by Georgius 
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Agricola in the mid-1500s as an occupationally relevant disease [23], it has only been clinically 
recognized in the past century.  
Silicosis was a grossly neglected occupational outcome of dusty trades until what is 
considered one of  the worst industrial disasters in the history of the United States, “The Hawk’s 
Nest Incident.” In an effort to redirect the New River for hydroelectric utilization, a 3-mile-long 
tunnel through a mountain face in West Virginia, and still one of the greatest engineering feats 
of modern civilization, was commissioned by the Union Carbide and Carbon Corporation in 
1930. The rock face was comprised heavily of crystalline silica. Nearly 5,000 workers 
contributed to the project, 2500 of whom worked underground at some point during that year. Of 
the 2,500 men who worked underground, 1,500 would eventually die due to complications 
associated with silicosis. Within 5 years of the project completion, 764 men lost their lives to 
acute silicosis. Due to underreporting of this disease, it is suspected that these numbers are 
actually an underestimation of mortality. Prior to this tragedy, silicosis remained fairly 
undiagnosed as it was difficult to distinguish from other respiratory diseases with similar 
symptomology and presentation such as pneumonia and tuberculosis [24]. 
Following this and other occupational exposure incidents, efforts have been made to 
improve the detection and prevention of silicosis, particularly by the International Labour 
Organization that set the standard for Chest Radiograph determination of silicosis in 1930, 
which has undergone several revisions to its current form in 2011 [25]. Silicosis is characterized 
based on criteria including clinical presentation, exposure history, exclusion of other diagnoses, 
and finally of radiographic evidence of rounded opacities. Earlier and improved detection has 
also been enhanced by the use of Digital Thoracic Radiography and Thoracic Computed 
Tomography with High Resolution [26].  
 Pneumoconioses such as silicosis develop in the lung due to unconstrained 
inflammation that eventually results in the fibrosis.  Specific mechanisms that relate to this 
process are still actively investigated; however, it is understood that phagocytosis of silica 
causes the production of reactive oxygen species (ROS). ROS initiates inflammatory processes, 
which lead to the death of silica-containing phagocytes resulting in reuptake of silica particles by 
new cells and the cycle is perpetuated [4, 21, 27, 28]. In an effort to control local inflammation, 
fibrotic mediators are secreted to sequester damage within the formation of a granuloma. These 
granulomas, also referred to as silicotic nodules, become areas that are no longer capable of air 
exchange and therefore cause restrictive fibrosis or areas where lung expansion by air is no 
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longer possible. Furthermore, prolonged inflammation may also lead to the upregulation of 
pathways that result in carcinogenesis [21].  
Silica is listed as a Group 1 carcinogen by the International Agency for Research on 
Cancer (IARC) [29]. In a retrospective study conducted by Dong et al. silica exposure in 
refractory workers was linked with a higher incidence in mortality from lung cancer [19]. These 
studies showed a correlation in the outcomes of silicosis and lung cancer that were dependent 
upon severity of silicosis and the latency since exposure. However, these findings were 
determined to be independent of smoking tenure.  Attfield and Costello reported that increased 
incidence of lung cancer in granite workers was associated with duration and extent of silica 
exposure and suggested that the exposure regulations from OSHA of 1.0 mg/m3 over 8 hours 
as a time-weighted average (TWA) and the National Institute for Occupational Health (NIOSH), 
0.05 mg/m3 as a TWA for respirable crystalline SiO2 [30, 31] at that time, were not sufficient for 
protection of workers with a lifetime tenure for occupational exposure to silica [32]. Data 
published by Preller et al. indicated similarly that silica was a lung carcinogen and that 
confounding factors including smoking and exposure to asbestos, while associated with 
increased risk of cancer, did not singularly result in increased risks observed for silica-exposed 
workers, which were dependent on duration of exposure and overall cumulative exposure [33].  
Liu et al. corroborated former findings in their extensive lung cancer risk assessment cohort 
examining over 34,000 workers in which they concluded that silica was a carcinogen, that 
exposure limits in many countries may be insufficient, and that smoking tenure increases risk for 
lung cancer when combined with silica exposure [34]. These findings were reaffirmed by 
Kachuri et al. in a population study of Canadian men where investigators found that exposure to 
silica regardless of silica source or smoking history was associated with an increase incidence 
of lung cancer. These findings were exposure duration dependent and additionally coincidence 
with smoking tenure increased risk beyond that of silica exposure alone [35]. While lung cancer 
dominates the carcinogenic findings associated with silica exposure, it does not stand alone as 
the only malignancy related effect.  
Beyond the growing data implicating silica exposure in the incidence of lung cancer is 
the support for other malignancies such as upper airway neoplasms. In a case study conducted 
by Elci et al. data suggested that patients who had been exposed to silica dust had a higher 
incidence of laryngeal cancers specifically of the supraglottic region, and that this relationship 
was dose- dependent [36]. The same group reported consistently that silica exposure increased 
the incidence of laryngeal cancers in a group of non-smoking and non-drinking men, with the 
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majority of cases occurring in the supraglottic region  [37]. Laryngeal cancer was reported as 
occurring more frequently in those exposed to free respirable crystalline silica by Sartor et al. in 
a case study conducted in Brazil [38].  
Autoimmune Disease  
Silica exposure has been shown to have an increased association with disease resulting 
from autoimmune etiologies, as reviewed by Maeda et al. [39], although the American Thoracic 
Society recognizes that some of these associations may need further examination including: 
scleroderma (SC), systemic lupus erythematosus (SLE), and  rheumatoid arthritis (RA) [40]. In 
1995, during a prospective cross-sectional medical study of 764 patients admitted to a 
rheumatology clinic performed by Koeger et al., it was found that work-related exposure to silica 
coincided with autoimmune connective disorders in 24 patients who had been exposed to silica 
for at least three years including: progressive systemic sclerosis (PSS), RA, and SLE [41]. 
Similarly, Makol et al. reported that silicotic patients were at a significantly increased risk for 
connective tissue disorders such as SC and anti-neutrophil cytoplasmic autoantibody-related 
(ANCA) vasculitis but also an increased risk for RA and SLE in a retrospective medical survey 
covering patient data reported from 1985-2006 [42]. A retrospective study investigating data 
collected from past medical examinations in a large cohort conducted by Blanc et al. also 
showed increased risk for rheumatological diseases like RA, SLE, and SC in silica-exposed 
construction industry workers and that this risk was increased for ever-smokers. The authors 
used an exposure matrix to determine occupational exposure based on exposure estimations 
from the 1970s. The study included over 200,000 patients after exclusions were applied and 
over 35,000 non-exposed controls who performed office duties at similar job sites [43]. 
Beaudreuil et al. studied the hypothesis that silica exposure may result in increases in ANCA in 
the plasma resulting in diseases like vasculitis or nephritis. This group concluded that silica 
exposure was the only investigated hazard that resulted in a significant difference in the 
presence of ANCA compared to controls suggesting silica played a role in the development of 
ANCA-related autoimmunity [44]. Results from the studies of Shtraichman et al. suggest that 
those exposed to silica may even be at risk for mixed connective tissue disorder reporting that 
many patients have overlapping symptoms consistent with multiple autoimmunological 
diagnoses [45]. In a population-based case-control study, Parks et al. found an association 
between work-related silica exposure and incidence of SLE in a cohort of people from the 
Southeastern United States, n = 265 SLE and n = 355 control. Further, job histories were 
determined by blind assessments, and most dusty trades for this study pertained to agricultural 
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work performed in sandy soil [46].  Bovenzi et al. conducted a case-referent population study of 
scleroderma patients from 1976-1991. The authors examined 21 patients with scleroderma 
compared to 42 matched controls, which suggested that among other occupational exposures, 
silica increased the risk for SC and systemic sclerosis (SSc). A minimum of six months of 
relevant exposure was required for inclusion [47].  
Association of silica exposure with development of autoimmune disease has led 
investigators to examine how silica initiates this pathological process. One group has reported 
that soluble Fas, an alternatively spliced variant of the important autoimmune regulator Fas, is 
over-expressed in the serum of silicotics when compared with healthy donors. The increase in 
soluble Fas may lead to reduced apoptosis in aberrant immune cells resulting in a loss of self-
tolerance and production of autoantibodies [48, 49]. Furthermore, Wu et al. reported that T-cell 
activation occurring continuously by silica from consistent exposure, or buildup in the host, may 
cause activity of T regulatory cells in peripheral blood to be reduced by replacement by 
activated T-cells that express CD4 and CD25. It was also noted that this data was collected 
prior to clinical autoimmune presentation suggesting that pools of regulatory T cells may serve 
as a way to monitor autoimmune development and that silicosis may be a predetermining factor 
[50].  These findings led Otsuki et al. to hypothesize that there are two subpopulations of 
surviving silicosis lymphocytes: one, which is long surviving that recognizes self-antigen, and 
one, which undergoes apoptosis in response to silica and is sensitive to anti-fas autoantibody 
[51].  
Studies conducted by Rocha-Parise et al. examined markers of immune activation in 
silica-exposed workers belonging to various industries: ceramics, mining, stonecutting, 
quarrying, and foundry among others. Peripheral blood was collected from 103 patients as well 
as 103 matched controls. Authors focused on the interleukin (IL)-2 axis where they report that 
patients exposed to silica had higher serum levels of IL-2 receptors and inflammatory cytokines 
such as IL-1α, IL-6, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ. The authors also 
examined immune cells and demonstrated that those from silica-exposed patients were much 
more proliferative than controls [52], suggesting hyperactivation of the immune system. In an 
earlier study Rocha et al. produced data that points to reduced self-tolerance due to 
polymorphisms that occur in the PD-1 and reduced expression of CTLA-4 involved in signaling 
that regulates apoptosis of autoreactive cells in silicosis patients [53]. Therefore, while the 
relationship of silica exposure and autoreactivity is well-characterized, the role of silica in 




 The incidence of tuberculosis (TB) or infection with Mycobacterium tuberculosis is also 
reported to increase in individuals exposed to silica [54]. It has been recognized for centuries 
that exposure to dusty trade and phthisis or silicosis increases susceptibility to “consumption” or 
TB infection [23, 55, 56]. When both conditions occur simultaneously, it is known as silico-
tuberculosis, oftentimes presenting in non-classical ways, particularly fibroid without tendency 
toward cavitation, patients may present as sputum-negative despite radiological evidence of 
tuberculosis [57]. More recently, it was demonstrated that workers exposed to silica were more 
susceptible to TB infection even in the absence of silicosis, though susceptibility was increased 
with silicotic disease [58-62]. Though TB is the most common infection associated with silica 
exposure, there is evidence that chronic exposure to silica causes susceptibility to other 
infections as well.  
 Non-tuberculous mycobacterial (NTM) infections were reported in workers exposed to 
silica and most typically in those with pre-existing lung conditions such as pneumoconiosis, 
silicosis, or COPD. In a case study, Bailey et al. reported on various TB and NTM infections that 
occurred in silicotic sandblasters. These researchers concluded that these infections might be 
opportunistic due to reduced pulmonary defenses upon the development of occupational 
disease [55]. Schaefer et al. addressed NTM infections with an avian-Battey group that typically 
do not infect healthy adults. Their data suggested that damage to the lungs by industrial 
exposure was associated with opportunistic infection and typically poor prognosis [63].  In a 
review of NTM by Wolinsky, predisposing conditions most commonly associated with NTM 
infections include pneumoconiosis, previous TB infection, and COPD. Not surprisingly the 
investigator outlines silicosis as being related with NTM infection as documented in several 
studies [64].  Suzuki et al. more recently investigated atypical cases of M. scrofulaceum in 
adults, a pathogen more typically associated with childhood lymphadenitis. They concluded that 
chronic pulmonary disease was associated with this opportunistic infection and that literature 
covered most-noted history of dusty occupations and silica exposure [65].  Finally, it has been 
acknowledged that diagnosis with multiple and mixed pulmonary NTM is possible in patients 
with underlying pulmonary disease [66]. Furthermore, it should be noted that mycobacterial 
infections following silica exposure, while dominating the literature on silica-associated 
infections, are not exclusively reported. 
 Among other infections recorded for occupational exposure to silica include bacterial 
infections with nocardiosis [55] as well as infection with Acinetobacter. Cordes et al. examined 
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three reported cases of non-nosocomial Acinetobacter calcoaceticus variety anitratus 
pneumonia that occurred among foundry workers, one of whom had a confirmed silicotic nodule 
upon post-mortem examination. It was stated that worker exposure to mixed dust, free silica, 
and metallic particles were in excessive levels. Specifically, free silica exceeded NIOSH REL. 
All three cases of pneumonia were of the same strain and were likely contracted by aerosol 
route [67]. Though bacterial infections have been more consistently associated with silica 
exposure, fungal infections are also recognized. Bailey et al. noted a few cases of sporotrichosis 
and crytococcosis known among sandblasters [55]. The importance of further investigations 
involving atypical tuberculosis was stressed by da Silva et al. in a report on a patient with 
concomitant silicosis and crytococcosis [68]. Though complete understanding of how silica 
affects the immune system remains elusive, and taking into consideration that these infections 
are known to cleared by cell-mediated mechanisms, it is likely that chronic exposure to silica 
impairs this response at least partially. Subra et al. showed that in individuals with pulmonary 
silicosis resulting from occupational exposure, circulating numbers of total lymphocytes were 
reduced when compared with controls [69]. Further, Schuyler et al. reported that lymphocytes 
recovered from silicotics were less responsive to low concentrations of concanavalin A [70]. 
Further studies are needed in order to determine the full effects of silica exposure with regard to 
cell-mediated immunity. 
Effects of Respiratory Exposure to Crystalline Silica in In Vivo Models 
 
Pulmonary Effects 
 Animal studies of silica exposure have been conducted over the past few decades. The 
study of silica exposure in vivo has not only led to support for epidemiological/human studies 
but has primarily elucidated possible mechanisms for disease progression. These studies 
include, but are not limited to, mechanism related to pulmonary clearance or lack there-of, 
oxidant-induced lung injury and inflammation, and the role of immune regulation in the 
development of fibrosis.  
It is widely accepted that the initiation of toxicity in the host is directly related to uptake of 
silica particles by alveolar macrophages (AMs) and cytotoxicity on the path to progression 
towards fibrosis. Schapira et al. demonstrated that instillation of silica into rat lungs caused 
increased acute inflammation driven by the production of hydroxyl radicals produced in excess 
when compared to instillation of a less toxic material, titanium dioxide (TiO2) [71]. In a later 
study, Shapira et al. showed that phagocytic cells ex vivo produced increased levels of nitric 
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oxide (NO) following exposure to silica by increased uptake and metabolism of L-arginine, 
unveiling another potential mechanism for silica-induced ROS production in vivo [72].  In a 
series of studies examining silica inhalation exposure in rats, Porter et al. demonstrated that NO 
and ROS were increased in the lung following exposure to silica and that the production of 
these molecules was associated with pathological lesions in the lung caused by silica particle 
exposure [73]. Additionally, oxidative effects of silica continued after silica exposure ceased. 
Their results indicated that even after exposure ends and a period of recovery occurs, and 
though silica may be cleared from the lung below a specific threshold of exposure, although 
slowly, damage induced by silica particles continues to increase. [74]. It was also confirmed that 
these results were obtained for a level of exposure below the threshold for what would be 
considered to be “overload” [75]. Moreover, it was shown that this damage was mediated by 
oxidative stress resulting from increased presence of NO and ROS in the lung [76]. Sato et al. 
showed that progressive inflammation caused by ROS production upon exposure led to 
infiltration of cells into the lung and production of signaling molecules, but that these effects 
could be reduced by treating with oligodeoxynucleotides (ODN). The authors hypothesize that 
ODN suppress mitochondrial instability that contributes to the production of ROS as their data 
supported that ODN helped to maintain mitochondrial stability [77].  
ROS is known to upregulate the activation of transcription factor, nuclear factor-kappa B 
(NF-κB) [78, 79]. Consequently, Porter et al. [80] and Castranova et al. [81] investigated the 
effects of silica exposure on the activation of NF-κB. Data reported in this study concluded that 
the relationship between silica exposure in vivo and the degree of NF-κB activation was directly 
related to time beginning at 5 days of exposure and increasing steadily throughout the time-
course. Since fibrosis was not found to occur until a later phase of inflammation, it is reasonable 
to surmise that NF-κB may be involved in the development of fibrosis in the lung following silica 
exposure. Studies conducted by Zhu et al. showed imbalances of redox due to increased 
production of ROS and the down regulation of the thioredoxin (TRX) system resulted in 
oxidative stress, which may eventually lead to fibrosis [82]. Further, more recent investigations 
have delineated mechanisms that demonstrate that TRX may have a role in inflammasome 
regulation. 
Peeters et al. investigated the role of TRX and inflammasome upregulation downstream 
of ROS production. They concluded that rats treated with crystalline silica particles had 
increased inflammasome activation indicated by increased activation of caspase-1 and IL-1β 
[83]. Studies conducted by Ghio et al. focused on silica particle chemistry and the ability of silica 
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to sequester iron leading to collagen deposition [84]. Supporting this mechanism, Shimizu et al. 
discovered that silica particles in mouse lungs were correlated with increased iron complexes. In 
addition to increased silica-iron complexes, accumulation of p62 was demonstrated in 
histiocytes, primarily shown to be macrophages, of granulomas. Increased levels of p62 are 
indicative of downregulation of autophagy. Decreased autophagy may allow for cell survival, 
and prolonged secretion of inflammatory and fibrogenic factors by these macrophages.  
Oxidative stress is initiated by iron-silica complexes, which may ultimately result in decreased 
cell death by autophagic mechanisms and hence silicotic progression. It should be noted, 
however, that a direct connection between increased iron-silica complexes and increased p62 
have yet to be established [85].  Moreover, Jessop et al. elucidated that autophagy in vivo 
following silica exposure was at least in part responsible for the regulation of the inflammasome, 
and alterations in autophagy led to enhanced inflammation and cytotoxicity. Authors exposed 
autophagy deficient mice to silica, which led to increased production of inflammasome products 
including IL-18 in lavage fluid. These results highlight the importance of autophagy during 
homeostasis of cells following particle exposure/uptake [86].  
Similar to autophagy, apoptosis has been implicated in the development of silicosis and 
lung cancer following exposure to silica. Upstream of the inflammasome in the proposed 
pathway, Moncao-Ribeiro et al. examined the role of P2X7, a purinergic receptor that responds 
to extracellular ATP, in the development of silicosis. Their data supports the conclusion that 
P2X7 regulates silica-induced changes in the lung by responding to extracellular ATP produced 
in response to damage created by silica, and mediating the production of ROS, which in turn 
result in mitochondrial damage and eventually apoptosis and progressive inflammation [87]. 
Wang et al. investigated the role of the transcription factor p53 in apoptosis following silica 
exposure in animals and found that when p53 was knocked out, silica-induced apoptosis was 
diminished [88]. Adding to the evidence that increased apoptosis may play a role in the 
development of silicosis is a study performed by Borges et al. These investigators showed the 
importance of Fas ligand in the development of silicosis and the pro-inflammatory role of 
apoptosis following exposure to silica. The authors demonstrated that in mice lacking Fas 
ligand, macrophages failed to undergo apoptosis in response to silica exposure and neutrophil 
infiltration was reduced blunting the progression to prolonged inflammation and advancement to 
silicosis. These results were further supported by both the adoptive transfer of wild-type (WT) 
macrophages restoring these responses in Fas ligand knock-out (KO) mice and the blockade of 
silicosis induction using a Fas ligand antibody in WT mice [89]. 
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Inflammation is an important initiating event modulating disease following silica 
exposure; therefore, research has emphasized the role of innate mechanisms following silica 
particle phagocytosis in disease. However, in light of the fact that silica has such a pronounced 
effect on cell-mediated immunity and disruption of proper antigen recognition, investigators have 
also focused on pathways that may be involved in toxicity including, at least in part, the 
development of fibrosis. Suzuki et al. report that, although T lymphocytes regulate a portion of 
fibrogenesis, athymic mice still developed fibrosis in response to silica administration, 
demonstrating that T cell regulation is only partly involved [90]. Langley et al. report that there is 
a “biphasic” response to silica and while hyperresponsiveness of T cells occurs during the first 
of two phases, this is not required for the development of granulomas and progression to 
fibrosis in the second phase as adaptive immune responses were found to have returned to 
normal [91]. Migliaccio et al. determined the importance of antigen presenting cell (APC) 
phenotype shift and lymphocyte activation that may initiate prolonged inflammation. Treatment 
of mice with silica intranasally induced increased APC activities in AMs as wells as the 
expansion of a subset of interstitial macrophages with APC markers. It remains to be 
determined whether these cells are recruited to the lung or if activation of existent cells occurs 
due to exposures. However, it was hypothesized that these cells and the shift of their phenotype 
to increase APC activity were responsible for increased activation of T-cells and therefore 
initiation of inflammatory and pro-fibrotic mechanisms [92].   
Due to previous findings that demonstrated the importance of T-helper Cell Type 1 (Th1) 
and Type 2 (Th2) cytokines in the development of silicosis and the known role for T regulatory 
lymphocytes (Tregs) for maintaining immune homeostasis, Liu et al. suggest that depleting 
Tregs might help to balance the Th1 and Th2 axis and shift response back toward Th1 from Th2 
to evade fibrogenesis. They showed that Treg cells modulate inflammation in early stages by 
expression of CTLA-4, and IL-10 and transforming growth factor (TGF)-β expression in later 
stages promote fibrosis [93]. Guo et al. examined the balance of the Th1/Th2 axis as well. Their 
data suggests that suppression of IL-1β, a cytokine that is expressed following exposure to 
silica, and upregulation of the Nod-like Receptor, pyrin domain-containing 3 (NLRP3) 
inflammasome, may inhibit other fibrogenic mediators downstream of IL-1β, such as collagen I 
and fibronectin, and offset prolonged inflammation leading to fibrosis. The authors blocked IL-1β 
using an antibody in silica-exposed mice and demonstrated that inhibition of this cytokine 
resulted in reductions in TNF-α and macrophage chemoattractants. Gene expression of 
important fibrogenic factors was also reduced by the blockade of IL-1β [94]. Chen et al. reported 
that neutralization of a different inflammatory cytokine, IL-17, known to be involved in the 
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progression of autoimmune responses, resulted in reduced initial phase inflammation in 
response to silica. They found that blockade of IL-17A resulted in decreased IL-6 and IL-1β 
following silica exposure in mice and, therefore, a reduction in acute phase inflammation. The 
authors hypothesize that IL-17A plays a role in the silica-initiated disruption of Th1/Th2 
homeostasis leading to fibrosis [95]. Another group led by Li explored the possibility that 4-1BB, 
a co-stimulatory molecule in T cell activation might be involved in the development of silicosis. Li 
et al. reported that blockade of 4-1BB reduced fibrosis by controlling the initial Th1 driven 
inflammatory response resulting in a decreased Th2 response following initial inflammation [96]. 
Altogether these data suggest dual phase response of the immune system following silica 
exposure, which results first in hyperactivity of Th lymphocytes that may be induced by 
increased and highly active macrophages and, secondly, an uncontrolled progression of 
inflammation and fibrogenesis that is likely in part modulated by the inflammasome with a role 
for Treg cells.  
Although most in vivo studies have emphasized the development of restrictive lung 
disease, fibrosis, studies also have aimed to elucidate the mechanisms that result in obstructive 
lung disease following exposure to crystalline silica. Wright et al. examined quartz exposure in 
rats and determined that in an animal model, quartz was capable of not only inducing silicosis 
but also obstructive lung disease characteristics including morphologic alterations to small 
airway tissue and functional changes consistent with emphysema [97]. Results from studies by 
Li et al. demonstrated that changes observed in the former study by Wright et al. may be due to 
destruction of elastic fibers that may be due to neutrophilic-derived enzymes. It was concluded 
that loss of this form of connective tissue played a role in the development of silica-induced 
emphysema [98, 99]. 
Perturbations of connective tissue by silica may also be implicated in the development of 
cardiopulmonary disease. Herget et al. showed that quartz caused pulmonary hypertension and 
increased heart ventricle weights [100]. Similarly, Zelko et al. showed that vascular remodeling, 
endothelial dysfunction, and inflammation were responsible for pulmonary hypertension in mice 
following intratracheal instillation (IT) exposure to silica [101]. Elevations in mRNA of 
inflammatory mediators and matrix proteins were observed in the heart and kidney of rats 
exposed to silica by Guo et al. Additionally, it was shown that neutralization of IL-1β decreased 




Systemic Immune Effects 
There have also been extensive studies in animals investigating correlations of silica 
exposure with systemic disease and autoimmune diseases, as in the case of ANCA. 
Autoimmune diseases, such as SLE and SSc, have been shown to occur in populations 
susceptible to the production of autoantibodies when exposed to silica. Brown et al. examined 
silica exposure in New Zealand mixed mice, a strain prone to lupus, to determine if a 
predisposed population exposed to silica might develop autoimmune disease. This group 
showed that silica significantly exacerbated the course of SLE development in these mice, 
indicated by increased mortality, proteinuria, circulating immune complexes and autoantibodies 
compared with saline and TiO2 control treated animals [103]. Additionally, mice had increased 
inflammation collagen deposition in the lung consistent with pulmonary fibrosis. The same 
investigators showed in a later study that alterations in populations of lymphocytes, primarily 
increased CD4+ T cells, resulted in reduced overall numbers of Tregs, which may allow for 
autoreactivity [104]. In experiments conducted by Pfau et al. it was determined that silica-
induced apoptosis led to autoimmune response, by demonstrating that when apoptosis was 
blocked, increased binding of autoantibodies in mice treated with silica was inhibited [105]. 
Brown et al. went on to investigate the hypothesis that silica-induced apoptosis in AMs 
contributed to the generation of autoantibodies and showed that reduction of apoptosis by 
treatment with rottlerin decreased autoimmunity related to silica-exposure [106]. Further, 
Strickland et al. examined the effect of oxidants on CD4+ T cells to determine if this may be a 
cause for lupus-like autoimmune developments in animals exposed to agents that cause 
oxidative damage. Adoptive transfer of these oxidant-exposed T cells, which were shown to 
overexpress CD40L cause anti-DNA antibodies and result in lupus flares [107]. These findings 
demonstrate that silica exposure may lead to altered DNA methylation by production of oxidants 
resulting in autoimmune developments in susceptible populations.  
Bates et al. examined repeated, short-term silica exposure on SLE-susceptible mice and 
found that silica induced pulmonary inflammation and elevated cellular infiltrates to the lung 
suggestive of ectopic lymphoid tissue development. Additionally, this group showed that silica 
exposure led to systemic inflammation and initiation of pathogenic mechanism in the kidney 
consistent with glomerulonephritis [108]. The same investigators also showed in a later study 
that the influence of diet, which alters the lipidome, may play a role in off-setting mechanisms 
that promote silica-induced autoimmune development indicating that certain populations may be 
at a greater risk for the initiation of autoimmune disease and recurring flares following silica 
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exposure dependent upon balance of the lipidome. They found that consumption of a 
polyunsaturated fatty acid, docosahexaenoic acid (DHA) may prevent onset of autoimmunity. 
Treatment with DHA or consumption of DHA in susceptible populations may help to reduce or 
delay the onset of autoimmune disease [109]. Ultimately, it has been demonstrated that silica 
results in autoimmunity through apoptotic mechanisms, which increase production of 
autoreactive antibodies, and also shifts in normal circulating T cell populations.  
Susceptibility to Infectious Disease 
Mechanisms elucidating susceptibility to mycobacterial infection following silica exposure 
are not well investigated due to the lack of adequate animal model for investigation until 
recently, because an increase in susceptibility to mycobacterial infection due to silica exposure 
could not be demonstrated in vivo [110].  Interestingly, past correlations have been drawn 
between human susceptibility to tuberculosis infection following exposure to silica and animal 
susceptibility to infection. Badgers have always been considered to be inherently susceptible to 
mycobacterial infection. Higgins et al. elucidated a possible connection with environmental 
exposures to silica and propensity for disease through the discovery of silicotic fibrosis 
developments in the lungs of wild badgers upon post-mortem examination [111]. While it has 
been recognized for several centuries that those employed in dusty trades had a higher 
incidence of infectious diseases like tuberculosis, models examining infectious disease as it 
relates to occupational silica exposure have only been developed in vivo within the past few 
decades. Hatch et al. investigated variable occupational exposures in mice, and their 
susceptibility to infection following exposure. The authors reported that for silica, there was only 
a slight increase in infectivity, though this study was conducted following acute exposure to a 
low dose of silica (100 µg) and only mortality was used as an end-point for infectivity [112]. 
Pasula et al. describe one of the first studies conducted in mice in which they uncovered a 
mechanism for silica to alter macrophage populations in a way that favors mycobacterial 
persistence in the host [110] to model silicotuberculosis. Conversely, Antonini et al. showed that 
short-term silica exposure resulted in enhanced microbial clearance owed to the increase in 
cellular recruitment to the lung and production of oxidants likely aiding in bacterial clearance 
[113]. Antonini et al. state that in a chronic study of silica exposure host defenses were impaired 
requiring further examination of silica-exposure and the importance of time in relationship to 
exposure and infection.  
In vivo work has been critical in helping to elucidate mechanisms of disease associated 
with silica exposure, but also of value are the vast number of studies that have been performed 
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in vitro. Many of the limitations involving in vivo work relate to inadequate modeling of 
physiological exposure of animals to silica, time-constraints, dose constraints for modeling 
exposure, or insufficient techniques for examining intricate mechanisms within a host; therefore, 
cellular studies have also been useful and have provided insights into the mechanisms of 
disease. 
In Vitro Models of Silica-Induced Toxicity 
 
It has been shown that depending upon model of animal used, responses to silica varied 
significantly. Huaux and Barbarin et al. investigated the release of cytokines by AMs following 
exposure to silica and reported species-dependent expression of TNF-α [114, 115]. Dorger et 
al. examined the release of NO from macrophages in response to stimulation/activation by 
pulmonary irritants and found species dependent results [116]. Silica elicited fibrotic responses 
varied between models also, with rats being the most sensitive to pro-inflammatory changes 
induced by silica [117, 118]. These studies suggest that responses in biological systems may 
vary dependent upon species. Additional studies in cellular systems including human cell lines 
have been beneficial in advancing the field, particularly with regard to mechanisms of direct 
particle-cell interaction.  
Pulmonary Toxicology  
Although most work contributing to the expansive body of silica-exposure related studies 
has focused on addressing silicotic developments in the pulmonary tract, there are studies 
examining other detrimental effects of silica previously mentioned including cardiovascular 
disease [119]. Although, for the purposes of this review, emphasis in the in vitro section will be 
focused on pulmonary related effects and mechanisms involved in immunity to respiratory 
infection. 
The mechanisms of action in silica toxicology and pathology have yet to be fully 
elucidated, although investigators have outlined several critical events in silica toxicity, which 
are widely accepted including interaction with resident alveolar macrophages [120, 121] 
followed by sustained inflammatory cascades resulting from macrophage mediation [122, 123], 
recruitment of additional cells [124-126], further activation of the immune system [127-129], and 
cell death [130, 131]. Research on particle-cell interactions has led to 4 basic overarching 
mechanisms for toxicity [27]. While an overwhelming body of literature exists addressing 
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specific aspects of crystalline silica toxicity, most of this work is aimed at examining one of these 
broad categories. 
1) Cytotoxicity of Lung Cells Caused by Silica Particles Directly 
The principle that crystalline silica causes direct cellular toxicity resulting in the creation of 
cytotoxic mediators [4] is well-established.  There are possible mechanisms that address the 
toxicity of silica particles relating to the surface chemistry and the reactivity of SiO2 when in 
direct contact with cells. 1) Free radical groups are formed when the surface of silica contacts 
aqueous solutions causing direct damage to biological membranes by lipid peroxidation. Nash 
et al. concluded that the toxic effects of silica are related the ability of silica to form complexes 
with structures such as phospholipids within membranes and act as a hydrogen donor [132]. Shi 
et al. showed that these effects were more significant in freshly fractured silica particles 
compared to those aged in aqueous solution [133]. Dalal et al. further examined this reaction 
and showed that radicals were likely the initiating step in the peroxidation of lipids caused by 
silica particles [134]. 2) Negative charges on the surface of silica interact with scavenger 
receptors on macrophages resulting in the production of ROS. Kobzik et al. found that anionic 
particles like silica were taken up by scavenger receptors (SR) on AMs. When SR were inhibited 
a reduced binding occurred [120]. Research by Iyer et al. examined the potential of silica 
particles to initiate apoptosis in AMs leading to the release of fibrogenic factors. Blockade of 
either SR or downstream mediators of apoptosis resulted in reduced apoptosis and release of 
IL-1β from silica treated AMs [131]. 3) Fracturing silica creates Si radicals on the particle surface 
resulting in oxidant damage. Vallyathan et al. compared free-radical concentrations in freshly 
ground silica with aged silica by using electron spin resonance (ESR). Freshly ground silica 
produced silicon radicals that decreased over time in air and more rapidly in aqueous solution. 
Introduction of silica particles to aqueous solution increases the biological reactivity by methods 
described above. Further, freshly crushed silica induced greater lipid peroxidation as 
demonstrated by Castranova [135]. Experiments that suggested surface chemistry of silica as 
the initiating step in biological toxicity were further confirmed by research that showed that 
coating silica particles with substances such as organosilane [136],  aluminum [137], 
polyvinylpyridine-N-oxide (PVNO) [132], or surfactant phospholipid [138, 139] resulted in 
reduced toxicity. Though direct cytotoxicity to AMs likely initiates mechanisms of chronic 
inflammation and fibrogenesis, there is a body of work that described additional mechanisms 
that are crucial for the development of silicosis and silica-related pathogenesis. The reaction of 





2) Activation of Phagocytes and their Release of Oxidants 
Upon activation, AMs and polymorphonuclear cells (PMNs) or neutrophils release oxidants 
in a ‘respiratory burst’ prior to phagocytosing particles, as reviewed by Badwey and Karnovsky, 
Babior, and Fubini and Hubbard [130, 140, 141] and as demonstrated by Zhang et al. [142]. 
Vallyathan et al. showed that occupational particles including silica, particularly freshly fractured 
crystalline silica, enhanced the respiratory burst of phagocytes [28]. Also, upon phagocytosing 
silica materials, production of oxidants continued through effects on mitochondrial function 
resulting in generation of mitrochondrial ROS (mtROS). Mintz determined that phagocytosis of 
silica increased the mitochondrial redox state compared with the uptake of inert beads [143]. 
Fazzi et al. also have shown that reduction of mtROS may lead to reduced apoptosis of 
macrophages due to silica exposure and overall reduction in pathogenesis [144]. Additionally, it 
was suggested by Driscoll et al. that although cells have mechanisms that typically balance 
these redox reactions, particles that enhance production of ROS disturb this balance and may 
lead to increased cellular toxicity and mutagenesis of surrounding epithelial tissue, thereby 
recruiting additional phagocytes, which further perpetuates this cycle [145]. This may in part be 
due to a mechanism for chronic inflammation at the site of initial injury termed alveolitis. Lugano 
et al. showed in vitro that macrophages exposed to silica released more chemotactic factors for 
neutrophils and additional macrophages compared to control [126, 146]. Furthermore, it is 
proposed that the release of reactive radicals by particles and ROS production by phagocytes 
may interact to form additional toxic oxidant compounds contributing to cell cytotoxicity [147]. 
Pricop et al. have demonstrated that RO intermediates caused increased phagocytosis acting 
as a mechanism for further inflammation and enhanced phagocyte effector functions [148]. 
Further studies have indicated a role for additional ions such as iron and calcium in the 
modulation of oxidant production by phagocytes. Ghio et al. revealed that iron complexes on the 
surface of silica particles may influence their potential for stimulating respiratory burst and 
subsequent recruitment of cells by exposed macrophages [149]. Kim et al. investigated the 
suppression of the respiratory burst of phagocytes and found that protein kinases and 
intracellular calcium transport were both intimately involved in the activation and subsequent 
response of AMs to silica particles [150].  
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Additionally, ROS have been implicated in the initiation of several carcinogenic pathways as 
well. Vallyathan et al. highlighted the importance of the increased activation of a transcription 
factor for inflammatory pathways and cell adhesion, activator protein (AP)-1. AP-1 was 
significantly increased in cells exposed to freshly fractured silica. This effect was attenuated by 
treatment with an ROS scavenger, leading to the conclusion that ROS may be involved in the 
activation of AP-1 [151]. Gwinn et al. examined the role of a transcription factor, p53, in the 
regulation of gene expression as it relates to DNA repair in the context of oxidant related 
damage caused by silica, both fresh and aged. Following this study, it was concluded that silica, 
particularly freshly fractured and highly reactive, caused cellular damage, which if persistent 
may lead to the potential to elicit carcinogenesis [152]. Based on the evidence described above, 
oxidative stress response by phagocytes is a key step in the initiation of carcinogenesis and 
fibrosis; however, the cascade of subsequent cell signaling events has been shown to be 
equally pivotal.  
3) Inflammation Caused by Immune Cell Signaling 
Recent studies have shown that the respiratory burst triggered by silica particles results in 
an intricate, yet not fully elucidated, series of signaling events [153, 154].  These signaling 
events are part of a normal innate immune response to pathogen-associated molecular patterns 
(PAMPs) and danger-associated molecular patterns (DAMPs) that trigger upregulations of 
inflammation mediated by a large multi-protein complex sensor, the inflammasome [155, 156]. 
The studies described below focused on investigations aimed at delineating the role of 
inflammasome formation as a critical part of the signaling cascade that may lead to more 
chronic lung injury.  
Alveolitis or chronic inflammation caused by the influx of immune cells into the lung following 
exposure to particles is initiated by resident macrophages in an attempt to clear directly 
cytotoxic particles from the lung [157]; nevertheless, other immune and pulmonary cells also 
contribute to progression toward chronic inflammation. Beamer and Holian reported that 
dendritic cells (DCs) may be important for the production of some inflammatory cytokines in this 
progression [158]. Lo Re et al. have shown that T lymphocytes, including CD4+ and γδT cells, 
may play an important role in early neutrophilic responses to silica exposure by IL-17A 
mediation [159]. Lastly, Van Berlo et al. demonstrated that alveolar epithelial cells also may 
contribute to inflammation following quartz exposure and these results were independent of NF-
κB driven mechanisms [160]. As previously mentioned, signaling by macrophages to different 
cell types is partially mediated by the upregulation of the inflammasome [155]. However, the 
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secretion of mature IL-1β by activated macrophages in response to silica, which requires the 
transcription factor NF-κB [161], has been shown to be a two-step process based on reports 
from Beamer and Holian, as well as Cassel et al., suggesting that induction of the 
inflammasome by silica necessitates that macrophages first be primed by a stimulant, such as 
bacterial lipopolysaccharide (LPS) [123, 158]. Chen et al., have shown that silica itself can 
induce the activation of NF-κB, differentially from LPS [162]. Therefore, pro-IL-1β may be 
produced in response to this priming signal and later be cleaved when the inflammasome is 
upregulated by lysosomal damage, a DAMP resulting from the phagocytosis of silica as 
investigated by Hornung et al. and Hughes et al. [129, 163]. Moncao-Ribeiro et al. as well as 
Riteau et al. suggest that uptake of silica causes release of extracellular ATP succeeded by the 
activation of purinergic signaling that ultimately activates the NLRP3 inflammasome [87, 164].  
Additionally, Peeters et al. demonstrated that the activation of the NLRP3 inflammasome by 
silica was related to particle surface reactivity, and moreover, that upregulation of this 
inflammatory pathway occurred in epithelial cells of the pulmonary tract in addition to myeloid-
derived cells [83]. Tsugita et al. have suggested that inflammasome activation may also be 
receptor signal dependent and that certain subsets of macrophages may contribute differently to 
acute versus chronic inflammatory processes [165]. Cassel et al. performed studies to address 
whether progression to silicosis is dependent upon inflammasome mediated IL-1β secretion, but 
not all inflammatory cytokines/chemokines secreted in response to silica related to this pathway 
[123], indicating the involvement of multiple pathways. 
Other studies indicate that additional signaling mechanisms within the alveoli and 
associated tissue, particularly in the interstitium and lymphoid tissue, may play key roles in 
progression to chronic inflammation and fibrosis. Migliaccio et al. stated that alterations in APC 
phenotype and presentation may contribute to the initiation of chronic inflammation [92], though 
this is not necessarily independent from inflammasome activation. Other investigations led by 
Migliaccio et al point to a role for Th2 mediated immunity in development of silicosis as well 
[166]. While it is well-established that chronic inflammatory immune cell signaling is integral to 
the development of fibrosis, this is due in part to the release of fibrogenic factors by similar cells 
such as macrophages. Rom et al. demonstrated that macrophages exposed to silica signal for 
the proliferation of structural cells and their release of extracellular matrix proteins [167]. 
4) Release of Fibrogenic Factors from Cells 
While uncontrolled inflammation has been stressed as a major factor in the development of 
fibrosis, it is likely not the only mechanism involved in the development of silicosis. Studies 
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examining the role of immunosuppressive pathways in the development of fibrotic disease are 
being investigated. In work involving eicosanoids, Koren et al. highlighted the importance of 
silica modulation on the expression of eicosanoids and the opposing effects of lipoxygenase 
and cyclooxygenase (COX) enzyme pathways in macrophages following silica exposure. These 
experiments indicated that while the release of leukotrienes was increased, the expression of 
prostaglandin (PG)E2 was reduced, suggesting the potential for increased leukocyte chemotaxis 
as well as fibroblast proliferation [168]. Studies conducted by Barbarin et al. recapitulated these 
findings and further elucidated that IL-10 influenced macrophages and lung fibroblasts to 
increase production of fibrogenic cytokines such as TGF-β, while down regulating COX-2, an 
important enzyme in the expression of an antifibrotic eicosanoid prostaglandin, PGE2 [169]. 
Other cell types have also been shown to be involved in the TGF-β-elicited effects during 
silicotic fibrosis. For example, Th17 cell activity has been implicated in many inflammatory 
diseases. Recently, Th17 cells were associated with epithelial-mesenchymal transition (EMT), 
an important process in embryonic development in normal tissue and also for cancer metastasis 
[170] and tissue fibrosis in pathogenesis [171]. Mi et al. demonstrated that IL-17A promoted the 
expression of EMT– related biomarkers in alveolar epithelial cells and that this was dependent 
upon TGF-β. Furthermore, this group established that IL-17A elicits the secretion of collagen by 
lung epithelial cells and that this too is dependent upon TGF-β [172]. Therefore, the anti-
inflammatory cytokine TGF-β is instrumental in these processes. Lo Re et al. evaluated the role 
of Tregs in expression of platelet-derived growth factor (PDGF) and found that this occurred 
through a TGF-β mediated pathway and when these cells were transferred in vivo collagen 
deposition occurred. This group concluded that the inflammatory effects of T effector cells may 
lead to fibrosis in the absence of Tregs; however, Tregs play their own role in the fibro-
proliferative wound healing of the lung following silica exposure and both arms of the immune 
response need to be addressed to achieve effective therapy [173].  
Immune Effects 
There is a clear body of evidence suggesting the involvement of silica exposure and the 
development of autoimmune disorders, both from epidemiological data and in vivo study. The 
mechanisms by which this occurs have also yet to be fully elucidated. Most studies investigating 
this to date have been conducted ex vivo in samples from silicotic patients. Therefore, in vitro 
data is limited.  It is likely that several pathways are involved as a vast diversity of autoimmune 
disorders are causally linked to silica exposure. Lee et al. hypothesize in their review that long-
term stimulation of T effector cells and aberrant apoptotic response in contrast with increased 
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apoptosis of Tregs is likely to be involved in this process [174]. In vitro evidence for this exists; it 
has been shown by Rao and Frey that silica exposure may cause altered APC presentation to 
lymphocytes that may result in their aberrant activation [175]. Additionally, Wu et al. examined 
the early activation marker CD69 on T cells exposed to silica and found that chronic activation 
of these T cells may lead to disruption of normal apoptotic mechanisms resulting in a chronically 
activated population of cells [176]. In their study examining the importance of apoptosis in self-
antigen recognition, Pfau et al. concluded that silica exposure results in repeated apoptosis of 
cells that can increase the presentation of self-antigen and, therefore, autoantibody 
development [105]. Furthermore, Holian et al. showed that silica exposure resulted in a shift of 
macrophage phenotype to elicit more inflammatory conditions supporting the findings of Pfau et 
al. [177].  
Other studies by Beamer and Holian suggest that the inhalation of silica might predispose 
individuals to infections due to alterations in APCs, disrupting their ability to adequately respond 
to pathogenic stimuli by downregulation of surface molecules and production of NO in response 
to bacteria [158].  Allison and Hart performed one of the earliest studies examining susceptibility 
to M. tuberculosis in macrophages. They determined that bacteria could more readily replicate 
and were released earlier from macrophages exposed to silica, and that this was dependent on 
very low dose exposure. These findings led them to hypothesize this as an explanation, in part, 
for susceptibility of silicotics to tuberculosis infections following chronic low dose exposure to 
silica [178]. 
The body of work mentioned above is only a summary of available literature comprising the 
current knowledge of silica exposure and the effects thereof. Though the field of silica exposure 
is widely examined, the mechanisms by which silica elicits toxicity, fibrosis, and susceptibility to 
infection are still not fully elucidated and require further investigation, especially when 
considering the potential for complications and alterations to these mechanisms in models of 
exposure to particle mixtures, which are prevalent in many current occupational platforms. 
Therefore, the current study is necessary to explore these effects further.  
Exposure to Diesel Exhaust (DE) 
 
Following the increased dependence on the combustion engine in the industrial era and the 
introduction of the diesel engine into the public-sector of transportation in the 1950s, hazardous 
health effects as a result of exposure to combustion exhausts have been extensively 
investigated. The association between pulmonary exposure to diesel and the development of 
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diseases such as COPD, bronchitis, asthma, respiratory infection and cancer is well recognized 
[5, 6]. The complex nature of diesel exhaust has resulted in variable methods of measuring and 
preventing exposure. Regulations exist for several common constituents of diesel exhaust 
including total particulate, total carbon (TC), elemental carbon (EC), carbon monoxide, and 
nitrogen oxides [179-183]. While the United States does have RELs in place for several 
constituents of diesel, the only regulations targeting diesel exhaust specifically use EC and TC, 
which encompasses DPM concentrations. The State of California Department of Health 
Services recommends an EC exposure limit of 20 µg/m3 [184], and the Mine Safety and Health 
Administration sets an exposure limit for TC at 160 μg/m3  in below-ground settings [182]. 
Furthermore, in addition to the known respiratory complications associated with diesel 
exposure, other systemic diseases related to these exposures have also been investigated, 
including cardiovascular and ischemic disease [185-192] and malignant diseases outside the 
lung including bladder cancer [193], prostate cancer [194], and ovarian cancer [195]. However, 
for the purposes of the current study, the review will focus on research related to the 
development of respiratory conditions as they relate to DE/DPM exposure, particularly as they 
relate to prolonged inflammation and alterations in immune function. 
Respiratory Effects of Work-Place Exposure to DE 
 
The results of epidemiological studies related to lung effects caused by occupational 
exposure to DE are variable and conflicting. The data available for these exposures are 
confounded by other respiratory exposures including cigarette smoke and inorganic dusts, 
particularly in the context of mining/tunneling. Additionally, the studies depend heavily on proxy 
interviews, and predominately examined risk for lung cancer only [196, 197]. Nevertheless, 
studies in the last few decades indicate DE exposure is involved in the development of not only 
malignancies, but also pulmonary diseases, and is particularly highly correlated with decreased 
lung function. Ulfvarson and Alexandersson conducted a study in stevedores utilizing diesel 
fueled trucks to load ships. The authors determined that the DPM component contributed to a 
reduction of lung function in workers exposed to total DE compared with groups exposed to 
particle-filtered DE. Further, it was concluded that declination in function reflected a restrictive 
pattern [198]. Chattopadhyay et al. showed DE exhaust exposure may lead to both restrictive 
and/or obstructive lung symptoms in their study investigating workers in a transit diesel bus 
garage. Data suggested that restrictive lung disease developments were dependent upon age, 
job function, and working tenure to some extent; additionally, it was suggested that current and 
previous smoking status played a role in these results [199]. Due to confounding exposures, 
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there is very little epidemiological evidence to suggest that exposure to DE independently 
results in fibrosis or pneumoconiosis; although, some parameters such as radiographic findings 
have been examined. However, at very high levels of exposure, or in combination with other 
toxic respiratory exposure, outcomes of fibrosis may be plausible. In studies performed by 
Gamble et al. examining underground salt miners where diesel equipment was used, some 
evidence of pneumoconiosis was evident in a small number of cases; however, due to the small 
quantity of radiographic findings in these workers and the likelihood of confounding factors, 
these outcomes were not further investigated [200, 201]. Similarly, Gamble et al. examined 
respiratory symptoms in diesel-bus garage workers, and deemed radiographic evidence of 
pneumoconiosis to be insufficient for analysis and likely a result of confounding factors. 
However, it was found that a decrease in overall lung function occurred compared to other non-
diesel exposed “blue-collar” workers; this result was associated with working tenure. Overall, 
smoking was the most significant risk factor indicated in this study [202].  
Decrements in lung function due to DE exposure are more commonly associated with 
obstructive lung changes related to COPD, chronic bronchitis, and asthma. In an examination of 
workers who tested diesel engines at a manufacturing plant in China, Zhang et al. showed that 
exposure to DE led to lung function decrements, which were associated with long-term 
exposure. It was noted that these changes were most consistent with obstructive lung disease. 
Further, it was established that decreased lung function was not dependent upon smoking 
status [203]. Historically, COPD has been strongly linked with tobacco smoke and cigarette 
smoking in these studies. However, in addition to the Zhang et al. study, accumulating evidence 
suggests that exposure to DE specifically is linked with COPD in never-smokers. One medical 
surveillance study by Ulvestad et al. examined symptoms of COPD in tunnel workers (TW) 
compared with other heavy construction workers and determined that DE likely enhanced the 
risk for respiratory symptoms and COPD in TW [204]. An investigation of mortality in a cohort of 
construction workers by Bergdahl et al. led to the conclusion that fumes including DE may 
increase the risk of death by COPD particularly in never-smoking, construction workers [205].  
In two retrospective cohorts examining railroad workers following the initiation of diesel 
locomotive use, Hart et al. determined that workers exposed to DE were at a higher risk for 
mortality caused by COPD than those who were not exposed to DE, and that this was 
dependent on amount of time worked, as well as job function. Further, while smoking status was 
positively associated with increased risk for COPD and tended to correlate with higher DE 
exposure, after controlling for this confounder, higher risk for mortality following DE exposure 
persisted, though it was slightly attenuated [206, 207].  In a population-based study examining 
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cumulative lifetime occupational exposure and risk for COPD, Weinmann et al. found that those 
exposed to DE were at an increased risk for diagnosis with prevalent COPD regardless of 
smoking status [208].  
Several studies have examined other obstructive respiratory symptoms associated with 
chronic upper airway inflammation or bronchitis. Jӧrgensen and Svensson found that among 
miners who worked below ground with diesel-powered vehicles, the frequency of bronchitis was 
increased and that this finding was dependent upon smoking status and age; however, no 
difference in lung function was noted [209]. Oliver et al. examined a cohort of Highway and 
Heavy (HH) construction workers for lung function and respiratory symptoms. Authors 
concluded that only TW in the cohort were at an increased risk for chronic bronchitis. 
Additionally, it was found that risk for bronchitis increased with age and smoking status; 
conversely, working tenure was inversely associated with incidence of bronchitis. Workers who 
experience respiratory symptoms and/or are properly diagnosed by a physician may leave the 
trade contributing to a phenomenon known as the “healthy worker” effect. The authors suggest 
that this effect likely contributed to the finding that incidence of chronic bronchitis decreased as 
working tenure increased [210].  Gluck et al. investigated the role of chronic DE exposure on the 
nasal mucosa of customs officers who clear large diesel trucks. Their findings suggest that 
workers exposed to DE have increased hyperplasia of the nasal mucosa resulting from 
prolonged inflammation [211]. Finally, a study of toll-workers exposed to DE conducted by Safak 
et al. revealed that increased work duration resulted in increased bronchus wall thickening and 
decreased diameter of the large airways [212].  
 The incidence of asthma as a result of occupational DE exposure is now well-recognized 
and dates back to an initial case study by Wade and Newman in which they concluded that 
three railway workers developed asthma due to overexposure to DE, having no previous history 
of airway disease or exposure resulting in asthmatic symptoms [213]. Adewole et al. reported on 
three workers in diesel bus garages who developed asthma. It was concluded that the most 
probable cause of the asthma was chronic low-level exposure to DE with long periods of latency 
[214]. Furthermore, Oliver et al. reported an increased incidence of asthma in HH construction 
workers and TW exposed to DE, specifically in women, though this may partly be due to better 
reporting of symptoms to physicians by women. Additionally, it was established that incidence of 
asthma resulted in reduced lung function [210]. 
 Research investigating the effects of DE exposure in the work-place has most 
historically been in an effort to determine the risk for developing lung cancer. Investigations on 
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this subject vary widely in conclusion due to several confounding factors including the complex 
and variable properties of DE, potential co-exposure to other chemicals, particles and irritants, 
cigarette smoking, duration and magnitude of exposure, as well as age and other health 
complications. The findings relating to the development of lung cancer as a result of exposure to 
DE are summarized briefly (Table 2). Furthermore, based on this research and in vivo 
investigations, diesel exhaust was recently identified as a Group 1 carcinogen in the 2014 
Monograph of the IARC [215]. The working group states that among the most convincing 
studies related to DE causality of lung cancer are the occupational cohort studies on railroad 
workers, miners, and transportation industry as a result of the clearly defined exposure levels 
and adjustment for confounding factors including cigarette smoking [216-219]. 
Respiratory Effects of Environmental Exposures to DE 
 
 In order to investigate the effects of inadvertent environmental exposure to DE, 
investigators have conducted studies examining traffic-related pollutants. Air pollution, and more 
specifically DE-related air pollutants, have been linked to reduced lung function, development of 
respiratory diseases, and malignancies. Brunekreef et al. examined school children who lived 
nearby to major roadways and measured pollutants in their schools. The authors of this study 
determined that decrements in the lung function of children were more closely associated with 
diesel-powered truck traffic, as compared to other motor vehicle exhaust (MVE) for which there 
was less correlation. Furthermore, the data suggested that this association was strongest in 
children who lived nearest to the motorways [220]. In a similar study, Northridge et al. examined 
students who attended a school in Harlem to assess whether bus depots placed in 
underprivileged areas of New York might contribute to the development of chronic lung disease. 
The authors suggest that adolescents in this region were subjected to above normal exposure 
to DE. Data gathered from this study also indicated that small airway obstruction, in the absence 
of symptoms, suggestive of asthma occurred in as many as 30% of participants. Furthermore, it 
was stated, since less than a third of those participants had ever been identified as having a 
history of asthma, that underdiagnosing and/or underreporting of asthma was likely occurring 
among Harlem adolescents [221]. Moreover, a cross-sectional study of asthmatic children living 
in close proximity to heavy traffic performed by Margolis et al. explained that distance of 
residence from highway was predictive of reductions in small distal airway size and risk for 
greater susceptibility to lung function decrements supporting the hypothesis that DE exposure 
may exacerbate existing asthma [222].  Further strengthening evidence for allergic disease 
outcomes is an epidemiological study that examined proximity of children to traffic-related air 
27 
 
pollutants and the development of syndromes such as asthmatic bronchitis, hayfever, eczema, 
and allergic sensitization. Conclusions from this study demonstrated that children exposed to 
ambient particulate matter and living less than 50 meters from busy streets were at the greatest 
risk for atopic disease. Significant increased risk was found for bronchitis, hayfever, and pollen 
sensitization with relation to particulate matter with a diameter smaller than 2.5 µm (PM2.5), and 
eczema was more closely associated with nitrogen dioxide (NO2) exposure [223], both of which 
are components of DE. 
 In a population-based research study of traffic-related pollution conducted by Lindgren et 
al. it was found that residential traffic was associated with increased incidence of asthma and 
COPD diagnosis, as well as, symptoms associated with asthma and chronic bronchitis, 
suggesting that traffic-related pollution may have both short and long-term effects on human 
health [224]. A study by Beatty and Shimshack analyzed the ability of filters to reduce school 
bus exhaust emissions within residential communities and their impact on the health of adults 
and children living nearby. Overall, it was found that incidence of asthma, bronchitis, and 
pneumonia were reduced in both children and adults with chronic respiratory symptoms and 
numbers of hospital cases for these complaints were reduced after retrofitting the school buses 
to reduce DE [225]. Salameh et al. concluded that outdoor air pollution caused by both heavy 
traffic or residing in proximity to a power plant may increase incidence of chronic bronchitis, 
though home heating methods and passive smoking were also found to be factors [226]. In a 
study by Shultz et al. the associations between the development of asthma, allergies, and 
wheezing were investigated in relation to either annual PM2.5 exposure, industry related 
exposure, or traffic exhaust exposure. The data demonstrated results similar to studies 
described above; incidence of allergic asthma was associated with increasing exposure to 
particulate matter, and proximity to roadways had the largest increase in asthma that suggests 
traffic-related PM2.5 may be a significant risk factor for developing asthma [227].  
Environmental Exposure to DE and Susceptibility to Infection 
 Evidence from epidemiological observations also suggest that susceptibility to infections 
in the respiratory tract may be increased following environmental exposures to DE. Increases in 
some components of DE, including NO2 and PM10, and ozone (O3), an allotrope of oxygen that 
is created as a result of chemical interactions between combustion products (NO2 and volatile 
organic compounds (VOCs)) and sunlight, were shown to be associated with increased hospital 
admissions for pneumonia and influenza  [228].  A population-based study by McGowan et al 
suggested that increases in PM10 in the environment resulted in increased hospital admissions 
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for pulmonary infections including pneumonia, influenza and other acute respiratory infections. 
Furthermore, they explained that while admissions across age groups were similar, children 
were at a slightly higher risk for hospitalization [229]. Neupane et al. revealed that older adults 
exposed to higher levels of air-pollution including components of DE, including PM2.5 and NO2 
were at an increased risk for hospitalization for pneumonia [230].   
Experimental Exposures to DE in Human Volunteers 
 
Pulmonary Effects 
 In an effort to determine the risk posed to humans by DE exposure by eliminating 
confounders that are present in epidemiological and occupational assessments, several 
researchers have conducted experiments in human volunteers in controlled environments. 
Many of these studies examine a particular component of DE in order to determine which 
properties have a causal relationship with the health effects that have been observed in 
epidemiological studies. A study by Rudell et al. used particle trap filters to reduce DPM when 
exposing healthy human subjects to DE. Additionally, they sought to determine what effects DE 
had on cells recovered from bronchoalveolar lavage. Findings from this investigation resulted in 
the conclusion that DE exposure caused inflammatory cell influx into the airways and that 
trapping particulate did not significantly reduce these effects, suggesting that gaseous 
components might be partially responsible for these effects [231]. However, in a separate study, 
Rudell et al. examined additional methods of filtration in the cabins of diesel automobiles and 
evaluated their effects on vehicle occupants following exposure. Particle-only filtration did not 
reduce symptoms experienced, though particle filters in combination with active charcoal 
filtration did significantly reduce reported symptoms. This is attributed to the reduction in the 
hydrocarbon components of the gaseous fraction of DE. It should be noted that reduction of 
symptoms with filtration was based on self-reporting by subjects. No measured parameters of 
lung function or nasal lavage were altered between exposure filtration variations or controls 
[232]. It is also important to note, with regard to self-reporting, that a separate study conducted 
by Carlsten et al. demonstrated that perceived exposure to DE by study subjects in a blinded 
exposure study was more important in prediction of symptom reporting than DE exposure itself, 
and therefore, symptom-independent studies may be more useful in determining effects of DE 
[233]. Conversely to findings relating to DPM by Rudell et al., are the conclusions of a study by 
Nightingale et al. that investigated whether or not DPM caused inflammatory response in the 
airways of healthy volunteers. While they did not observe any changes in lung function or 
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cardiovascular parameters measured in this study, authors did observe airway inflammation at 
high concentrations of DPM [234], a conclusion not based on self-reported symptoms. 
 In order to more fully elucidate the impact of DE on the airways, Salvi et al. exposed 
healthy volunteers to dilute DE during intermittent exercise. The authors of this study reported 
that acute short-term exposure to DE caused systemic and pulmonary inflammation 
demonstrated by elevated neutrophils recovered in peripheral blood and lavage fluid, 
respectively [235]. Behndig et al. exposed healthy volunteers to DE to determine if pulmonary 
cells would elicit an antioxidant response to low doses of DE, similarly to results observed in in 
vitro studies. Though they did observe inflammation and antioxidant responses in response to 
DE exposure, it was in the conducting bronchial airway and not in the alveolar region suggesting 
that pulmonary response to DE was compartmentalized [236]. In an investigation of DE 
exposure on airway inflammation, Sehlstedt et al. aimed to clarify whether engine load or 
transient speed altered effects observed with DE generated by idling engines. Authors 
explained that DE produced by urban engine cycling increased the expression of adhesion 
molecules in bronchial vascular endothelial cells and resulted in bronchoalveolar eosinophilia, a 
finding not previously reported in relation to responses to DE generated from idling engines. 
These results support the idea of variable health outcomes in response to DE produced under 
differing conditions [237].  
Furthermore, the composition of DE is complicated by the interaction of its components 
with properties of the environment such as water vapor and sunlight. As previously mentioned, 
when some combustion components chemically react with the environment, additional 
hazardous inhalants such as O3 may be formed. Therefore, some experiments have been 
performed to determine whether these reactions may contribute to health effects observed for 
environmental exposures to DE. A non-invasive technique for the detection of airway 
inflammation following controlled exposures that measures fraction of exhaled nitric oxide 
(FENO) as the injury parameter has been used as a marker of adverse effects in the lung. In a 
study conducted by Barath et al. DE was shown to enhance FENO and that this effect was 
localized to the central airways; however, this technique was not effective for detecting the 
inflammation caused by O3, possibly due to the varying mechanisms by which DE or O3 induce 
inflammation [238]. An investigation carried out by Bosson et al. showed that O3 exposure 
subsequent to DE had the ability to enhance DE-related airway inflammation, highlighting the 
complexity of additional influences when considering health effects caused by exposure to 
environmental pollutants [239].  A study by Madden et al. investigated the combinatorial effects 
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of DE and O3 on lung function, both on healthy volunteers, as well as subjects with the 
gluatathione S-transferase-Mu1 (GSTM1) genotype. GST enzymes have been shown to 
mediate damage caused by air pollution health effects by detoxifying products of oxidative 
stress and individuals with this phenotype have been shown to be more susceptible to 
inflammatory diseases [240]. Madden et al. confirmed the effect of environmental mixtures 
demonstrated by Bosson et al. In their study, O3 caused a decrement in lung function, and 
although DE did not mirror this effect on its own, in combination with O3 it led to greater 
decreased lung function. However, this effect was not observed for GSTM1 individuals 
suggesting that oxidative stress may not be involved in decreased lung function [241].  
 Based on epidemiological findings suggesting that DE may exacerbate pre-existing 
conditions of allergies and asthma [242], several studies have conducted controlled human DE 
exposure in asthmatics and allergic rhinitics. Larsson et al. exposed allergic rhinitics to DE, at 
doses known to cause inflammation in healthy individuals, in an effort to determine whether DE 
exposure enhanced inflammation in the lower airways of individuals with pre-existing allergies. 
No neutrophilic inflammation in the lower airways of participants was detected. However, 
evidence of possible mast cell degranulation was found [243]. In a study carried out by Stenfors 
et al., asthmatics were compared to healthy subjects in an exposure study investigating whether 
DE PM10 may exacerbate existing allergic responses in asthmatics. Similar to the study by 
Larsson et al., DE exposure did not enhance neutrophilic inflammation in asthmatics. This is in 
contrast to the study that previously demonstrated healthy subjects did experience airway 
inflammation [244]. Another study by Behndig et al. also examined DE exposure on asthmatics 
comparing results to healthy controls. While they found that DE induced neutrophilic 
inflammation in healthy subjects, this was not the case for asthmatics leading to the conclusion 
that neutrophilic inflammation and classical cellular indicators of allergic airway response are not 
necessarily accurate measure of allergic airway response to traffic-related pollutants [245]. 
Findings from these experiments demonstrate the complicated nature of exposure-related 
health effects, particularly in the context of complex particle mixtures and the need for further 
studies directly examining mechanisms for pathological development.  
In order to more fully understand the response of asthmatics to environmental pollution 
in an environmental setting, McCreanor et al. exposed asthmatics to real-time traffic exhaust. 
The authors reported that those participants exposed to higher amounts of ultrafine particles 
and EC from diesel-powered traffic developed increased sputum myeloperoxidase, an indicator 
of neutrophilic inflammation, and greater reductions in lung function. These results were 
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exacerbated for individuals with more severe pre-existing asthma. The data from this real-time 
exposure study are more consistent with epidemiological data suggesting that laboratory-
controlled measures may not accurately represent physiological exposures in the environment 
[246]. Additionally, this study highlights the importance of designing studies aimed at examining 
complex exposures modelling realistic exposure scenarios to the greatest degree possible. This 
was corroborated in a study by Hosseini et al. demonstrating that effects of DE exposure may 
be overlooked by administering exposures in a sterile, uncomplicated environment, such as a 
laboratory. Hosseini et al. sought to elucidate whether DE may be acting as an adjuvant in 
combination with allergen-induced asthma and airway inflammation. These authors found minor 
or nonexistent changes in eosinophilia and mast cells of the airways; however, other sensitive 
measures of allergic response including CD4, IL-4, neutrophil elastase, and CD138, were 
increased. Moreover, these parameters of allergic response were not elevated for either DE or 
allergen exposure individually, but were synergistic in combination. This study further highlights 
the important interactions of the environment with pollutants, which may affect health effects 
[247]. 
Susceptibility to Infection 
 In addition to the studies of pulmonary effects following controlled exposures in human 
subjects discussed above, studies investigating epidemiological findings that support the 
hypothesis that DE may lead to enhanced susceptibility to infection have also been conducted. 
Due to ethical ramifications of directly infecting individuals with pathogens, there are a limited 
number of these controlled exposure investigations. Additionally, many of these studies use a 
two-step approach with the toxicological exposure performed in vivo, while the investigations on 
susceptibility are conducted ex vivo using cellular samples collected following the exposure, 
which should be taken into consideration when interpreting the data. In a study conducted by 
Frampton et al., it was shown that macrophages obtained from humans exposed to the DE-
component NO2 were less effective in inactivating influenza virus ex vivo [248]. Another recent 
study indicated that DPM reduced natural killer (NK) cell recruitment and activation during 
influenza infection in allergic rhinitics following exposure to particles. Further, it was 
demonstrated that during the context of viral infection in allergic rhinitics, allergic inflammation 
may be worsened due to an inability or decreased ability for NK cells to target and clear 
eosinophils [249]. Helleday et al. examined the mucociliary function of bronchial cells in human 
volunteers following short-term exposures to NO2 as a measure of effects on mechanical 
barriers to infection. The authors concluded that pollutant exposure caused significant reduction 
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in the mucociliary activity of these cells, but that the effect was reversible [250]. Though NO2 is a 
known component of DE, studies of this nature have not examined DE itself as a whole, and 
therefore, results relating to whole DE may vary from these depending on the composition of DE 
with relation to NO2. 
Effects of Respiratory Exposure to Diesel Exhaust in in vivo Animal Models 
 
Pulmonary Effects 
 While controlled studies in humans are valuable in determining physiologically relevant 
health effects that may be caused by exposure to DE, ethical restraints and limited participation 
significantly restricts mechanistic determinations of disease etiology. Therefore, equally 
important are studies using laboratory animal models of exposure. As in epidemiological 
studies, studies evaluating systemic effects of DE exposure, particularly related to 
cardiovascular disease have been conducted [251-257]; however, the review below will focus 
on the animal studies related to respiratory effects specifically. 
    Chen et al. examined species-specific responses in rats and guinea pigs to DE and 
demonstrated that DE, while not necessarily cytotoxic to pulmonary macrophages studied ex 
vivo following exposure, did demonstrate reductions in phagocytosis despite sufficient 
adherence and motility. [258]. This study provided some of the first evidence that DE may 
reduce function in AMs. Another study by Chen et al. examined the species-specific effects of 
DE in a one-year, chronic, time-course study. Data indicated that biological responses were 
dose and duration dependent. [259]. A study by Pepelko et al. conducted in cats suggested that 
minor changes in some lung function measurements may occur after 28 days of exposure to 
DE, but data was not suggestive of significant lung damage for the dose and duration examined 
[260]. Abraham et al. examined lung function in sheep following exposure to DPM but did not 
find significant alterations in pulmonary resistance or airway reactivity, though exposures were 
acute [261]. Gross assessed the effect of chronic exposure to DE on the pulmonary function of 
rats. Similarly, no significant changes were observed following approximately 9 months of DE 
exposure [262]. A continued study by Gross examining function in rats after 2 years of 
continuous exposure to DE suggested some significant alterations in lung function including 
changes in vital capacity and forced expiratory volume (FEV) [263]. Patterns of lung function 
reductions consistent with restrictive changes were found by Moorman et al. in their study, 
though amounts of DE were high compared to other studies, and they used a cat model [264]. 
In a study of chronic DE toxicity conducted in three species, Heinrich et al. determined that 
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chronic exposure to unfiltered DE caused significant changes in lung function and alveolar 
clearance primarily in rats as compared with mice and hamsters. Additionally, tumors developed 
in mice in response to both unfiltered and filtered DE; whereas, only unfiltered DE resulted in 
lung tumor incidence in rats. This study further outlines the importance of animal model choice 
in demonstrating relevant health effects of exposure to DE [265]. Moreover, in a study 
comparing exposure of rats and mice to dilute DE, Henderson et al. established that despite 
mice having a higher soot burden in the lung, rats exhibited more fibrogenesis. The authors 
determined that this was related to the propensity of rat alveolar cells to release greater 
amounts of inflammatory mediators including leukotriene B4 and PGF2 alpha than mouse cells 
[266]. Finally, in a study by Ulfvarson et al. examining effect of DPM trapping on changes in 
respiratory effects on rabbits it was established that the gaseous components of DE may result 
in reduced compliance of the lung suggestive of fibrotic changes [267]. It is important to note 
that, in addition to species-specific effects, the studies discussed above employ different doses 
and durations of exposure, which may also account for differences observed in the study 
outcomes. Therefore, model should be chosen based upon which health outcome is being 
examined. While rats demonstrate similar inflammatory response and histological changes 
observed in humans, cats may reflect more consistent functional changes, and guinea pigs 
allergic developments, which are more similar to epidemiological findings.  
  Beyond characterizing overall pulmonary toxicity caused by DE in animal models, 
investigations have aimed to determine more specific mechanisms for outcomes observed in 
humans. Inflammation, specifically, has been widely investigated as the initiating event leading 
to different pulmonary diseases caused by inhalation of DE through a variety of pathways. Inoue 
et al. examined the role of toll-like receptor (TLR-4) in inflammation caused by DPM. By 
comparing responses to IT administration of DPM, at a dose of 12 mg/kg, in TLR-4 mutant mice 
to WT, the authors discovered alterations in the expression of inflammatory mediators of 
chemotaxis, suggesting that DPM signals in part through the TLR-4 pathway in order to induce 
inflammation [268]. Fujimaki et al. showed that IL-6 was essential for the induction of airway 
inflammation mediated by cellular influx and the expression of chemotactic factors. The authors 
determined this by comparing DE inhalation exposure; either 1 or 3 mg/m3 for 12 hours per day 
for 4 weeks, in WT and IL-6 deficient mouse strains [269]. Ahn et al. investigated the role of 
COX-2 in inflammation induced by DPM. In this study, the authors exposed mice 
oropharyngeally to 1, 10, or 25 mg/kg of DPM per day for five consecutive days and showed 
that DPM exposure caused inflammation that is mediated by COX-2 by ameliorating these 
effects with an anti-inflammatory treatment with glucocorticoid, dexamethasone [270].  
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Oxidative stress, as discussed at length with regard to inflammation caused by silica 
exposure, has been indicated as a potential initiator of lung injury caused by DE as well.  Sagai 
et al. examined the possibility that DPM may produce biologically active ROS in the lung 
following IT exposure of mice to varying doses of DPM between 0.4 mg and 1.0 mg. Data from 
their experiments showed that DPM-exposed mice had increased mortality due to oxidant 
radical-mediated endothelial damage resulting in pulmonary edema [271]. Lim et al.  
demonstrated that either 100 or 200 μg of DPM, administered in repeated IT, 1 time per week 
for 10 weeks, elicits airway hyperresponsiveness mediated by inflammation caused by 
superoxide (SO) and NO. They showed that DPM increased the activity of NO synthases (NOS) 
and decreased superoxide dismutase (SOD) activity. Further, treatment with inhibitors of NOS 
reduced inflammatory effects of DPM treatment [272]. Ito et al. found that in rats exposed to 
2mg/0.5ml/kg of DPM intratracheally, alveolar cells infiltrating the lung were nearly doubled 
compared to controls, that peroxynitrite formation was increased, and that levels of inducible 
NOS (iNOS) mRNA were enhanced, suggesting that DPM caused oxidative-induced 
inflammation in the lung [273]. Han et al. used noninvasive spectroscopy in conjunction with a 
membrane-impermeable nitroxyl probe to detect the generation of hydroxyl (OH) radicals 
following exposure to DPM in mice. When scavengers of radicals were applied, the rate of 
decay of the probe was decreased. The study provides further evidence that DPM causes 
increased production of ROS that may contribute to lung injury following exposure [274]. Finally, 
Nemmar et al. aimed to determine if Emodin, an antioxidant, may reduce DPM-induced 
inflammation and oxidative stress, which contribute to decrements in lung function following DE 
exposure. In their findings, it was reported that treatment with Emodin reduced airway 
resistance, neutrophilic inflammation, and production of inflammatory cytokines. The authors 
concluded that anti-oxidant treatments like Emodin may be useful for protection against 
pollutant-derived lung toxicity [275]. 
An important factor in toxicity of DE is the composition of the material. DE composition 
can vary based on a number of factors including fuel source and engine type as discussed 
previously. Similar to studies with human volunteers, investigators have sought to determine 
which component(s) of DE may be contributing to oxidative stress. Madden et al. explored the 
possibility that, similar to effects observed in humans, O3 may cause exacerbation of DPM-
related toxicity. Treatment of DPM particles with O3 prior to administration in rats resulted in 
enhanced inflammatory and injurious responses in the lung. These effects were not observed 
with the control particle, CB (a core component of DPM), suggesting that this effect was related 
to interactions of O3 with components adsorbed to DPM particles [276]. Investigations by Zhao 
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et al. examined the effect of DPM or the organic extract of DPM (DPME), which lack the carbon 
particulate core, on parameters of toxicity. In one study, they examined blockade of iNOS and 
cytochrome p450 (CYP)-1A1 in mediating oxidative stress caused by AMs. It was highlighted 
that NO played a role in inflammation caused by the organic fraction of DE and expression of 
CYP1A1 by both the particulate and organic fractions of DE, but that NO regulation does not 
affect inflammation induced by DPM [277]. In their subsequent study, Zhao et al. examined 
oxidative stress in both WT and iNOS knockout mice. Their results demonstrated that 
inflammation initiated by DPM was mediated by AM production of ROS and NO. Lack of NO 
production had little effect on DPM induced oxidative stress. NO was also important for initial 
induction of neutrophilic inflammation, pulmonary capillary damage, and IL-12 production. 
Further, since DPM and carbon black (CB) induced inflammatory responses and injury, but the 
DPME did not, these results were attributed to the particulate core and not the substances 
adsorbed to it [278].  
As epidemiology studies and in vivo studies indicate, obstructive lung diseases including 
COPD and bronchitis are commonly associated with DE exposure. In vivo studies have been 
conducted to determine the potential etiological mechanisms. A study by Fedan et al. indicated 
that chronic inhalation exposure of rats to 2 mg/m3 of DE 7 hours per day, 5 days per week, for 
two consecutive years, resulted in alterations of airway smooth muscle functions that may 
contribute to airway obstruction [279]. A chronic exposure study, conducted by Ishihara et al., 
over a 24-month time-course evaluating rats exposed to DE, determined that moderate to high 
levels of DE exposure (corresponding to between 1-3 mg/m3 particles at 18 months) resulted in 
chronic inflammation, increased mucus and phospholipid production consistent with the 
development of COPD. Moreover, these responses occurred in a time and concentration 
dependent manner; though, some parameters plateau just after a year of exposure [280]. To 
further understand which components of DE may be associated with obstructive lung disease, 
Laks et al. treated DPM by different extraction processes and assessed whether exposure to 
the extractions altered airway and lung mechanics following intransal exposure to 15 μg of DPM 
in mice. Treatment with hexane was the most effective in removing measured polycyclic 
aromatic hydrocarbons (PAHs), common components adsorbed to the carbon core of diesel 
particles. Data suggested that PAHs may be important for pulmonary health effects observed 
based on the findings that hexane treatment reduced alterations in lung parenchyma and lung 
mechanics observed with untreated DPM [281]. Experiments examining airway inflammation in 
response to repeated exposure DPM, the particulate fraction of DE, intranasally instilled in mice 
were conducted by Yoshizaki et al. who demonstrated that exposure to 30 μg DPM 5 days per 
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week for 60 days resulted in increased mucus production and nasal epithelium thickness, 
indicating that DPM treatment resulted in respiratory tract inflammation [282]. A study by 
Shaheen et al. aimed to understand the role of ceramide in airway inflammation following 
exposures to DE at concentrations below those required to initiate biomarkers of oxidative 
stress and inflammation. Cell stressors can induce ceramide regulated NF-κB initiation and 
apoptosis. Inhibiting ceramide following exposure to DE, reduced not only ceramide but also 
increased expression of enzymes involved in sequestration of ceramide-related precursors. 
Overall, data suggested that even in the absence of measurable inflammation as a result of DE 
exposure, biomarkers related to inflammatory initiation are up-regulated, demonstrating more 
sensitive measures for low-level exposure health effects [283]. Overall, in vivo studies have 
demonstrated that subacute and chronic exposures to DE resulted in enhanced airway 
inflammation, increases in mucus production, and airway changes consistent with obstructive 
pathologies such as COPD; moreover, this may be related to the presence of PAHs in DE since 
some of these effects were attenuated when PAHs were reduced. 
The development of AHR, asthma, and allergic asthma are the most well-investigated 
respiratory diseases relating to DE exposure. DE has not only been shown to result in the 
presence of asthma de novo, acting as an allergic adjuvant, but also to exacerbate the clinical 
presentation of pre-existing disease following exposure in humans [213, 214, 227, 242, 246]. 
Therefore, extensive investigations have been made into discovering the biological mechanisms 
that promote this pathology. Several studies have examined the role of oxidants in development 
of asthma following DPM exposure. Sagai et al. examined the role of oxidant inflammation on 
airway reactivity. In one study, it was shown that DPM reduced scavenging of oxygen species in 
the airways resulting in increased NO2 and enhanced AHR [284]. In a subsequent study, Sagai 
et al. determined that DPM caused increased inflammation, proliferation of mucus producing 
cells, secretion of mucus, respiratory resistance and constriction of airways. Additionally, 
eosinophilic infiltration was exacerbated. These parameters were abrogated by pre-treating with 
polyethyleneglycol-conjugated SOD (PEG-SOD) to quench oxidants, suggesting that oxidants 
derived from DPM exposure resulted in symptoms consistent with asthma [285]. A group led by 
Aguilera-Aguirre showed that mitochondrial dysfunction resulting from oxidative stress was 
responsible for exacerbating allergic inflammatory response. This finding suggests that DE 
exposure leads to production of oxidants that stimulate further cellular ROS and induce 
dysfunction of mitochondria in airway epithelium and in turn may be responsible for induction of 
airway inflammation [286]. 
37 
 
Though increased oxidant burden may result in increased parameters of inflammation 
resulting in asthmatic disease, it may also stimulate the release of proteins from immune cells, 
which may contribute to mechanisms of pathology. Ohta et al. conducted a study to further 
elucidate the role of cytokines in response to DPM exposure in the development of 
bronchoconstriction and airway hyperresponsiveness. It was demonstrated that granulocyte 
macrophage colony stimulating factor (GM-CSF) was intrinsic to the development of airway 
hyperresponsiveness to DPM. Blockade of GM-CSF resulted in reduction of 
bronchoconstriction, and hyperplasia of clara cells, both hallmarks of asthma. While IL-4 also 
contributed to these effects, it was to a lesser extent [287]. A related study led by Yamashita 
established that PDGF contributes to the remodeling of the airway following DPM exposure. 
Although PDGF antibody treatment did not alter influx of inflammatory cells into the airways, it 
reduced airway wall thickening elicited by DPM. These results suggest that PDGF, a regulator 
of fibroblast growth and proliferation, played a distinct role in collagen modulation and thickening 
of the asthmatic airways following exposure to particle [288]. More recently, IL-17 has been 
implicated in the pathogenesis of inflammatory diseases. Brandt et al. sought to establish 
whether DPM exposure exacerbates allergic asthma via an IL-17 mediated response. Results 
from this study suggest that Th17 cells contribute to DPM-mediated allergic asthma. Antibody 
neutralization of IL-17 resulted in abrogation of the enhanced AHR caused by DPM in this 
model. Furthermore, the authors examined children with pre-existing allergic asthma in order to 
determine their serum levels of circulating IL-17 based on estimated DPM exposure. They 
report that children with high estimated exposures have levels nearly 6 times higher than 
children exposed to low levels of DPM and that they reported more frequent and severe 
symptoms [289]. 
Others have examined the role of DPM exposure in conjunction with allergen to elicit 
airway responsiveness. A study by Suzuki et al. indicated that DPM and pyrene, a PAH 
associated with DPM, act as adjuvants and stimulate greater production of immunoglobulins 
when given in co-exposure with house dust mite (HDM) allergens [290]. Increased antibodies to 
allergens may ultimately result in incidence of asthmatic symptoms. Investigation by Takano et 
al. corroborated these results with a different allergen. The authors of this study reported that 
DPM in combination with ovalbumin (OVA) resulted in increases of parameters of allergic 
asthma including increased eosinophilic inflammation, goblet cells, and expression of Th2 
cytokines IL-4 and IL-5. Further, they demonstrated enhanced levels of immunoglobulin (Ig) G 
and IgE. Results indicated exacerbation of allergic asthma when compared with DPM or 
allergen alone [291]. Miyabara et al. established that DE caused enhanced eosinophilic and 
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neutrophilic infiltration, expansion of goblet cells increases in IL-5, IgG, and AHR in combination 
with OVA sensitization. An increase in IgE was not observed, but authors speculate this may 
have been due to the difference in route of administration. Inhalation was used in this study, 
whereas, in previous studies instillation by nasal route was used. It is possible that sensitization 
by direct contact with the nasal epithelium might result in increases observed in IgE observed 
previously [292]. Results have been reviewed for two types of allergen models, HDM and OVA, 
but another group sought to determine whether DPM would enhance allergic response to pollen 
as well. Steerenberg et al. determined that, as demonstrated in previous allergen studies, DPM 
enhance allergic response to pollen. This study further demonstrated the adjuvant effect of DPM 
on allergy and asthma [293]. An investigation by Hao et al. sought to determine what acute 
effects DPM may have on airways in the absence of their adjuvant allergic influences. The 
authors established that even in the absence of allergen, DPM exposure increased airway 
reactivity suggesting that not only does DPM elicit/exacerbate allergic asthma but that it may 
directly induce acute asthmatic symptoms associated with AHR [294].  
Many studies have been conducted to try to determine what component of DE and/or 
DPM are correlated to pathogenesis. The composition of DE/DPM is widely variable as 
previously discussed and this tenet appears to govern the course of pathologies associated with 
exposure. Variable responses to DE/DPM reported epidemiologically and based on research 
investigations appear to be directly related to the characteristics of the particles used to conduct 
studies, and those conducted in vivo are briefly summarized below. An investigation by Al-
Humadi et al. demonstrated that the adjuvant effect of DPM on the development of allergic 
airway disease may not be dependent on particle composition. By comparing DPM combined 
with OVA sensitization with CB combined with OVA sensitization as a particle comparison 
control, the authors showed that both co-exposures elicited similar increases in OVA specific 
IgG and IgE, suggesting that both augmented allergic sensitization [295]. Inoue et al. aimed to 
determine which components of DPM might be responsible for observed toxicities. This group 
examined extracts of DPM organic components and washed DPM carbon nuclei. It was 
explained by the authors that in response to co-exposure to OVA antigen organic components 
did not elicit responses that were significantly different than the OVA control group; whereas, 
washed DPM nuclei had the greatest impact on induction of airway hyperreactivity (AHR). 
These results point to the carbon nuclei as being important in airway inflammation in the context 
of allergic asthma [296]. As previously mentioned in a study by Laks et al. it was found that the 
PAHs associated with DPM contributed to pulmonary toxicity [281]. A third study by Park et al. 
investigating the components of DE and their importance in the context of inflammation found 
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that how DPM are recognized by phagocytic cells, determines the inflammatory effect that they 
will induce. They explain that DPM, which are engulfed by cells result in a Th2-type response; 
whereas, DPM, which are not taken up by cells induce a Th1-type response. Furthermore, they 
suggest that the physicochemical properties like size and charge determine how well they are 
able to be taken up and how well they elicit stress responses like oxidation that has been 
associated with both Th1 and Th2-types of inflammation caused by DPM [297]. A study by 
Tanaka et al. determined that the gaseous components of DE may be most important for the 
Th2 polarizing skew of DE, as exposure to DPM combined with OVA in the absence of gaseous 
components failed to enhance eosinophilic inflammation or Th2 cytokines to the level of DE 
without particles [298].  
Though IgE is well-established in the importance of allergic development, IL-4 upstream 
of IgE is also critical as is the polarization of the immune system to a Th2-mediated response to 
stimulus that acts as a signal to initiate immunoglobulin class switching [299].  Experiments 
conducted by Jang et al. aimed to elucidate whether O3 in combination with DPM might lead to 
increased presence of asthmatic symptoms. These studies established that, similar to studies 
conducted in human volunteers, O3 may exacerbate the induction of asthma observed following 
exposure to DPM and allergen. Increases in pathological response were additive and related to 
enhanced levels of IL-4 and AHR following co-exposure to DPM and O3 in an allergen sensitized 
mouse [300]. More recent experiments relating to T cell differentiation following exposure to 
DPM were performed by Liu et al. in a study of DPM effects on DNA methylation. These authors 
demonstrated that combined exposure to DPM and fungal allergen resulted in increased 
methylation of IFN-γ and decreased methylation of IL-4. Additionally, IgE production was 
enhanced following exposure to both DPM and fungal allergen. These results suggest that DPM 
exposure altered differentiation/function of immune cells in the presence of allergen by altering 
DNA state, potentially leading to a Th2 helper polarization and allergic asthma [301]. Finally, in 
a recent study of DPM, De Grove et al. investigated the role of newly discovered innate 
lymphoid type 2 cells (ILC2) in allergic asthma elicited by DPM. They compared responses of 
WT mice with either ILC2 deficient, lymphocyte deficient, or Gata 3 insufficient mice following 
exposure to DPM in combination with HDM allergen. The co-exposure resulted in AHR and 
inflammation in WT mice and this was reduced in either Gata 3 insufficient and marginally so in 
ILC2 deficient animals. In lymphocyte deficient mice, it was abolished entirely suggesting that 
intact adaptive responses are required for an adjuvant effect by DPM to be provoked [302]. 
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Extensive research has also been conducted in an effort to understand whether and by 
what mechanism DE initiates tumorigenesis in the lung. These studies date back to the 1950s to 
a study by Kotin et al. that determined that PAH components of exhaust resulted in tumors 
when painted onto the skin of mice [303, 304]. The validity of many of the respiratory toxicity 
studies in animals have created controversy due to evidence that species such as rats may 
reach a burden of particle considered to be “overload” in which the mechanisms of clearance 
are overwhelmed resulting in neoplasms [75], but that this bears little on the toxic properties of 
the particles themselves due to composition. Further these studies were often conducted at 
doses unrealistically higher than correlated to physiologically relevant levels of exposure in 
humans, and due to more superior clearance mechanisms it was suggested to be unlikely for 
humans to reach overload, and therefore carcinogenesis was not considered to be a valid 
detriment posed by DE exposure [305, 306].  
In their very thorough review of DE cancer effects, Hesterberg et al. weighed the 
advantages and disadvantages of traditional (old technology emission prior to 2000) DE 
exposure research to address that point. Study design, dose, route of exposure, models, 
methods, and composition of the particles are all among the examined variables relating to 
research findings on DE tumorigenesis. Ultimately, the authors do conclude that the only 
consistent findings for carcinogenicity in laboratory animals are in rats and do not provide 
sufficient or convincing evidence that these results translate to humans, as it appears to be a 
species-specific phenomenon. However, they do allow that new technology (since 2000) DE  
(NTDE) exposure risks be assessed separately as the chemical composition of new emissions 
renders it completely different chemically from traditional DE [306], whereby the particulate 
component is significantly lower, but other gaseous components may not be.  
 Additional investigations into both traditional and NTDE exposure and the potential for 
carcinogenesis have been conducted. Moreover, research has also been conducted in animals 
evaluating levels of DE exposure or exposure to specific components of DE, which are far lower 
than what would be considered “overload” but that still show evidence for carcinogenesis. 
Further, as of 2012, DE was reclassified by IARC as a Group 1 carcinogen, carcinogenic to 
humans, ‘having sufficient evidence’ in humans for the carcinogenicity of diesel engine exhaust. 
Additionally, in the 2014 Monograph it is also stated that there is ‘sufficient evidence in 
experimental animals’ for the carcinogenicity of whole diesel engine exhaust and diesel engine 
particulate matter, but ‘inadequate evidence’ in the gas-phase of diesel engine exhaust [215]. 
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Therefore, only a brief summary of studies employing whole DE or DPM will be summarized 
here.  
Heinrich et al. found that exposure of rats to diesel soot increased incidence of lung 
tumors in rats, but no significance for lung tumors was indicated in mice [307]. In a study 
conducted in rats by Mauderly et al. it was determined that DE and CB particles produced 
similar carcinogenic effects. Their findings suggest that small, carbonaceous particles, in the 
respirable range are responsible for lung cancer development at high concentrations, and that 
constituents of DE otherwise determined to be mutagenic play a lesser role in tumor 
developments in rats. Though they report the biological mechanism to be unknown as of yet, it 
does correlate to impaired particle clearance and progressive particle accumulation resulting in 
increased particle load [308]. An investigation by Nikula et al. examining rats also showed 
increased neoplasms, both malignant and benign, following exposure to DE or CB. Additionally, 
they observed increased incidence in females when compared with males, and in males the 
incidences were slightly higher for DE than for CB, though this may have been due to an 
enhanced mortality that occurred in male rats exposed to CB. Overall, the particulate 
component of DE was determined to be the more critical portion for carcinogenic effects [309]. A 
study by Iwai et al. showed more mechanistic results explaining that tumor formation in the 
lungs of rats following a long latent period subsequent to exposure was due to oxidative stress 
on DNA induced in early phases of exposure to DE [310]. Stinn et al. also reported that DE 
particle deposition and accumulation led to tumorigenesis in rats exposed to DE; however, they 
report that this happened in the absence of any significantly noted DNA adduct formation or cell 
proliferation, but rather correlated to a dose related increase in sustained inflammation [311]. 
Ultimately, in animals, evidence of mutagenicity is limited and mostly observed in rats. However, 
evidence suggests that DE results in impaired clearance mechanisms, which requires further 
investigation, particularly at low levels of exposure. 
Immunological Effects and Susceptibility to Infection  
Human-controlled experiments in addition to epidemiological evidence suggest that 
exposure to DE results in increased susceptibility to infection, particularly in the respiratory tract. 
Therefore, in vivo animal studies have been conducted to examine mechanisms associated with 
DE effects on the immune system and host defense. In one study, Harrod et al. observed 
susceptibility to respiratory syncytial virus (RSV), a common respiratory pathogen in children. 
RSV gene expression in the lungs was increased following prior DE exposure as well as 
inflammatory and epithelial cell modulations consistent with reduced resistance to RSV, 
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specifically a shift from normal cuboidal clara cell appearance to the presence of thickened 
columnar appearing mucus cells. These findings suggest a thickening of the airway. Additionally, 
reductions in clara cell-secreted, immunoregulatory proteins including clara cell secretory protein 
(CCSP) and surfactant protein A (SP-A) were shown to be modulated following co-exposure to 
DE and RSV. These findings indicated increased susceptibility to RSV following DE in a typically-
resistant mouse model [312]. Interestingly, in another study by Harrod et al. it is determined that 
DE inhalation resulted in reduced clearance of a bacterial infection, Pseudomonas aeruginosa 
(PA), in a concentration-dependent manner. Reductions in clearance were again determined to 
be related to inflammation and alterations in airway epithelial cell morphology, ciliated cells in the 
airway were decreased. Further, CCSP was reduced in clara cells of the distal airway following 
infection. Therefore, since the protein thyroid transcription factor (TTF)-1 has been shown to be 
an important transcription factor for lung host defense proteins including SPs and CCSP, the 
effect on TTF-1 was investigated. TTF-1 expression during infection was reduced following DE 
exposure. Altogether, these results point to DE exposure resulting in reduced respiratory 
resistance to PA infection [313]. Ciencewicki et al. examined the effect of DE on subsequent 
influenza infections, and showed that DE increased susceptibility to infection as determined by 
increased presence of hemagglutinin mRNA, and increased staining of viral proteins in the lung. 
Increased expression of IL-6 and decreased SPs occurred consistent with aforementioned 
studies. The findings indicate that DE increases susceptibility to viral infection by modulating host 
defense proteins [314]. Gowdy et al. demonstrated that exposure to occupational levels of DE 
caused increased lung injury, inflammation, and decreases in innate immune molecules including 
CCSP, and SPs consistent with Harrod et al. The authors determine that these finding point to 
possible decreases in respiratory resistance to infections [315].  
Other investigators have expanded their studies to examine both branches of the immune 
system, examining both innate and adaptive alterations. Yin et al. studied the effect of DPM on 
the functions of AMs and lymphocytes from the lymph nodes of rats. In their first study, the authors 
exposed rats to DPM acutely and examined the clearance of bacteria from the lung following 
Listeria monocytogenes (LM) infection. It was determined that DPM inhibited phagocytosis of 
bacteria and reduced expression of cytokines from AMs. The authors also conclude that cell-
mediated immunity may be inhibited due to suppressed AMs effector functions [316]. In a follow-
up study by Yin et al., the authors studied whether DPM had effects on T-cell development based 
on findings that AM function was altered by DPM in the presence of infection. It was found that 
DPM exposure resulted in decreased expression of IFN-γ, and that co-exposure to DPM and 
bacteria resulted in increased bacterial counts in the lung on day 3 post-infection. However, 
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lymphocytes from these animals increased in number and were able to clear infection, despite 
alterations in innate immunity in an acute exposure to DPM [317]. Furthermore, Yin et al examined 
whether DPM exposure exerts a sustained effect on lymphocytes resulting in susceptibility to LM 
infection. Lymphocytes from infected animals previously exposed to DPM displayed decreased 
production of cytokines compared with animals exposed to bacteria only suggesting that DPM 
altered cytokine expression by lymphocytes. Further, it was found that DPM modified expression 
of cytokines by AMs that initiate lymphocyte development, including IL-1β and TNF-α, as well as 
cytokines that suppress macrophage function including IL-10. Overall, it was concluded that DPM 
altered susceptibility to lung infection by inhibiting AM function and suppressing development of 
Th1 immune-mediated responses in the lung [318]. Similarly, Hiramatsu et al. demonstrated that 
long-term exposure to DE before infection with Mycobacterium tuberculosis resulted in increased 
lung burden due to decreases in IL-1β, IL-12, IFN-γ expression, and iNOS mRNA [319]. An 
investigation by Saito et al. showed that DE exposure resulted in modulation of cytokine mRNA 
expression and their corresponding secretion. It was found that levels of important inflammatory 
cytokines such as TNF-α, IL-6, and IL-1β were down-regulated by exposure to DE; whereas, anti-
inflammatory cytokines like IL-10 were increased by DE exposure. Further IL-4 was increased by 
exposure to DE. These results indicate that DE may alter immunological defenses while 
promoting allergic responses contributing to asthma [320]. Hahon et al. examined the role of DE 
exposure on susceptibility to infection with influenza. Higher levels of viral growth compared to 
control occurred animals exposed to DE. Additionally, depressed levels of interferon were 
uncovered in DE exposed groups. Further, antibodies to hemagglutinin were reduced in DE 
exposed animals compared with control. The authors concluded that results demonstrate reduced 
host defense to influenza following exposure to DE [321]. Overall, DE/DPM was shown to 
decrease host defenses. Both innate and adaptive immunity were hindered as decreases in 
phagocytosis, the expression of inflammatory cytokines by both AMs and lymphocytes, and 
decreases in antiviral antibodies were observed following DE/DPM exposure, although acute 
bacterial infections are cleared effectively despite these findings.  
Studies have not only examined infection concurrently or subsequent to particle exposure 
but also while infection was ongoing in an effort to determine if DE exposure may result in 
exacerbated or prolonged infections. Gowdy et al. conducted experiments aimed to determine if 
DE would result in increased severity of and ongoing influenza infection. The authors state that 
DE exposure during viral infection resulted in increased viral titer, but that this effect was not due 
to reduced IFN levels, and that IL-4 expression was increased at early time points after exposure. 
Blockade of oxidative stress with an antioxidant did not reduce enhanced viral titers but blocked 
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alterations in cytokine profiles and inflammation. It was concluded that exposure to DE during an 
active influenza infection polarizes the immune system to a Th2 response and that some of these 
effects may be reversed in the absence of oxidants [322]. A study by Larcombe et al. aimed at 
establishing whether DPM exposure could exacerbate existing infection reported that exposure 
to DPM following influenza infection resulted in increased viral titers and inflammation but not 
impairment of lung function. They concluded that although there was a presence of increased 
viral titers, one dose of DPM was not able to exacerbate respiratory disease [323]. 
Lastly, researchers have aimed to determine which components of DE may be responsible 
for the observed susceptibility to infection and alteration of immune functions described above. 
Yang et al investigated the potential of DPM to impair host defense to LM compared to CB, the 
core component of DE. Exposure to DPM decreased clearance of bacteria from the lungs and 
oxidants produced by phagocytes. These effects were not observed following exposure to CB 
and LM. Therefore, results suggest that suppression of host defenses by DPM are at least in part 
a result of components adsorbed to the core of DPM [324]. Castranova et al. compared different 
components of DE and CB in an effort to determine which properties of DE related to 
immunological alterations. Following their investigation, authors reported that exposure to DPM 
decreased bacterial clearance from the lung and that this was not observed with CB exposure. 
Further DPM reduced production of interferon and suppressed lung phagocyte production of 
oxidants, which was not observed with the control particle. The authors concluded that effects of 
DPM on host defense are likely related to organic components adsorbed to the carbon core of 
DPM [325]. Subsequently, Yin et al. explored whether DPM, specifically the organic extract or 
washed core particle resulted in ROS contributing to effects observed on AMs leading to 
increased intracellular infection. The authors reported that the organic extract of DPM but not the 
washed DPM particle elicited heme oxygenase (HO-1) expression and production of IL-10 and 
decreased expression of TNF-α and IL-12. Moreover, these effects were reversed by antioxidants 
[326].  
In Vitro Models of Diesel Exhaust Toxicity 
 
Pulmonary Effects 
 It is understood that DE causes an array of pathologies including; pulmonary-related 
disease, exacerbation of allergy, reduced immunity toward infectious insult, vascular-related 
diseases, and finally, under chronic exposure conditions, cancer [327]. What is less clearly 
understood, is which constituents of DE are responsible for provoking each specific response 
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and the mechanisms of action of DE; however, oxidative stress, as a result of ROS production, 
has been demonstrated to be one of the integral mechanisms involved in these pathological 
signaling events [328]. In vitro models of toxicity have been employed to further delineated this 
pathway. Furthermore, in order to maintain focus on pulmonary disease, only those studies that 
pertain to respiratory pathology are summarized below. 
 Both carbonaceous and organic components of DPM have been implicated in the 
induction of oxidative stress. Dong demonstrated in the author’s thesis work that DPM, washed 
DPM, and CB induced AM production of ROS; whereas, the organic extract from washed DPM 
failed to initiate a respiratory burst in AMs. Data from this study suggests that the carbonaceous 
component of DPM is at least partly responsible for activating AMs to initiate oxidative stress 
mechanisms leading to inflammation [327, 329]. Additionally, studies by Shukla et al. examined 
increased intracellular oxidative stress following DPM exposure in murine C10 alveolar cells. 
When comparing PM2.5 to both CB and glass beads, it was shown that both PM2.5 and CB 
stimulated intracellular oxidant production, while glass beads did not. These results also 
suggest that PM2.5 carbonaceous core components are capable of stimulating cells to produce 
ROS [330]. However, there is overwhelming evidence that the organic fraction of adsorbed 
chemicals, including PAHs on the surface of the carbon core, contributes to oxidant production, 
particularly through the intracellular pathway. Sagai et al. examined whether DPM could induce 
ROS production in an acellular system. The investigators were able to show that DPM released 
SO and hydroxyl radicals until washed with organic solvents. Also, this process could be 
inhibited by the addition of SOD or dimethylsulfoxide (DMSO). These results suggest that DPM 
toxicity is at least in part due to the presence of radicals and ROS, and that this process is 
driven by organic constituents adsorbed to particles [271]. Greenwell et al. compared the 
oxidative potential of coarse and fine fractions of DPM to CB using the Plasmid Assay. The goal 
was to examine the protective effects of surfactant and antioxidants against injurious inhalants. 
The authors established that the coarse fraction of DPM displayed a higher oxidative potential in 
this study and that soluble constituents were most directly responsible for toxicity. Moreover, it 
was found that antioxidants from lung lavage with low molecular weights offered some 
protection against DNA damage caused by oxidation, even when mimicked in a synthetic 
surrogate lung fluid [331]. Xiao et al. examined the effects of organic extracts of DPM on the 
induction of oxidative stress in mouse macrophages, examining newly formed proteins 
associated with stress pathways. The authors demonstrate a dose-dependent relationship with 
DPM-extract and induction of oxidative response as decrements of antioxidant ratios occured, 
suggesting that organic components of DPM are responsible for the upregulation of oxidative 
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responses associated with exposure to pollutants [332]. Similar studies, by Jung et al., went on 
to highlight the importance of the unfolded protein response (UPR) in bronchial cells exposed to 
organic extracts from DPM using proteomics approaches. The results of this study suggested 
that oxidant damage caused by organic constituents of DE result in mis/unfolded proteins 
leading to inflammatory damage [333]. Contrasting results obtained between studies may be 
attributed to wide variations in dose, type of diesel fuel, or composition of extracts making it 
difficult to clearly attribute effects to any one component of DE. Taken together, these studies 
demonstrate that both the carbon core of DPM as well as the absorbed constituents are capable 
of initiating oxidative stress. 
Reactive oxidants have further been associated with modulating the process of 
programmed cell death or apoptosis [332]. The pathways that drive this process following 
exposure have been the focus of several in vitro investigations. Hiura et al. demonstrated that 
DPM that had organic constituents extracted no longer caused macrophages to produce ROS 
that were shown in this study to be important for initiating the process of apoptosis in these cells 
following exposure [334]. Further, a subsequent study showed that ROS production by AMs 
induced by DPM extracts resulted in mitochondrial toxicity and the initiation of apoptosis 
mediated by mitochondrial damage [335]. The transcription factor NF-κB pathway is also known 
to be involved in regulation of apoptosis following response to ROS, as previously discussed in 
the context of silica exposure [79]. Therefore, Shukla et al. aimed to understand whether 
pollutants such as PM2.5 could initiate NF-κB translocation. The authors demonstrated that PM2.5 
does cause translocation of NF-κB subunits into the nucleus and subsequent DNA binding in 
murine type-II alveolar epithelial cells. Further, they showed that this was dependent upon 
oxidative stress and resulted in the expression of increased inflammatory cytokines [330]. 
Bonvallot et al. showed the importance of NF- κB transcription of cytokines following exposure 
to DPM in human bronchial epithelial 16HBE cells. These authors added that activation of this 
pathway was dependent on oxidants produced by organic components of DPM, such as PAHs. 
Further, the mitogen-activated protein kinase/extracellular-signal related kinase (MAP/ERK or 
MEK) pathway was implicated in this process as DPM was shown to cause phosphorylation of 
ERK. However, inhibition of MEK did not always result in decreased NF-κB transcription in 
response to oxidant stress. Therefore, these pathways may not be directly linked to each other 
following DPM-induced oxidant stress [336]. Activation of NF-κB by DPM was increased by the 
combined exposure with O3, further demonstrating a role for ambient interactions in the 
environment worsening effects of air pollutants. The investigators indicated that increased NF-
κB activity in A549 (human airway epithelial-type II like) cells exposed to DPM and O3 resulted 
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in increased expression of downstream cytokines including IL-8. IL-8 is a robust chemotactic 
factor for neutrophils, and is integral to the signaling mechanism for increased inflammation 
[337]. Effects of O3 in combination with DPM altered DPM pathology, as has been suggested in 
several studies [228, 239, 241, 276, 300]. Kaimul Ahsan et al. established that thioredoxin 
(TRX), a redox regulation protein and antioxidant was important for mitigating the effects of 
DPM-induced apoptosis. Results from this study suggest that DPM reduces phosphorylation of 
an anti-apoptotic protein, Akt1. TRX prevents this effect on Akt1 allowing for A549 lung cells to 
resist damage and resultant cellular death [338]. Conversely, Kafoury and Madden reported that 
DPM failed to initiate apoptosis despite activated NF-κB and triggered release of TNF-α. 
Further, when activation of NF-κB was blocked, apoptosis was initiated by DPM. Conversely to 
others, the investigators conclude that NF-κB activation in response to DPM may actually have 
a protective role against apoptosis [339]. Differences may be dose-dependent, and are also 
likely specific to the type of DPM used in the studies and the relative amount of adsorbed 
organic constituents that are present. From the studies above, it may be concluded that the 
organic fraction may be strongly influencing the apoptotic pathway. 
 Trace metals associated with DPM have also been implicated in the production of ROS. 
Park et al. measured ROS production comparing two types of DPM to determine importance of 
transition metals in oxidative stress. The authors determined that iron was more important than 
other transition metals in the production of ROS in response to hydrogen peroxide [340]. 
Distefano et al. examined the role of transition metals in generating ROS in response to DPM 
exposure. They found that transition metals did play a role in redox activity of DPM using a 
newly described assay, where ascorbic acid is used to reduce metal ions and oxygen in order to 
generate SO, which is then reduced to OH radicals in the presence of transition metals [341]. 
Ghio et al. further showed that ROS production by BEAS-2B cells in response to the soluble 
fraction of DPM does not account for total ROS production indicating that the insoluble fraction 
of particulates caused the generation of quantifiable ROS as well [342].  
The study by Ghio et al. also highlights a major discrepancy between studies of this 
nature as described above. Studies examining the oxidative nature of components of DE 
resulted in findings that were inconsistent between similarly designed studies. This is due to 
several factors, the first of which being the complex nature of DE itself and the variable qualities 
of DPM from different sources and collection methods. Further, these samples were produced 
at different times of the year under variable conditions, resulting in environmental variability in 
constituents. Methodologies used to wash particles or extract particular fractions were not 
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constant nor were methods used to quantify the generated oxidants. Culture conditions, cell 
types, and doses examined were also variable. Finally, the studies examined different species 
of ROS, i.e. SO, hydroxyl, peroxynitrite. A review by Ghio et al. summarizes these discrepancies 
[343]. All of these factors should be taken into consideration when drawing conclusions from this 
body of work and when making further determinations relating to DPM-generated oxidants and 
their role in the initiation of inflammation and pulmonary toxicity.  
In vitro models have been employed in an effort to understand how exposure to DE 
alters respiratory responses observed in obstructive pulmonary disorders such as asthma and 
bronchitis, particularly in the context of pre-existing disease. In an ex vivo human study, Bayram 
et al. studied the differences in airway cell responses in cells recovered from asthmatics 
compared to non-atopic individuals, followed by exposure of the cells to DPM. Constitutively, 
cells differed in their expression of inflammatory mediators between the experimental groups, 
with asthmatic cells secreting significantly more mediators at baseline, though ciliary beat 
frequencies were determined to be similar regardless of atopic status. Further, it was 
determined that in response to DPM, bronchial epithelial cells of atopic individuals were more 
sensitive than those of nonasthmatic individuals, with regard to cytokine secretion. Moreover, 
this response was dose-dependent. The authors conclude that the altered expression of 
inflammatory mediators in response to DPM in asthmatics may contribute to exacerbation of 
symptoms [344].  
From a mechanistic perspective, Li et al. examined the importance of matrix 
metalloproteinase (MMP)-1 in the development of obstructive diseases following exposure to 
DPM. MMP-1, like other MMPs, is a modulator of inflammation, tissue remodeling, wound 
healing, and pathogenesis in some pulmonary diseases[345]. The authors established that 
MMP-1 transcription was upregulated in primary human bronchial cells exposed to DPM, and 
that this was dependent upon the MEK signaling pathway. Further, a polymorphism identified in 
the MMP-1 promoter may increase susceptibility of many individuals exposed to DPM to 
developing respiratory diseases associated with increased MMP-1 secretion [346]. Another 
study by the group examined the involvement of calcium signaling in airway epithelial cells in 
response to DPM exposure in relation to COPD pathogenesis. This set of experiments further 
elucidated the link between DPM exposure and MMP-1 secretion resulting in obstructive 
pulmonary disease implicating the signaling pathway upstream from the MEK pathway involved 
in the influx of calcium following direct interaction between DPM and the receptor it initially 
activates upon contact with cilia on epithelial cells, proteinase-activated receptor (PAR)-2. Upon 
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activating PAR-2, components of DPM upregulated PI3K signaling, which in turn upregulated 
influx of extracellular calcium by way of the transient receptor potential vanilloid (TRPV)-4. This 
was described as being dependent upon the organic fraction of DPM. Further, a polymorphism 
in TRPV4 already identified with enhanced susceptibility for COPD [347], increased the 
upregulation of MMP-1 activation described in the former study further [348].  
Additionally studies have also focused on the effects of DPM on the COPD 
characteristics of airway mucus hypersecretion and stimulation of C-fibers in airway reactivity. In 
an effort to better understand increased secretion of mucus in the airway following exposure to 
pollutants, Park et al. designed studies for evaluating expression of the gene for mucin 4 
(MUC4) in nasal epithelium and human lung mucoepidermoid cells (NCI-H292). The authors 
determined that exposure to DPM increased the mRNA expression and protein secretion of 
MUC4. Further, these results were reversed when proteins in the MAPK pathway or the cAMP 
response element-binding protein pathway (CREB) were blocked. This occurred in both cell 
types. These findings reveal a mechanistic understanding for hypersecretion of mucus in airway 
epithelial cells following exposure to DPM [349]. More recently, the respiratory reflexes and 
more specifically the innervation of the airway have been examined in response to DPM. 
Robinson et al. exposed airway C-fiber afferents to DPM and observed direct activation. The 
results of this study suggest that activation of the ahR causes production of ROS by 
mitochondria and the downstream activation of the transient receptor potential ankyrin-1 
(TRPA1) followed by depolarization of the vagal nerve c-fibers causing an action potential that is 
experienced in the form of a cough or bronchospasm. Further, washing the particles of the 
organic components abrogated this activation of the vagus nerve, suggesting that the organic 
PAHs are primarily responsible for observed effects [350].  
Due to the rise in asthma and allergic prevalence over the past few decades worldwide, 
efforts have been made to advance the understanding of DE exposure in the development of 
allergies and allergic asthma as discussed above for the reviewed in vivo studies. In vitro 
studies have also been performed to further investigate mechanisms of DE exposure in cells 
involved in allergic response. Terada et al. established that DPM organic extracts were able to 
enhance the adherence of eosinophils to nasal epithelium. Further, their results demonstrated 
that DPM extracts induced eosinophilic degranulation though not altering eosinophilic viability. 
These findings lead the authors to conclude that DPM, more specifically PAH components of 
DPM, play a role in nasal hypersensitivity and the development of allergic response [351]. The 
same group further demonstrated the role of DPM in allergic responses by elucidating the 
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effects of DPM on the expression of the histamine H1 receptor (H1R). Their experiments 
demonstrated that extracts of DPM increased H1R mRNA expression in nasal epithelium and 
mucosal endothelial cells. Further, the secretion of IL-8 and GM-CSF stimulated by histamine 
was higher in cells treated with DPM than controls. The results of these investigations suggest 
that organic components of DPM upregulate allergic inflammation by increasing the release of 
histamine [352]. 
Studies have also focused on the involvement of lymphocytes in the development of 
allergic disease and the skew toward a Th2-mediated response. Though these cells are 
important for upregulation and induction of this response, other immune cells have been shown 
to be important for polarizing lymphocytes toward allergy. Saneyoshi et al. conducted a study to 
determine the role of environmental pollutants in development of allergic disease by examining 
the effect of DPM on mast cells. Results from this study suggested that low levels of DPM were 
capable of enhancing the expression of IL-4, which is important for the differentiation of T cells 
during allergic response. However, interestingly, it was determined that this was dependent 
upon time of exposure relative to activation state of the mast cells. Further, it was shown that 
the enhanced expression of IL-4 may not be entirely dependent on oxidant production, 
suggesting other mechanisms for allergic induction following exposure to DPM [353]. 
Devouassoux et al. examined the effects of DPM organic constituents on basophils, since 
basophils are a major source of IL-4, and IL-4 is important for the polarization of Th2 mediated 
responses. Basophils exposed to extracts of DPM displayed enhanced expression of IL-4 and 
increased release of histamine compared with basophils exposed to allergen. However, no 
synergy was observed when cells were co-exposed to DPM extracts and allergen. Additionally, 
secretion of IL-4 by basophils exposed to DPM extract persisted for longer periods of time than 
those stimulated with allergen only. Furthermore, authors demonstrated that IL-4 expression 
was not altered by alternative cell types suggesting that basophils were the major contributors to 
the increase observed. Finally, the study showed that antioxidant pre-treatment of basophils 
reversed the expression of IL-4 observed in response to DPM extract treatment establishing that 
ROS are involved in the initiation of allergic responses of basophils to pollutants [354]. 
 Nilsen et al. investigated the importance of Th1 polarizing cytokine, IL-12, in the 
involvement of allergic response. The authors determined that levels of IL-12 expressed by 
activated monocytes were inversely associated with concentration of DPM exposure. 
Suppression of IL-12 expression by monocytes could skew the Th1/Th2 balance in favor of a 
Th2 dominated response providing further mechanisms for DPM-induced atopy [355]. 
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Mamessier et al. further explored the role of T cell activation involvement in allergic response to 
DPM. It was determined that T cell activation and proliferation, specifically IL-4 producing T 
cells, was increased in higher proportions in cells obtained from asthmatics compared with 
healthy controls. These results were exacerbated for cells obtained from severely uncontrolled 
asthmatics suggesting an increased susceptibility for respiratory symptoms following exposure 
to DPM in these individuals [356]. A study conducted by Takenaka et al. determined that while 
the organic components of DPM were able to enhance IgE production by B lymphocytes. PAHs 
from DPM were not inherently able to induce IgE production or class switching of 
immunoglobulin. Therefore, it was concluded that DPM exposure plays a role in upregulating 
ongoing allergic responses [357].  Plé et al. more recently determined that the Th17/Th22 axis 
may play a role in allergic response following exposure to air pollutants. The authors exposed 
monocytes from either allergic asthmatics or non-asthmatics to DPM PAHs in order to 
determine whether the organic constituents of DPM play a role in the up-regulation of allergic 
response by way IL-17 and IL-22 expression. IL-17 and IL-22 were both expressed more highly 
in the monocytes of asthmatics at baseline. Exposure to DPM PAHs increased expression of IL-
22 while decreasing IL-17 expression regardless of predisposition to disease. The increase of 
IL-22 was found to be partly dependent on up-regulation of the ahR transcription factor [358]. 
These studies indicate a role for DPM, and specifically the organic components of DPM for up-
regulating the expression of cytokines important for Th2 response; further, these results were 
worse in individuals predisposed to allergy/asthma suggesting that DPM may exacerbate 
ongoing allergic responses.  
Additionally, several ex vivo studies in addition to those of Mamessier et al. and Bayram 
et al. described above, have also aimed to elucidate mechanisms leading to enhanced allergic 
response caused by DPM. Similar to work previously described by Bayram et al., a study by 
Devalia et al. examined the mechanisms associated with enhanced sensitivity of airways in 
asthmatics. By exposing bronchial cells of asthmatics and non-atopics to DPM and comparing 
the secretion of inflammatory mediators to constitutive secretion of the same mediators, it was 
determined that bronchial cells of asthmatics were more sensitive to DPM at lower doses and 
overall had higher constitutive secretion of inflammatory mediators than those of non-atopic 
individuals [359]. Fahy et al. aimed to understand whether organic components of DPM in 
concert with HDM allergen could result in hyperresponsiveness in atopics. DPM PAHs and HDM 
allergen both elicited increased allergic mediators in monocytes from allergic patients. 
Moreover, when co-exposed to DPM PAHs and HDM allergen, synergistic responses were 
observed. Further, MEK pathway activation was implicated in the role of increased expression 
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of mediators detected in response to co-exposure. The authors conclude that DPM PAHs and 
allergens act jointly on the MEK signaling pathway to increase expression of inflammatory and 
chemotactic proteins important in the development of hyperresponsiveness [360]. To further 
investigate this, Fahy et al. exposed monocytes from HDM allergic patients to combined DPM 
and allergen stimulants and observed expression of monocyte-derived chemokine (MDC), a 
recruiter of Th2 cells, and IFN-γ-induced protein 10 (IP-10), a Th1 cell recruiter, to determine if 
DPM might skew recruitment of T lymphocytes to allergic response. It was found that DPM 
exposure alone resulted in down-regulation of IP-10 expression constitutively while exposure to 
DPM in combination with HDM allergen further increased expression of MDC observed with 
exposure to HDM alone. Additionally, blockade of the CD28 and CD86 pathways abrogated 
increased MDC expression suggesting that this adjuvant effect is in part caused by Th2 
polarizing chemokine milieu dependent upon CD28 signaling, though this effect was also 
reduced by blockade of CD80, it was to a lesser extent. Further, these results were found to be 
independent of IL-4, IL-13 and IFN-γ expression [361]. Chang et al. sought to examine whether 
allergic responses were not only increased by contributions from DPM or whether DPM may 
enhance predisposition toward allergic response even in previously non-atopic individuals. The 
authors designed experiments examining the stimulation of either Th1 or Th2 chemokines in 
response to DPM in peripheral blood monocytes of non-atopic individuals. Results from this 
study suggest that DPM exposure induces expression of chemokines that are involved in the 
recruitment of Th2 lymphocytes and down-regulation of chemokines that favor Th1 recruitment, 
suggesting that even in non-atopic individuals DE exposure may result in the induction of 
allergic responses [362]. These studies demonstrate that DPM, by up-regulating inflammatory 
signaling may result in increased hypersensitivity and allergic response; further, this may be 
related to organic components of DPM skewing response of the immune system from Th1 
mediated to Th2 mediated especially in the presence of allergen.  
Don Porto Carero et al. conducted studies to examine the role of pollutants in altering 
expression of antigen presentation receptors as a mechanism in DPM-induced allergic 
response. Human THP-1 monocytes were stimulated with environmental pollutants including 
DPM simultaneously with IFN-γ in order to determine if pollutant-altered antigen presentation 
might be responsible for adjuvant effects during allergic response. Although pollutants did not 
stimulate expression of antigen presentation receptors on their own, they potentiated effects of 
IFN-γ induced expression of these receptors. These investigators state the results suggested a 
mechanism for adjuvant effect observed for environmental pollutants during allergic disease. 
Additionally, the authors speculated that particle size and surface area relative to dose is critical 
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for these effects to occur based on varied responses between DPM and urban particulate 
matter [363]. Similar to the previous study, Takizawa et al. examined the role of antigen 
presentation following exposure to DPM in the development of allergic response. The authors 
specifically aimed to determine whether nasal epithelium cells (NEC) were able to act as APC 
during allergic response and if DPM altered this phenotype. Experiments demonstrated that 
NEC expressed APC-related receptors and that compared with pre-seasonal allergy, these 
receptors were upregulated in the NEC of patients during allergy season. Further, exposure of 
these NEC to DPM resulted in further increases in the expression of these receptors. These 
results were dependent upon the CD86 pathway, and not the CD80 pathways, similar to the 
study by Fahy et al. Co-exposure to allergen with DPM further increased the expression of APC 
molecules in NEC, and initiated the proliferation of lymphocytes in response to NECs. Blockade 
of APC receptors and CD86 pathway abrogated proliferation of T-cells. Overall, the results 
demonstrate the role of NEC as APCs in allergic response to antigen and DPM [364]. 
 Dendritic cells are also important for the differentiation of T cells. A study by Chan et al. 
examined the effect of DPM on DCs and how this may influence the adjuvant effects of DE 
exposure in the development of allergic asthma. This study demonstrated that DPM elicited 
oxidant-related stress on DCs. Oxidants were shown to interfere with the TLR-mediated 
expression of receptors and the production of cytokines including IL-12. These changes resulted 
in altered interaction between DCs and lymphocytes, and therefore aberrant T cell differentiation 
shifted toward a Th2 response. Further, the authors were able to determine that activation of 
nuclear factor-erythroid 2 (NF-E2)-related factor 2 was responsible for the altered DC function. 
NF-E2-related factor 2 expression suppresses IL-12. Blockade of this axis resulted in restored 
DC function in the presence of DPM exposure. Therefore, altered DC function is essential in the 
adjuvant effects of DPM [365]. Another study by Braun et al. examining the role of DCs in 
allergic response investigated whether exposure of DCs to DPM in the presence or absence of 
LPS stimulations would affect cell function or viability. Authors examined multiple types of DPM 
at varying doses and concluded that only DPM with high levels of adsorbed pollutants (as from 
traditional DE), were capable of altering DC phenotypes. DPM with high pollutants resulted in 
altered DC expression of cytokines, as well as, inability to suppress immunoglobulin class 
switching in B cells. Further they alter DC maturation. The authors conclude that aberrant DC 
maturation and function contributes to the Th2 favoring environment observed following 
exposure to highly polluted DPM, but that organic components may not be responsible for these 
effects [366]. Taken together, these studies suggest that DE exposure up-regulated allergic 
response in atopic individuals but also may play a role in induction of allergic response in 
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previously non-atopic individuals. Furthermore, though many mechanisms were investigated 
experimentally, the conclusions were in general agreement that allergic responses are related to 
DPM constituents that alter antigen presenting cell responses and shift the inflammatory 
response to one that is Th2 driven. Additionally, the components of DPM most likely responsible 
are those adsorbed to the core and not carbonaceous particles themselves.  
Though evidence of DE elicited carcinogenesis is conflicting in in vivo studies, in vitro 
studies allow for investigations in more varied cellular systems and cultures including human 
cell lines. These studies provide more mechanistic implications for the pathogenesis of DE 
exposure and for the development of cancer, beginning with mutagenicity testing upon the 
development of the Ames S. typhimurium assay. [367]. Therefore, after early evidence that 
DPM causes mutagenicity [368-371], further analysis has been conducted to determine 
carcinogenicity including more modern assays including but not limited to micronuclei assay, 
cell cycle assay, and DNA damage analysis. 
Bieler et al. examined a known mutagen from diesel exhaust, 3-nitrobenzathrone (NBA) 
and determined that it was able to covalently bind DNA and create DNA adducts in an acellular 
system. Ultimately, these adducts may result in carcinogenesis, supporting that organic 
fractions of DPM may be tumorigenic [372]. Further, Shi et al. examined DPM mutagenicity 
using the Ames assay following alterations to engine operating conditions and using filters for 
particulate. Mutagenicity was found to be strongly correlated with engine operating condition 
and although filtration reduced the concentration-normalized mutagenicity of DPM, it is likely 
that mutagenicity is dependent upon the organic fraction of DPM that was allowed to pass 
through the filters [373].  
Arimoto et al. explained how production of oxidative stress by DPM components could 
lead to carcinogenesis. DPM generated oxidative radicals in biological systems due to enzyme 
activation by P450 reductase. These radicals hydroxylated guanine residues causing 8-hydroxy-
2’-deoxyguanosine (8-OHdG) lesions in DNA, lesions that are thought to lead to tumorigenesis 
[374]. Don Porto Carero et al. also demonstrated that DPM as well as CB caused DNA damage 
following exposure to non-cytotoxic doses in two human cell lines. Therefore, it is plausible that 
the organic fraction of DPM is not the only genotoxic fraction of DE, though the organic extract 
was shown to be genotoxic as well as whole particulate. These results suggest that 
carbonaceous constituents of DPM may be partly responsible for the carcinogenesis of these 
substances observed in vivo and in humans [375].  
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Jardim et al. exposed human bronchial cells to DPM and examined expression of micro 
RNAs (miRNAs) to determine if miRNAs might have a role in tumorigenesis of DPM.  miRNAs 
altered to the greatest degree were related to inflammatory pathways and tumorigenesis. 
Further, DPM disruption of miRNA expression patterns was significant, leading the authors to 
conclude that cellular homeostasis is generally affected by alterations in gene expression 
regulated by miRNAs [376]. Zhou et al. also reported on the importance of miRNA in the 
development of malignancy following exposure to DPM. The authors describe a novel pathway 
for carcinogenesis caused by DPM through dysregulation of miRNA, miR-21. It was established 
that upregulation of miR-21 by DPM leads to downregulation of phosphatase and tensin 
homolog (PTEN) that suppresses PI3K/AKT. The PI3K/AKT pathway has anti-apoptotic activity; 
therefore, upregulation of PI3K/AKT activity by miR-21 acting on target protein PTEN results in 
an anti-apoptotic mechanism for cell persistence by evading programmed death [377]. A 
specific amino acid transporter (LAT1/CD98hc) has been identified as upregulated in lung 
cancers and is associated with poor prognosis [378, 379]. Le Vee et al. demonstrated that 
exposure of bronchial epithelial cells to DPM extracts resulted in dose-dependent expression of 
LAT1/CD98hc. This was found also to be dependent upon activation through the ahR pathway, 
as inhibition of ahR prevented LAT1/CD98hc induction caused by DPM extracts. These results 
suggest that DPM extracts initiate tumor promoting pathways through ahR pathways [380]. A 
study by Yadav et al. demonstrated how a mechanism that protects cells from toxicity caused by 
DPM may ultimately lead to tumorigenesis. Ubiquilin (UBQLN) proteins aid in the degradation of 
ubiquitinated proteins and their gene expression has been found to be down-regulated in lung 
cancers. In fact, loss of UBQLN1 may result in EMT [381]. The current study established that 
exposure to DPM resulted in the upregulation of UBQLN proteins overall in two cancer cell lines 
and that this was dependent on the suppression of miR-155. Conversely, over-expression of 
miR-155 resulted in EMT in lung cancer cells by downregulation of UBQLN1/2. The authors 
speculate that initial increases in UBQLN1 and reductions in miR-155 are part of an acute stress 
response to DPM exposure leading to an eventual feedback mechanism causing the selective 
deletion of UBQLN1 by increased miR-155 expression during chronic exposure [382].  
Bao et al. determined that some mutagenicity by DPM is reliant on cell particle 
interaction requiring the internalization of particles by the cells. The investigators exposed 
human-hamster hybrid cells to DPM and examined increases in mutagenicity that were dose-
dependent. Further, when phagocytosis was blocked, mutations induced in the nuclei were 
reduced. These results suggest that ingestion of particles and radicals produced in response to 
this process may be responsible for initiation of carcinogenic processes [383]. An investigation 
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led by Landvik found that nitrated PAHs (n-PAHs) commonly found in DPM have varying effects 
on mutagenicity and induction of apoptosis. While all n-PAHs induced some mutagenicity, most 
were pro-apoptotic due to increased phosphorylation of p53 or decreases in anti-apoptotic bcl-
xL. However, the authors concluded that the most mutagenic n-PAH examined, 1,8-
dinitropyrene (1,8-DNP), resulted in the least apoptosis induction. 1,8-DNP inactivated p53 by a 
pathway that was determined to be non-mutagenic. This study highlights the importance of 
individual components of DPM in health outcomes as this n-PAH is only present in some DPM 
based on the conditions in which the engine was run. Further, these results suggest that 
increased cell survival occurs with highly damaged DNA providing a mechanism for 
carcinogenesis following exposure to DPM-related substances [384]. Matsunaga et al. identified 
an aldo-keto reductase (AKR) involved in the progression of tumor growth associated with 
exposure to a quinone component of DE. They found that exposure of human lung cells to high 
concentrations of 9,10-phenanthrenequinone (9,10-PQ) resulted in apoptosis; whereas, 
exposure to lower concentrations led to proliferation and invasion. This was determined to be 
related to upregulation of AKR1B10; inhibition of AKR1B10 abrogated tumorigenic processes in 
9,10-PQ treated cells. Further the carcinogenic activity promoted by AKR1B10 was determined 
to be dependent on the production of ROS due to disruptions in the redox balance by 9,10-PQ. 
Altogether, these results from this study demonstrated a newly defined pathway for cancer 
promotion by components of DE [385]. 
Overall, mechanisms investigated for pulmonary carcinogenesis suggest that 
imbalances of redox systems result in DNA damage and initiation of pathway signaling 
associated with anti-apoptotic mechanisms. Together these effects result in dysregulation of 
cellular homeostasis and the persistence of aberrant cells. Further studies are needed to 
elucidate the multi-phase toxicological responses to air pollutants.  
Immunological Effects and Susceptibility to Infection 
Due to epidemiological observations that point to air pollution and DE exposure resulting 
in increased hospitalizations for pulmonary infections, many investigations have aimed to 
determine more causal mechanistic relationships between DE exposure and degradation of host 
defense. Thomas et al. examined peripheral monocytes and AMs exposed to either 2 or 200 
μg/ml of DPM in suspended in culture medium to determine whether DPM might alter 
phagocytosis mechanisms and/or secretion of TNF-α as parameters of effector functions 
compared with control cells stimulated with 5 ng/ml LPS. Though no change in cell viability or 
attachment was observed, reductions in phagocytosis by cells exposed to DPM occurred in a 
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dose-dependent manner [386]. Castranova et al. compared the effects of either DPM or organic 
extracts from DPM on the function of AMs in the context of their production of cytokines. Results 
showed that macrophages exposed to DPM were less able to respond to LPS, namely in the 
production of TNF-α. Further, methanol extracts of DPM were able to suppress cytokine 
expression in response to LPS, whereas washed DPM was not, suggesting that these effects 
were driven by the organic components adsorbed to DPM [325]. Saito et al. determined if DE 
exposure altered the ability of AMs to produce cytokines in the absence and presence of 
intracellular infection. The authors determined that the production of cytokines by AMs in 
response to DE was altered. IL-12 and TNF-α expression was decreased, while the secretion of 
IL-1β was increased. They also determined that expression of apoptotic factors was increased 
in AMs following DE exposure. The effects observed in the absence of infection were more 
pronounced following exposure to bacterial infection. These results suggest that DE exposure 
may reduce the AMs’ effectiveness in controlling infection, thereby, increasing susceptibility to 
infection [387]. Lundborg et al. established that AMs exposed to aggregates of ultrafine carbon 
particles and DPM diminish phagocytosis mechanisms. Further, phagocytosis was altered for 
receptors typically stimulated by four distinct ligands suggesting that phagocytosis was 
universally altered, and that this effect was not specific for one receptor-type relating to this 
mechanism. Since phagocytosis is crucial in the control and clearance of many pathogenic 
substances in the lung these findings provide important evidence for pulmonary susceptibility 
following exposure to particulate matter [388].  
Yin et al exposed AMs to DPM, its organic extracts, washed DPM (wDPM), or CB 
particles. Their results demonstrated that DPM and organic extracts decreased phagocytosis 
and bactericidal responses to LM by AM. wDPM and CB were also able to decrease 
phagocytosis. However, while CBs did not decrease bacterial killing by AMs, wDPM did affect 
bactericidal activity, but also not as significantly as DPM or its extracts. DPM and its extracts 
also decreased the expression of inflammatory proteins by AMs. Other particles were not 
effective in altering the expression of inflammatory proteins. These collective results provide 
evidence that organic components of DPM are instrumental in diminishing important 
antimicrobial activities of AMs and thus enhance respiratory susceptibility to infection [389]. 
Sarkar et al. examined the effect of DPM on inflammatory signaling pathways during 
mycobacterial infection in human monocytes. The authors demonstrate that DPM suppressed 
the expression of inflammatory cytokines, IFN-γ, TNF-α, IL-1β and IL-6, in response to 
mycobacterium in a dose-dependent manner. DPM treatment of cells altered the expression of 
many NF-κB, TLR, and IFN constituent mRNAs as well. These results jointly suggest that 
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cellular response to mycobacterial infection following DPM exposure is altered in favor of 
decreased resistance [390]. Since NK cells are known to be located in nasal mucosa, Müller et 
al. investigated their role in defense against viral infection and whether DPM altered these 
activities. The authors conclude that DPM may reduce the ability of NK cells to kill host cells that 
are infected with virus since they lose important expression of cytotoxic factors granzyme B and 
perforin when exposed to DPM, results that suggest diminished host defenses [391]. Altogether, 
these findings suggest that DPM reduce resistance to infection and that both the core and 
adsorbed components of DPM may play a role in these effects. 
Effects of DE on susceptibility to infection have also been examined in epithelial cells. 
Jaspers et al. infected respiratory epithelial cells with influenza following exposure to DE and 
established that exposure to DE enhanced the susceptibility to influenza infection in all cell 
types tested. Moreover, this was determined to be due to enhanced attachment and entry into 
cells. The effects observed were also dependent upon oxidative stress generated by DE as 
antioxidant treatment reversed the infectious effects observed by DE exposure. Lastly, the 
suppression of host resistance to influenza infection was shown to be independent of effects on 
interferon [392]. Ito et al. also examined the effect of DPM exposure on rat lung alveolar type-II 
epithelial cells. The authors observed up-regulations in mRNA expression of sites identified with 
bacterial and viral invasion. They established that expression of these receptors were increased 
in a concentration-and oxidative stress-dependent manner. Overall, the results of this study 
demonstrate a mechanism by which pathogens may invade the site of the lung more efficiently 
leading to increased host susceptibility [393]. Similarly, Ciencewicki et al. revealed that DE 
exposure of lung epithelial cells resulted in enhanced TLR3 expression and function that may 
provide opportunity for the increased pathogen invasion and susceptibility observed by Jaspers 
et al. [394].  
Taken in conjunction, the results of these studies consistently show that DPM, 
specifically the organic constituents associated with DPM, causes decreases in global 
phagocytosis, and reduce the ability of immune cells to secrete inflammatory mediators in 
response to pathogens. Further, evidence is provided that DPM upregulates certain receptors 
associated with bacterial and viral invasion of host cells. Therefore, in vitro systems provide 
mechanistic support for the susceptibility to infections observed in vivo as well as in human 




Co-Exposure to Diesel and Silica 
 
The literature summarized here is an overview of the extensive body of investigations 
that examine exposure to silica and DE as individual exposures. Co-exposure studies 
investigating the health effects of DE in conjunction with other exposures, or silica in 
combination with other exposures have been studied and primarily focus on ozone or asbestos 
[395-398]. However to date, no studies have specifically examined a co-exposure of crystalline 
silica and diesel. There are, however, a small battery of studies that examine DE in a co-
exposure with coal dust, which contains crystalline silica. In terms of epidemiological studies, a 
few investigations have examined the role of diesel exhaust and the incidence of lung cancer in 
coal miners; however, due to the lack of exposure related data, or the classification of exposure 
based on job category, it is difficult to determine a causal relationship. Furthermore, coincidence 
of confounding exposure including cigarette smoking needs to be considered [399, 400] . A 
chronic combined inhalation exposure evaluating DE and coal dust (CD) in rats found exposure 
related lesions consistent with simple coal worker’s pneumoconiosis, but this finding was not 
significantly different between diesel exhaust, high concentration coal dust, or the combination 
the two dusts. This finding was found to be time-dependent as longer exposures resulted in 
worsened severity of lesions [401]. However, this study combined doses of particles much 
higher than are permissible or consistent with underground survey measurements of particles.  
Another set of studies examined DE in combined inhalation exposures with CD in rats at 
exposure levels consistent with permissible exposure levels for particles (2 mg/m3) underground 
at that time. Many aspects of toxicity including AM function, airway function, cardiac and arterial 
pathologies, and liver and lung enzyme function were evaluated during a two-year chronic 
exposure to either DE (2 mg/m3), coal dust (2 mg/m3), or a combination of DE (1mg/m3)  and CD 
(1mg/m3). Castranova et al. determined that DE, when in combination with coal dust was not 
cytotoxic to AMs at the relatively low doses administered over the course of 2 years. However, 
DE did appear to suppress the phagocytic activity of AMs while coal dust increased it. 
Combining the exposures resulted in no significant enhancement in overall macrophages 
recovered but may be due to the reduction in CD administered in the combined exposure 
compared with the CD exposure alone [402]. From this same study, Vallyathan et al. reported 
that there was no evidence that combined or separate exposure to DE or CD resulted in 
detrimental effects to the heart or pulmonary arteries [251]. Lewis et al. published findings from 
this same study reporting similarly to Castranova et al. that DE suppressed macrophage 
function while CD enhanced these functions. Additonally DE contributed to increased 
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susceptibility to influenza infection and generally caused more health effects than did CD. While 
some alveolar epithelial hyperplasia and lipidosis was noted for individual exposures, these 
findings were not exacerbated by the combination of DE and CD. Furthermore, no evidence of 
obstructive or restrictive alterations were noted. Overall, this battery of studies suggested that 
combined exposure to DE and CD does not result in additive or enhanced risk beyond that of 
each component alone [403]. However, it should be noted that in this study, the co-exposure 
dose was normalized to total particle equivalent to that of DE or CD alone, resulting in lower 
concentrations of each in the co-exposure when compared to the individual dust exposures, 
which potentially attenuate particle-specific effects in the co-exposure group.   
Finally, in a separate study, Hahon et al. demonstrated that mice exposed to DE (2 
mg/m3) alone caused increased severity of a subsequent influenza infection, but that exposure 
to combined DE (1 mg/m3) with CD (1 mg/m3) did not significantly alter this effect. Further, these 
responses were most significant following 3-6 months of previous DE exposure [321]. Overall, 
these findings suggest findings similar to those previously mentioned that demonstrate that DE 
may diminish immune responses. While these results do not significantly implicate co-exposure 
to DE and CD as causing altered pulmonary toxicity in response beyond that observed for each 
particle individually, this study examined relatively low doses that were given over a long period 
of time. Furthermore, while coal dust does contain quartz, amounts are drastically variable 
based upon type and location of extraction, and effects in the CD groups cannot be directly 
correlated to the silica component in the studies described above. Therefore, further studies 
examining acute responses, as well as studies that evaluate DE in combination with higher 
concentrations of silica are necessary in order to more completely evaluate the potential 
combined toxicity of co-exposure to these particles.  
Summary 
 
To this day exposures to silica in the workplace are documented to occur in a numerous 
occupations in addition to mining including masonry, painting, sand blasting, construction, 
demolition, and ceramics [404, 405]. Inhalation of respirable silica has been shown to cause 
lung inflammation and injury, COPD, bronchitis, emphysema, fibrosis, silicotic pneumoconiosis, 
cancer, heart disease, autoimmune disorders, and increased risk for infection in humans [18, 
35, 404, 406-409], depending upon duration and level of exposure. 
DPM exposure in occupational settings is as long-standing as the use of the combustion 
engine for industrial purposes, though exposure-associated health effects have only been 
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recognized in the last few decades including airway inflammation, bronchitis, altered lung and 
vascular function, and the development of cancer [234, 410-415]. The complex nature of the 
chemical mixture that comprises DE inherently makes it difficult to study in controlled settings.  
Although the health effects of both particles individually have been reviewed at length; 
there is very little information available on effects of co-exposure to silica and diesel. The 
current studies were designed to address the risk for enhanced pulmonary fibrosis and 
alterations in innate immunity related to susceptibility to infection following a co-exposure to 
crystalline silica and DPM  administered at doses related to industrial settings with three major 
aims: (1a) characterize the pulmonary response to an acute co-exposure to DPM and SIL at 
varying doses; (1b) characterize the pulmonary response to a repeated co-exposure to DPM 
and SIL in order to determine if subacute exposure vs. acute exposure altered the effects 
observed for 1a; (2) establish if susceptibility to an acute respiratory infection was altered 
following a co-exposure of DPM and SIL; and (3) determine whether clearance of particulate in 
a co-exposure to DPM and SIL was altered compared with the clearance rate of either particle 


















Bentonite Milling 8 2-10 times the 
TLV (10.5 years) 
Examination of 8 workers from a 
bentonite milling mine revealed 
incidence of findings consistent 
with silicosis; one case was 
confirmed by histological analysis; 
3 surveyed workers had PMF, and 





Sandblasters 4 5 times the TLV 
(35 months) 
Acute silicosis, fibrotic lesions in 
all, co-morbidity with cor 





Stone Masonry 2 Patient 1: 0.1 
mg/m3 (30 years) 
followed by 2 
mg/m3 (5 years) 
Patient 2: 1.5 
mg/m3 (6 years)  
 
Low quartz exposure may 
contribute to hilar node fibrosis, 
which may lead to PMF following 







1 n/a (10 years) 37 year-old worker diagnosed with 
silicosis advanced to PMF 
following 10 year history of 









8 n/a (32.9 years) High exposure to silica in surface 
coal miners resulted in 





Stone Masonry 6 n/a (13 years) Though cases all had low 
predicted probability of 
pneumoconiosis based on health 
survey, all had radiological 
evidence of silicosis with half 
presenting with asymptomatic 
PMF upon screening exhibiting 





Silica Mining and 
Milling 
86 Above TLV (8 
years for those 
with silicosis) 
39% of workers with a mean of 
7.7 years of work had simple 
silicosis and 16% of workers with 
a mean of 7.1 years of work had 
PMF, determined to be due to 
high exposure levels of high 












years for cutters, 
7.62 years for 
non-cutters male 
and 14.69 for non-
cutters female) 
54.6% surveyed showed 
radiologic evidence of silicosis, 
incidence and severity of fibrosis 
correlated with degree and 
duration of exposure and was 
worse in females than males of 






Iron Foundry 188 Up to 30 times the 
TLV for 
coremakers 
Up to 9 times the 
TLV for fettlers 
(8.6) 
Incidence of silicosis in 9.6% of 
workers surveyed with 1% PMF, 
prevalence correlated to 
level/duration of exposure but not 
with cigarette smoking. Smoking 





Granite Workers 320 2.1 mg/m3 for 
silicotics 
0.95 mg/m3 for 
non silicotics 
(at least one year) 
Chronic simple silicosis is 
correlated to loss of lung function 
attributable to fibrosis, lung 
function losses correlated to 
exposure to respirable silica 
though declination in function may 







1,249 ≤1.0 mg/m3 
geometric mean 




Workers performing dustiest jobs 
such as rock drillers etc. 
increases risk for radiological 
findings consistent with 





Stone Carving 42 1.5 mg/m3 (15.5 
years) 
High prevalence of silica dust 
correlated with increased 
incidence of silicosis and reduced 
lung function, duration of 
exposure also contributed to 






Sand Blasting 75 n/a (14.2 years) Prevalence of progressive 
massive fibrosis among silicotics 
was 39.7%, high coincidence with 
tuberculosis and calcified lymph 
nodes also indicated as possible 
contributors to transition from 






60 n/a (18.5 months) 
but, (21.4 months 
for those with 
silica) 
73.3% of patients had silicosis, all 
cases were accelerated with 
11.4% having PMF, clinical score 
was positively correlated with 
duration of exposure, latency 







32 n/a (45 months) All silicosis cases began after 
acute and relatively short-term 
exposure (≤ 2 years) to silica, 
19% of patients died of PMF, 
mean age of mortality was 35 
years suggesting over-exposure 








2,328 n/a (≥ 1year – 
97%) 
2% of patients exhibited 
pneumoconiosis, with 0.5% 
exhibiting signs of PMF, many of 
which had no underground mining 
history, 37% of those with 
pneumoconiosis were shown to 
have radiological findings 
consistent with silicosis, incidence 
of these findings was increased 







250 n/a (13/14 
silicotics had less 
than 10 years of 
tenure) 
Of 250 employees surveyed 14 or 
5.6% had radiologic findings 
consistent with silicosis, all but 1 
had tenure of less than 10 years 
suggesting accelerated silicosis. 1 
worker had PMF, and 5 silicotic 
workers had findings consistent 
with latent TB. 
[432] 
Cohort Coal Mining 74 n/a (n/a) Higher quartz content in the dust 
of worker lungs resulted in more 
severe lung lesions 
[433] 
Cohort Granite Workers 777 granite 
workers, 122 
controls 
n/a (n/a) Highest prevalence of fibrosis in 
dressing workers, drillers, and 
sand blasters 
[434] 
Cohort Tungsten Mining 1,151 0.25 mg/m3 and 
2.25 mg/m3(n/a) 
Cumulative exposure to silica dust 
in tungsten miners was positively 





Cohort Construction 1,056 n/a (20-25 years) Chronic simple silicosis correlated 
to 20+ years of exposure to silica 
in the workplace, stone-splitters 
and caisson workers at highest 
risk, other coinciding 
complications included TB 
[436] 
Cohort Coal Mining 90,973 n/a (n/a) Increases in radiological findings 
associated with silica exposure, 
pneumoconiosis, and PMF 
occurred during 2000-2008 
compared with 80s and 90s 
suggesting coal miner exposure to 




145 n/a (40+ months) Despite short exposure and 
latency, incidence of silicosis and 
progression of silicosis increased 
in sandblaster previously 
evaluated in 2007. Of those 
surveyed only 1 patient of those 





Cohort Coal Mining 13  n/a (32 years) All but 1 miner in 13 surveyed for 
rapid progressive pneumoconiosis 
had PMF. Only 4 of 13 
demonstrated classic coal 
worker’s pneumoconiosis, while 
11 of 13 demonstrated mixed 
pneumoconiosis and lesions 
consistent with silicosis. Two of 13 
displayed alveolar proteinosis and 
interstitial inflammation along with 
silicotic nodules indicating 
accelerated silicosis. Findings 
suggest exposure to coal dust 







15 16,082 μg/m3-y 
lifetime mean 
(19.4 years) 
Fibrosis, evidence of 
pneumoconiosis in the absence of 
radiologic findings, consistent with 





Coal Mining 264 n/a (21 years) Degree of lung fibrosis was highly 
correlated with silica lung content 
while emphysema was positively 




Gold Mining 67 n/a (25-30 years) Lung quartz dust concentration 
was associated with severity of 
silicosis, though duration of 
exposure did not necessarily 








112 Total dust for the 
region PM10 range 
43.5-122 μg/m3 
(n/a) 
Higher prevalence of 
pneumoconiosis and small airway 
disease was observed in 
farmworkers compared with non-
farmworkers of the same region, 
airway lesions were strongly 
associated with mineral dust, 
crystalline silica was significantly 





Platinum Mining 30 n/a (≥ 1 year) Levels of silica that platinum 
miners are exposed to are high 
enough to cause silicosis, 25 
workers surveyed had fibrotic 
nodules in the lymph nodes, and 5 





















Varied 2,291 lung 
cancer, 2,570 
controls 
n/a (10+ years) n/a An increased risk for lung 
cancer mortality was 
found for truck drivers a 
finding that could not be 
accounted for by cigarette 









n/a Data suggest an 
increased risk for lung 
cancer mortality in long-
haul truckers and diesel 
truck drivers however 
quantifiable data on DE 







n/a N/a (n/a) n/a Excess risk for lung 
cancer in chauffeurs 
exposed to long-term DE 
fumes was found even 





Varied n/a Estimated into 
low-high 
quartiles (n/a) 
n/a Men were at a higher risk 
for incidence of lung 
cancer, especially 
squamous cell 
carcinomas. This risk 




estimated intensity of 
exposure. Risk for other 
malignancies were found 
but to a lesser and in 









Operating a locomotive 
was associated with 
increased risk of lung 
cancer mortality but this 
risk did not increase with 
working tenure. Lung 
cancer mortality was 












5/10/15 years Increased risk of dying 
from lung cancer 
compared with non-DE 










based on job 
function and 
years exposed 
(at least 1 year) 
5 years Excess risk of lung 
cancer was determined 
for truck drivers, taxi 
drivers, and railway 
conductors especially for 







1,280 drivers, n/a (n/a) ~10+ years Professional drivers in 







increased levels of DE 
and air pollution, which 
increases risk for 












between 0 and 
29.54 divided 
into quartiles of 
exposure 
mg/m3/year - EC 
(varied) 
15 years In a study of over 12,000 
miners, historical 
exposure to respirable EC 
was estimated. It was 
reported that an 
increased risk of dying 
from lung cancer was 
associated with exposure-
response relationship to 
DE. There was in 
increased trend in risk 
with increasing exposure 
to DE. This was 
regardless of facilities, 
noting that in some 





Mining 8,614 Surface – 14 
μg/m3/12 hrs - 








n/a Based on published risk it 
was determined that 
miners in Australia are 
exposed to levels of DE 
that would result in 
excess death of lung 
cancer and that additional 
controls for worker 




operators - 59 
μg/m3/12 hrs – 












n/a Occupational exposure 
was consistently 
associated with small 
increase in risk for lung 














n/a Both studies pooled 
found an increased risk 
for lung cancer 
associated with exposure 
to DE. Risk was higher for 
squamous cell carcinoma 





Varied Pooled 39 
studies 
n/a (n/a) 10+ years Epidemiological evidence 
suggests that 
occupational exposure to 
DE has a causal 









n/a (~10+years) n/a After adjusting for 
smoking, this study 
reported that professional 




increased risk for 
developing lung cancer. 
Cohort Dock Working 6,071  n/a (n/a) (n/a) A tendency for increased 
risk of mortality due to 
lung cancer was found; 
however, smoking related 
causalities could not be 
excluded. 
[456] 




n/a (n/a) (n/a) An increased risk for 
mortality due to lung 
cancer was found even 
after adjusting for 
smoking status. 
Occupations that were 
significantly associated 
with increased risk 
included miners and 
heavy equipment 
operators, while truckers 
and railroaders had a 
weaker association. 
[217] 
Cohort Bus and Tram 
Driving 




Increased incidence of all 
malignancies. For people 
employed longer than 3 
months risk of lung 
cancer incidence was 
significant for men and 
women. Smoking cannot 





Cohort Potash Mining 5,536 2.70 ymg/m3(15 
years) 
19 years Relative risk of lung 
cancer was doubled for 
miners exposed to the 
highest measure of Total 
carbon after >20 years of 
exposure, however, the 
elevation was still not 
considered to be 
significant. Smoking was 
not considered a 
confounder in this study, 









n/a (n/a) n/a Increased risk of lung 
cancer for truck drivers 
exposed to DE was 
found, but not for HEO. 
Increased risk for prostate 
cancer was also found for 
truck drivers. 
[458] 
Cohort Truck Driving 54,319 n/a (~20 years) n/a Among the US working 
population examined, 
increased mortality due to 
lung cancer was 
observed for all drivers 
and dock workers. 
Relative risk for lung 
cancer was found to be 
consistent with other 
occupational studies. 
Elevated risk for lung 
cancer was identified for 





especially for drivers; 
however, smoking and 
lifestyle may play a role in 
these health risks. 
Cohort Truck Driving 31,135 n/a (~20 years) n/a Regular exposure to DE 
and other MVE have an 
elevated risk of lung 
cancer, which was 
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Keywords 





The effects of acute pulmonary co-exposures to silica and diesel particulate 
matter (DPM) that may occur in various mining operations were investigated in vivo. 
Rats were exposed by intratracheal instillation (IT) to silica (50 or 233 µg), DPM (7.89 or 
50 µg), or silica and DPM combined in phosphate-buffered saline (PBS), or to PBS 
alone (control). At 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure 
bronchoalveolar lavage and histopathology were performed to assess lung injury, 
inflammation, and immune response. While higher doses of silica caused inflammation 
and injury at all time-points, DPM exposure alone did not.  DPM (50 µg) combined with 
silica (233 µg) increased inflammation at 1 week and 1 month post-exposure and 
caused an increase in the incidence of fibrosis at 1 month compared to exposure to 
silica alone. To assess susceptibility to lung infection following co-exposure, rats were 
exposed by IT to 233 µg silica, 50 µg DPM, a combination of the two, or PBS control 1 
week before intratracheal inoculation with 5x105 Listeria monocytogenes. At 1, 3, 5, 7, 
and 14 days following infection, pulmonary immune response and bacterial clearance 
from the lung were evaluated.  Co-exposure to DPM and silica did not alter bacterial 
clearance from the lung compared to control. Although DPM and silica co-exposure did 
not alter pulmonary susceptibility to infection in this model, the study showed that non-
inflammatory doses of DPM had the capacity to increase silica-induced lung injury, 







The natural gas and oil industry is one of the most rapidly growing industries in 
the United States. Specifically, the industry is expanding in the area of hydraulic 
fracturing, “fracking,” or horizontal drilling. This process extracts natural resources from 
otherwise inaccessible deposits below the earth’s surface, provided more than 2 million 
jobs in 2012, and is estimated to support approximately 4 million jobs by 2025 [460]. 
Two respirable particulates identified as possible exposure hazards in fracking 
workplaces include diesel particulate matter (DPM) and α-quartz crystalline silica (SiO2) 
[461].  These two particulates are also present in combination in other mining 
operations including below ground mining operations, particularly in coal extraction. 
Although toxicity of these two particulates have been studied in detail as individual 
exposures, there are currently no in vivo studies, as far as we are aware, that have 
examined the pulmonary effects of the particulates in combination at doses that are 
relevant to various mining operations. 
 In addition to underground mining operations and operations in hydraulic 
fracturing, where significant numbers of diesel engines are utilized (transport, drilling, 
and pumping), diesel exhaust (DE) exposure is also prevalent in industries including 
trucking and railroad operations [182]. DE is a highly complex mixture of chemical 
substances, but is primarily composed of an elemental carbon (EC) core having 
additional organic carbon constituents adsorbed to it. Other than the EC components, 
compounds typically contained in DE include: polyaromatic hydrocarbons (PAHs), 
sulfates, silicates, nitrates, as well as metallic particulates [182]. DPM exposure is linked 
to a variety of adverse health outcomes, including enhanced sensitization to allergic 
stimulus, development and aggravation of asthma, chronic bronchitis, decreased lung 
function, airway inflammation, decreased vascular function, and development of 
cancers, as reported in epidemiological studies [234, 410-415, 462]. Based on these 
studies, DE and DPM have been identified by the International Agency for Cancer 
Research (IARC) as a group 1 carcinogen [182, 463]. In addition to human cohort 
studies, studies involving healthy human volunteers exposed to DE/DPM in a controlled 
chamber have also shown that DE/DPM caused pulmonary inflammation in acute 
exposure scenarios [234, 464]. Controlled human studies as reviewed by Ghio et al. 
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[465, 466] show that inflammation occurs in the respiratory tract of humans exposed to 
DPM and that this occurs in a dose-dependent manner. DPM toxicity has also been 
investigated in vivo and in vitro. DPM has been shown to enhance airway reactivity, 
inflammation, production of reactive oxygen species (ROS), and increased development 
and severity of allergic asthma, lung fibrosis, lung injury, alveolar edema, lung cancer 
and mortality in exposed animals [289, 308, 327, 467-473]. Studies conducted in vitro 
suggest, similarly, that DPM contributes to airway inflammation, production of reactive 
oxidants, unfolded protein response, allergic response, decreased mucociliary 
clearance, and upregulation of cancer-associated proteins in lung cells [333, 377, 380, 
467, 474-479]. Furthermore, DPM has been shown to alter the pulmonary immune 
function and is associated with increased susceptibility to infection [316, 327, 480-485].  
Regulations to control occupational exposure to DE or DPM are recognized in 
several countries, and regulations vary relative to underground mining operations 
versus above-ground mining and non-mining workplaces. In addition, exposure is 
differentially regulated by DE constituents (total particle, elemental carbon, nitrogen) 
[179-182].  In the United States, recommended exposure limits (REL) exist for many of 
the components of diesel exhaust as individual emissions; however, there is currently 
no Occupational Safety and Health Administration (OSHA) regulation of DPM in non-
mining, occupational settings. The Mine Safety and Health Administration (MSHA) REL 
for DE and DPM in underground mine operations is a time-weighted average (TWA), 
based on an 8-hour work day, of  160 µg/m3 total carbon, which includes DPM as 
elemental carbon. Additionally, The California Department of Health Services (CDHS) 
has recommended an occupational exposure limit (OEL) of 20 µg/m3 elemental carbon 
[184]. Both Switzerland and Australia have set OELs at 100 µg/m3 elemental carbon 
[179, 183].    
 Workplace exposure to SiO2 also occurs in a multitude of occupations and are 
well documented for a variety of mining operations, as well as in masonry, painting, 
sand blasting, construction, demolition, and ceramics [404, 405]. SiO2 is one of the most 
common minerals occurring in the earth’s crust and is a major component of sand. Sand 
that contains SiO2 is the primary proppant, or substance used to stabilize the fracture 
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during hydraulic fracturing operations and subsequent resource extraction. A respirable 
fraction of this sand can become airborne when transported onto/around fracking sites 
or pumped at high volumes/pressure into the well-bore [486]. The respiratory toxicity of 
the crystalline form of  SiO2 is well-established, and therefore OSHA requires 
workplaces to follow the permissible exposure limits (PEL) set at 0.05 mg/m3 as a TWA 
for respirable crystalline SiO2. Inhalation of respirable SiO2 has been shown to cause 
lung inflammation and injury, chronic obstructive pulmonary disorders, bronchitis, 
emphysema, fibrosis, silicotic pneumoconiosis, cancer, heart disease, autoimmune 
disorders, and increased risk for infection in humans [18, 35, 404, 406-409], depending 
upon duration and level of exposure. 
 Further, in vivo studies of SiO2 exposure have investigated the mechanisms 
associated with pathologies, such as fibrosis and cancer, including: chronic 
inflammation and the up-regulation of acute inflammatory mediators like leukotriene B4, 
up-regulation of the NF-κB pathway, increased oxidant burden attributable to both the 
presence of free radicals associated with particles and oxidant production by cells in 
response to SiO2 exposure, up-regulation of genes associated with mucus production 
and pulmonary toxicity, and activation of the inflammasome [80, 123, 128, 487-489]. In 
vitro studies have shown production of oxidants and inflammatory mediators,  activation 
of cell-signaling pathways associated with cancer, damage to DNA, and increased 
expression of genes related to inflammation, apoptosis, cancer, and fibrosis in response 
to SiO2 exposure [490-495], furthering support for mechanisms underlying the 
pathologies observed in animal models of disease related to occupational exposure. 
SiO2 exposure has also been implicated in the alteration to the immunological 
environment in the respiratory tract [91, 496] and contributions to respiratory 
susceptibility to some infections [158, 497].  
While the pulmonary toxicity to constituents of diesel, and SiO2 are well-studied 
as individual exposures, little is known about the effects these particles may have when 
encountered as a mixed exposure. Mining operations including hydraulic fracturing for 
oil and gas and above and below ground metal and non-metal mining operations, are 
environments where workers may be exposed to constituents of diesel and SiO2 
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simultaneously, rendering it paramount to establish whether co-exposure to these 
particles will enhance or alter pulmonary toxicity. The current studies were designed to 
investigate the hypothesis that combined exposures to these particles would result in 
amplified injury, inflammation, and cellular recruitment to the lung in an acute exposure 
scenario. Additionally, the studies addressed whether or not cell-mediated clearance of 
a pathogen would be altered by the co-exposure. Existing in vivo and in vitro studies 
documenting the toxicity of DPM and SiO2 in vivo often examine doses of these 
materials representative of chronic exposures or doses that exceed typical workplace 
exposures in single bolus doses [84, 324, 498-501]. Therefore, doses for these studies 
were based on field measurements of SiO2 taken during active above-ground mining 
operations [486]. Values for diesel were derived from both underground mining values 
[502] for high dose values and from existing OELs for elemental carbon for the lower 
dose [181, 183, 503].  A single acute bolus dose of silica, diesel particulate, or a 
combination of the particles at different doses were administered to Sprague-Dawley 
rats by intratracheal instillation. Lung injury, inflammation, and immune responses were 
evaluated over a three-month time-course. Additionally, alteration in susceptibility to 
pulmonary infection following exposure to the particles in combination was evaluated to 
further assess alterations in immune response.  
Methods 
 
Particles. Particles in these studies are used as surrogates to represent work site 
exposures. DPM was obtained from the National Institute of Standards and Technology 
(NIST) as a commercially available NIST Standard Reference Material (SRM) 2975 
(referred to as DPM in the study). SRM 2975 was originally collected from an industrial 
forklift in the 1990s [504]. The surrogate particle used for SiO2 is α-quartz crystalline 
silica (SIL; MIN-U-SIL® 5, US SILICA; Berkeley Springs, WV).  
Dose Determination. Doses were derived from field measurements of particles and 
applied to the equation below (EQ1) to quantify the amount of particle that would 
deposit in the lung of an average male worker doing moderate work for 12 hours per 
day for a period of 14 continuous days using a pulmonary deposition efficacy for each 
particle derived using a software-based algorithm that considers particle characteristics 
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including shape and density [505]. These doses were then normalized to the surface 
area of both the worker’s and the rat’s lungs to obtain doses for in vivo studies (EQ2). 
DPM estimated as elemental carbon was reported to be variable depending on 
operations at hydraulic fracturing sites; (personal communication with JS related to 
Esswein et al., 2013; unreferenced) however, it was generally below the MSHA 
recommendation of 160 µg/m3 total carbon (120 µg/m3 elemental carbon equivalent), 
and DPM in underground mining operations has been measured in excess of 500 µg/m3 
as elemental carbon as reviewed by Pronk et al. (2009). Therefore, in this study, two 
doses of DPM were evaluated. The low dose (7.89 µg per rat) was derived from the 
OELs for DPM measured as elemental carbon of 100 µg/m3 TWA (0.100 µg/l) 
(EQ3).The high dose of DPM was derived from high elemental carbon level 
measurements taken during underground mining of 637 µg/m3 (0.637 µg/l)(EQ4) 
[506].The SiO2 high dose (233 µg SIL) was derived from the highest SiO2 levels 
measured during hydraulic fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ5). In 
addition, to assess exposure to equivalent doses of both particles at a less toxic dose of 
SIL, 50 µg of SIL was also evaluated as the low dose of SIL. 
 
EQ1 - Basic equation for standard worker lung deposition: 
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day, 
min/d) x (total fracking days, d) x (pulmonary deposition efficacy, unitless) 
EQ2 - Equation for normalization to rat lung surface area: 
= (worker’s deposited dose/average male worker lung surface area) x (average 
rat lung surface area) 
EQ3 - Equation for low DPM dose: 
Worker lung deposition = (0.10 μg/l) x (20 l/min) x (720 min/day) x (14 days) x 
(0.10) = 2,016 μg  
Dose calculated = (2,016 μg/102.2 m2) x (0.4 m2) ≈ 7.89 μg per rat 
EQ4 - Equation for high DPM dose: 
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Worker lung deposition = (0.637 μg /l) x (20 l/min) x (720 min/day) x (14 days) x 
(0.10) ≈ 12,842 μg  
Dose calculated = (12,842 μg/102.2 m2) x (0.4 m2) ≈ 50 μg per rat  
EQ5 - Equation for high SIL Dose: 
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x 
(0.118) = 59,472 μg per worker 
Dose calculated = (59,472 μg/102.2 m2) x (0.4 m2) ≈ 233 μg per rat 
DPM and SIL Preparation and Characterization.  Particles were prepared in USP-
grade phosphate-buffered sterile saline (PBS) without Ca2+ or Mg2+ (AMERESCO; 
Solon, OH) for intratracheal instillation. A sonication process was used to disperse 
agglomerated particles. DPM was prepared as a 2 mg/ml stock solution and SIL was 
prepared as a 10 mg/ml stock solution, vortex mixed for one min, followed by 1 min of 
continuous sonication (GE130PB ultrasonic processor; General Electric, Boston, MA).  
Aliquots of stock solution were then further diluted to: 7.89 µg DPM, 50 µg DPM, 50 µg 
SIL, 233 µg SIL, 7.89 µg DPM + 233 µg SIL , 50 µg DPM + 50 µg SIL , or 50 µg DPM + 
233 µg SIL in 0.3 ml PBS. Particles were then vortex mixed for an additional 30 sec, 
followed by 15 sec of sonication prior to intratracheal instillation. Particle preparations 
were dried onto filters and evaluated by field emission scanning electron microscopy 
(FESEM) to determine particle size. The average agglomerate size of the DPM was 
approximately 2 µm. SIL was evenly distributed in suspension with primary particle size 
of approximately 2 µm.  Energy dispersive X-ray (EDX) was performed to determine the 
elemental components of the particles as a measure of particle purity. The DPM was 
comprised primarily of the carbonaceous core, or EC of diesel, with very little detectable 
trace elements including: Chromium, Copper, Iron, Nickel, Oxygen, Silicon, and Zinc. 
Due to their volatile nature, PAHs cannot be measured using EDX, but the total 
extractable mass including the certified mass fractions of PAHs contained in NIST SRM 
2975 is given as 2.7% of the total sample as described in the certificate of analysis 
[504]. No trace metals were detected in the SIL sample. 
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Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals 
(Scottdale, PA), weighing approximately 300 g and free of viral pathogens, parasites, 
mycoplasmas, Helicobacter, and CAR Bacillus, were used for all studies. Rats were 
housed in the pathogen free, environmentally controlled, Association for Assessment 
and Accreditation of Laboratory Animal Care International (AAALAC)-accredited facility. 
The rats were housed in ventilated polycarbonate cages, two per cage, on Alpha-Dri 
cellulose chips and hardwood Beta chips as bedding; they were provided HEPA-filtered 
air, irradiated Teklad 2918 diet, and tap water ad libitum; and were allowed to acclimate 
for one week before exposure. Rats were not restricted from enrichment activity (i.e., 
chewing/climbing). All animal procedures used during the study were reviewed and 
approved by the Institutional Animal Care and Use Committee (IACUC). 
Time-Course Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0, 
rats were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium 
methohexital (Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 7.9 µg 
DPM, 50 µg DPM, 50 µg SIL, 233 µg SIL, 7.89 µg DPM + 233 µg SIL, 50 µg DPM + 233 
µg SIL, 50 µg DPM + 50 µg SIL, or vehicle control (PBS). All particles were delivered in 
0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 week, 1 
month, 2 months, or 3 months following particle exposure (n = 8/group/time point) with 
an intraperitoneal injection of 100-300 mg/kg sodium pentobarbital followed by 
exsanguination. The trachea was cannulated, bronchoalveolar lavage (BAL) was 
performed on the right lung lobes, and BAL cells (BALCs) and fluid (BALF) were 
retained for analysis of parameters indicative of inflammation, injury, oxidant production, 
and immune function. Lung injury and inflammation were evaluated as the presence of 
lactate dehydrogenase (LDH) activity, cytokines, and chemokines in BALF. BALCs were 
centrifuged onto slides, stained, and counted to determine cell phenotype differential. 
BAL lymphocytes were further differentiated by phenotype by flow cytometry. 
Lymphocytes from lymph nodes draining the lung were also differentiated by phenotype. 
Chemiluminescence assays were used to measure oxidant/free radical production by 
BAL phagocytes to evaluate the inflammatory response. The left lung was excised, 
pressure-inflated with 10% neutral-buffered formalin, and weighed with water-
displacement to determine fixed lung volume. Histopathological assessment of lung 
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injury, inflammation, and disease were performed and morphometric analysis of fibrillar 
collagen content was conducted.  
Infection Study Design.  Pulmonary Immune Response to Infection Following Particle 
Exposure. In this study, rats were exposed to 50 µg DPM, 233 µg SIL, 50 µg DPM + 
233 µg SIL combined in 0.3 ml PBS, or PBS alone (vehicle control) by intratracheal 
instillation as described above. One week following particle exposure, rats were 
intratracheally instilled with ~ 5 x 105 colony forming units (cfu) of Listeria 
monocytogenes (strain 10403S, serotype 1) in 0.5 ml of sterile PBS. Animals were 
euthanized at 1, 3, 5, 7, and 14 days following infection (n=8/dose/time point). BAL was 
performed on the right lung lobes, and BALC and BALF were retained for analysis of 
parameters indicative of inflammation, injury, and immune alteration as described for 
the time course study. The left lung was clamped during lavage and subsequently 
excised, homogenized, and cultured to evaluate bacterial clearance from the lung.  
BAL. BAL was performed at each time point after exposure. Following euthanasia as 
described above, the trachea was cannulated, the chest cavity was opened, the left lung 
bronchus was clamped off, and BAL was performed on the right lung lobes. BAL was 
recovered in two fractions. The first fraction of the BAL was obtained by inflating the 
right lung with 4 ml of PBS, massaging for 30 sec, withdrawing, and repeating the 
process a second time with the same 4 ml of PBS. The second lavage fraction 
consisted of repeated 6 ml volumes of PBS instilled with massaging of the chest cavity, 
withdrawal, and combination until a 30 ml volume was recovered. For each animal, both 
fractions of BAL were centrifuged, the cell pellets were combined and re-suspended in 
1 ml of PBS, and the acellular fluid from the first fraction was retained for further 
analysis described for BALF below. 
Analysis of LDH Activity. The level of LDH activity in the BALF of all treatment groups 
was measured at each time point after exposure to evaluate cytotoxicity as a measure 
of lung injury. Measurement of LDH activity in the acellular fluid was obtained using a 
Cobas Mira chemistry analyzer (Roche Diagnostic Systems; Montclair, IN). LDH activity 
was quantified by detection of the oxidation of lactate coupled to the reduction of NAD+ 
at a spectrophotometric setting of 340 nm. 
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BALF Protein Analysis. Cytokines and chemokines involved in inflammatory and 
immune responses were measured at each time point after exposure in the BALF of 
rats treated with PBS, DPM, SIL, or DPM/SIL combinations, with commercially-available 
enzyme-linked immunosorbent assay (ELISA) kits or by multiplex array. The following 
cytokines and chemokines were quantified by ELISA: tumor necrosis factor-α (TNF-α), 
transforming growth factor-β (TGF-β), interleukin (IL)-10, IL-12p70, monocyte 
chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-2 (Novex, Life 
Technologies; Grand Island, New York); IL-2, IL-4, IL-6, interferon (IFN)-γ (R&D 
Systems; Minneapolis, Minnesota); and osteopontin (OPN, Enzo Life Sciences; 
Farmingdale, New York). Additionally, two matrix metalloproteinases (MMP), MMP-2 
and MMP-9, were quantified by ELISA, as well as tissue inhibitor of metalloproteinases 
(TIMP)-1 (R&D Systems) as indices of tissue remodeling due to injury. IL-1α, IL-1β, IL-
5, IL-13, IL-17A, IL-18, granulocyte colony stimulating factor (G-CSF), granulocyte and 
macrophage colony stimulating factor (GM-CSF), eotaxin, leptin, MIP-1α, epidermal 
growth factor (EGF), IFN-γ inducible protein (IP)-10, growth-regulated 
oncogene/keratinocyte chemoattractant (GRO/KC), vascular endothelial growth factor 
(VEGF), fractalkine, lipopolysaccharide (LPS)-induced CXC chemokine (LIX) and 
regulated on activation, normal T-cell expressed and secreted (RANTES) were 
assessed by multiplex array (Eve Technologies; Alberta, CA).  
BALC Differentials. Total BALC collected from rats intratracheally-instilled with PBS, 
DPM, SIL, or DPM + SIL in combination were counted using a Coulter Multisizer II 
(Coulter Electronics; Hialeah, FL). BALC differentials were performed to determine the 
total number of alveolar macrophages (AMs), neutrophils, lymphocytes, and 
eosinophils. Briefly, 5 × 104 cells from each rat were spun down onto slides with a 
Cytospin 3 centrifuge (Shandon Life Sciences International; Cheshire, England) and 
labeled with Hema 3® stain (Fisher Scientific; Kalamazoo, MI) to differentiate cell types. 
Two hundred cells per slide were counted, and the percentage of AMs, neutrophils, 
lymphocytes, and eosinophils was multiplied by the total number of cells to calculate the 
total number of each cell type.  
89 
 
Chemiluminescence (CL). To measure the production of reactive oxidant species by 
BALC, CL was measured according to the method of Antonini et al. [507]. Luminol 
(Sigma-Aldrich; St. Louis, MO) was used as an amplifier to enhance detection of the 
light, and 0.2 mg/mL of unopsonized zymosan (Sigma-Aldrich) or 3 μM phorbol 
myristate acetate (PMA; Sigma-Aldrich) was added to the assay immediately prior to the 
measurement of CL to activate the cells. Because rat neutrophils do not respond to 
unopsonized zymosan, the zymosan-stimulated CL produced is from AMs, whereas the 
soluble stimulant, PMA, activates both neutrophils and AMs to generate reactive oxidant 
species [508]. CL was quantified using an automated Berthold Autolumat LB 953 
luminometer (Wallace, Inc.; Gaithersburg, MD). Each sample was measured for 15 min, 
and the integral of counts per minute (cpm) versus time was calculated. The production 
of CL was calculated as the cpm of stimulated cells minus the cpm of the corresponding 
resting cells, then normalized to the total number of BAL AMs for zymosan-stimulated 
CL and total BALC for PMA-stimulated CL. 
Phenotypic Quantification of BALC and Mediastinal Lymph Node (MLN) Cells by 
Flow Cytometry. Lymphocyte populations in BALC and MLN were differentially 
assessed for phenotype by multicolor flow cytometry analysis. Briefly, cells were 
obtained by lavage (BALC) or by homogenizing the MLN manually between frosted 
glass slides followed by filtration. 106 cells were plated in a 96-well round bottom plate. 
Cells were washed and blocked for non-specific staining using mouse anti-rat CD32 
(FCγRII) antibody (BD Pharmingen™; San Diego, CA). Cell were then fluorescently-
labeled with one or a combination of the following mouse-anti-rat antibodies to 
determine phenotype: CD3 (T cells), CD3 and CD4 (T-helper cells), CD3 and CD8a 
(cytotoxic T cells), CD161a (NKR-P1A; natural killer cells), or CD45R (B220; B Cells) 
(BD Pharmingen™). Cells were then washed and fixed with BD Cytofix/Cytoperm™ (BD 
Pharmingen™) and stored at 4 °C until phenotyped using a BD™ LSRII flow cytometer 
and BD FACSDiva™ software v6  (Becton, Dickinson and Company; San Jose, CA) 
(within 24 h). Results were gated and analyzed using ©FlowJo Software v10 (FlowJo, 
LLC; Ashland, OR).  
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Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by 
airway pressure fixation under 30 cm-water pressure to total lung capacity for 15 min. 
Lung volumes were assessed by weight of water displacement. The left lungs were 
embedded in paraffin, sectioned onto slides, and stained with hematoxylin and eosin 
(H&E) or trichrome. An n = 5 stained slides per treatment group per time-point per study 
block were assessed; blocks were designed with paired controls resulting in n = 10 for 
saline and SIL 233 µg groups from each of the blocks when combined. Stained slides 
were analyzed for indications of inflammation, injury, and fibrosis by a certified 
veterinary pathologist at Charles River Laboratories (Wilmington, MA) who was blinded 
to the treatment groups. Indices of pathology were scored on scale of 0 – 5, where 0 = 
no observed effect, 1 = minimal response, 2 = mild response, 3= moderate response, 4 
= marked response, and 5 = severe response. 
Morphometric Analysis of Connective Tissue Thickness. Tissue sections from left 
lung were deparaffinized and stained with Sirius Red for detection of connective tissue, 
particularly fibrillar collagen. Slides were immersed in 0.1% picrosirius solution (100 mg 
of Sirius Red F3BA in 100 ml of saturated aqueous picric acid) for 2 h followed by 
washing for 1 min in 0.01 N HCl. Slides were then counterstained with hematoxylin for 2 
min, dehydrated, and mounted with a coverslip for imaging. Quantitative morphometric 
methods were used to measure the average thickness of Sirius Red-positive connective 
tissue in the alveolar regions. Volume (% of the alveolar wall) and thickness were 
measured by standard morphometric analyses [509, 510]. This consisted of basic point 
and intercept counting. An eyepiece counting overlay consisting of 11 by 11 lines (121 
total points for each throw of the overlay) was used with a 40X objective. A grid pattern 
for throws of the counting overlay was used in order to ensure a uniform sampling of the 
section, which did not overweight interior points. The counting overlay throws of the 
eyepiece were positioned over the section at 12 uniformly spaced grid points in both X 
and Y coordinates. These 12 grid points were determined using the stage micrometer 
scale to measure the X and Y bounds of the section. Using the bounding rectangle of 
these coordinates a 3 by 4 grid was selected and the 12 intersections were used as the 
center point for each of the eyepiece counting overlay throws. Volume was determined 
by counting the number of points over the Sirius Red-positive connective tissues in the 
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alveolar regions. Surface density of the alveolar wall was determined from intercepts 
between a line overlay and the alveolar wall. To limit the measurements to alveolar 
parenchyma, areas containing airways or blood vessels 25 μm in diameter was 
excluded from the analysis. Average thickness of the Sirius Red-positive connective 
tissue of the alveolar wall was computed from two times the ratio of volume density of 
point to the surface density of the alveolar wall. 
 Bacterial Clearance from the Lung. To measure the clearance of bacteria from the 
lung, left lungs were excised and placed in 10 ml of sterile deionized water. Lungs were 
homogenized using a Polytron®PT-2100 homogenizer with PT-DA 2112/EC aggregate 
attachment (Kinematica; Bohemia, NY). Homogenates were diluted and cultured on 
prepared Brain Heart Infusion Agar plates (Becton, Dickinson and Company). Cultures 
were incubated at 37 °C for 24 h. Cfu were counted and multiplied according to culture 
dilution factors.  
Statistical Analyses. Results for all BAL parameters, cellular phenotype, morphometry 
and bacterial clearance were expressed as mean fold change from control ± standard 
error calculated as  
∆?̅?
𝑐𝑜𝑛𝑡𝑟𝑜𝑙?̅?
  and a one way analysis of variance (ANOVA) was 
performed between all treatments groups at each time point. Significant differences 
among groups were determined using the Student-Newman-Keuls post-hoc test. Data 
were analyzed using SigmaPlot for Windows Version 12.5 (Systat Software, Inc, Ekrath, 
Germany).  For all analyses, significance was set at p < 0.05. Because data from 
histopathology studies are inherently categorical, nonparametric analysis of variance 
was assessed using SAS/STAT software, Version 9.1, of the SAS System for Windows 
statistical programs (SAS Institute, Inc.; Cary, NC). In this instance groups were 
compared using the Wilcoxon rank sum test. 
Results 
 
Particle Characterization. One ml aliquots of 7.89 µg dose DPM, 50 µg dose DPM, 
233 µg dose of SIL, as well as 7.89 µg and 50 µg DPM in combination with SIL 233 µg 
(DS) in PBS solution, were dried on carbon filters and examined using FESEM in order 
to characterize size of the primary particles and their degree of agglomeration. In 
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solution, DPM was found to agglomerate to a size of approximately 2 µm in diameter. 
The primary particle size was found to be smaller in size, ~ 200 nm. The primary 
particles of SIL were approximately 2 µm in size and were evenly distributed in 
suspension (Figure 1A, 1B). The association between DPM and SIL in solution was 
minimal. EDX was used to evaluate the elemental components of each particle. DPM 
was found to be composed of primarily carbon, reflecting the carbonaceous core of the 
DPM, with very little detectable trace elements including: Chromium, Copper, Iron, 
Nickel, Oxygen, Silicon, and Zinc adsorbed to it (Figure 1C). The EDX spectrum of the 
SIL sample is depicted in Figure 1D. 
Time-Course Study. Lung injury was evaluated by examining LDH in the BALF 
collected from rats at 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure to 
particles. LDH activity was significantly increased in all groups that contained the high 
dose of SIL (233 µg), and the high dose of SIL alone at all time points following 
exposure when compared to control (Figure 2). At early time points, the increase in 
groups that were co-exposed to SIL and DPM was primarily driven by SIL particles.  
However, by 3 months, co-exposure to the high doses of DPM and SIL (DS 50/233) 
resulted in an increase when compared to all other groups. There were no significant 
increases in LDH activity in groups exposed to DPM alone at either dose, SIL 50 alone, 
or DS 50/50. 
Protein mediators were evaluated in BALF as a measure of inflammation and immune 
response (Table 1). The low dose of DPM (DPM 7.89) and the low dose of silica (SIL 
50) did not cause any significant changes in BALF protein when compared to control 
with the exception of DPM 7.89, whereby IL-10 was significantly elevated (data not 
shown).  The high dose of SIL caused increases in several proteins associated with 
inflammation; MCP-1, MIP-1α, RANTES, GRO/KC, MIP-2, IP-10, TNF-α, and IFN-γ 
compared with the control and groups exposed to DPM only. SIL 233 alone and the DS 
50/233 groups caused a decrease in the anti-inflammatory protein IL-10 from 1 week to 
2 months post-exposure compared with control and DPM exposed groups. SIL 233 
alone and the DS 50/233 groups also caused a significant increase in MMP-9, a protein 
associated with tissue remodeling that has implications in the development of fibrotic 
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changes in the lung, at all time-points following exposure. Additionally, SIL high dose 
exposure increased MMP-2 and OPN, additional proteins associated with tissue 
remodeling, wound healing, and fibrosis at one month post-exposure, and at all time 
points thereafter for OPN. Finally, the SIL high dose alone or in combination with the 
DPM high dose caused an increase in IL-18, a protein associated with upregulation of 
the NLRP3/NALP3 inflammasome, at later time-points.  DPM 50 alone did not illicit an 
increase in pro-inflammatory cytokines. However, the high dose of DPM did cause a 
decrease in IL-2 and IFN-γ proteins associated with the effector properties of Th1 cells, 
when compared with controls. The decrease in IL-2 was also present in the high dose 
co-exposure group (DS 50/233). Similarly, DPM in combination with SIL exhibited 
independent action on the expression of some cytokines like, MIP-α, GRO/KC, MIP-2, 
MMP-2 and MMP-9 at some time-points (Table 1), suggesting that DPM in a co-
exposure may have the capability to reduce the effects observed with SIL alone. These 
observations may indicate altered macrophage and lymphocyte activity in response to 
treatment with DPM. There were no significant changes in the following cytokines in any 
group: EGF, eotaxin, fractalkine, G-CSF, GM-CSF, IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-
12p70, IL-13, IL-17A, leptin, LIX, TGF-β, TIMP-1, and VEGF (data not shown).  
Cell differentials were performed on BALC to further assess inflammation (Figure 
3A&B). DPM alone at either dose did not cause an increase in the influx of AMs (Figure 
3A) or neutrophils (Figure 3B). AM influx was increased in all groups that contained SIL 
233 beginning at 1 week post-exposure. Neutrophil influx significantly increased as 
early as 1 day post-exposure in all groups containing SIL 233 (Figure 3B), and persisted 
throughout the time course. Exposure to SIL 50 µg showed a trend toward an increase 
in neutrophils up to 1 month following exposure with resolution of response over time. At 
1 month, exposure to DS 50/233 caused a significant increase in neutrophils when 
compared to all groups. The DS50/50 group followed a similar pattern as SIL 50 alone. 
BALC activation was also evaluated as oxidant production ex vivo (Figure 3 C&D). DPM 
only doses used in this study did not cause an increase in oxidant production by AMs 
and neutrophils as measured by CL. Oxidant production in the SIL 233 group 
significantly increased for both total phagocytes at 1 day and at 3 months post-exposure 
(Figure 3C), and oxidant production by macrophages followed a similar pattern  
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(Figure 3D). Interestingly, exposure to the higher dose of DPM combined with the high 
dose of SIL resulted in significantly increased oxidant production over exposure to the 
high dose of SIL alone at 1 week, 1 month, and 2 months post-exposure, suggesting a 
higher oxidant burden in the lung of rats in the high dose co-exposure group at these 
times. 
BAL and MLN lymphocytes were phenotyped by flow cytometry. In addition to 
phagocytic influx described in Figure 3, exposure to SIL at the high dose alone or in 
combinations with DPM 50 caused significantly increased lymphocyte influx into the 
lung as early as 1 day following exposure (Table 2) and proliferation in the MLN as early 
as 1 week post-exposure (Table 3). This effect was attributed primarily to CD4+ and 
CD8+ T cell population subsets. Exposure to DPM 50 alone did not cause a significant 
increase in lymphocyte populations in BAL or MLN.  Additionally, it was noted that for 
the co-exposed group, DPM exhibited independent action reducing the influx of the 
CD8+ subset of cells into the lung observed with the SIL only exposed group at 1 month 
and total T cells, which was mostly attributed to reduced influx of the CD4+ T cell 
subset, at 3 months following exposure. 
H&E and trichrome-stained tissue sections were evaluated by a board certified 
veterinarian pathologist (Table 4). DPM alone at either dose did not cause pathological 
changes in the lung.  Influx of AMs, as a measure of inflammation, was significantly 
elevated in the SIL 233 group alone at all time-points following exposure and when 
combined with DPM at 1 month following exposure. Alveolar epithelial hyperplasia 
(AEH) was also observed at all points following exposure in DS 50/233 exposed groups. 
At 1 month following exposure to particles, minimal to mild septal fibrosis was observed 
in groups exposed to SIL 233. Interestingly, incidence of septal fibrosis was significantly 
increased by co-exposure to the high doses of DPM and SIL at 1 month. By 3 months 
after exposure, occurrence of septal fibrosis was equivalent in both SIL 233 only and 
co-exposed groups. Groups exposed to SIL in combination with high dose DPM scored 
significantly higher for particles in tissue versus DPM alone as indicated by the 
presence of brown granules accumulated in macrophages, which corresponds to an 
observation of increased coloration in lymph nodes as well. Furthermore, mild 
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hyperplasia of the bronchiolar/alveolar epithelium was observed near the terminal 
bronchioles at 2 months following exposure and was found to be associated with the 
presence of macrophages loaded with high particle content, suggesting a correlation 
between tissue damage and the presence of particles (data not shown). SIL 50 and DS 
50/50 were not evaluated. Overall, most histopathological changes were attributable to 
exposure to 233 µg of SIL; however, the presence of DPM often increased the severity 
and/or incidence of these changes in the co-exposure groups.    
To further quantify observations of fibrosis, alveolar expansion, alveolar septal wall 
thickness, and thickness of fibrillar collagen were measured by morphometry to further 
assess the fibrotic response to exposure. Alveolar expansion was measured as a ratio 
of the total airspace volume to volume versus the surface to volume of the epithelial 
surface intercepts or thickness of airspace between alveolar tissues. Alveolar septal 
wall thickness was measured as a ratio of the total volume to volume of alveolar tissue 
versus the surface to volume of epithelial surface intercepts. No significant differences 
were observed between the treatment groups. Additionally, fibrillar collagen thickness 
was measured as the ratio of total collagen volume to volume versus total epithelial 
surface intercepts surface to volume. This measurement is indicative of fibrotic 
development in lung tissue. Although not statistically significant, there was a trend for 
increased fibrillar collagen volume in SIL 233-exposed groups and this trend was further 
increased for co-exposed groups at the latest time points measured (data not shown).  
Infection Study. In order to investigate the effects of particle exposure on respiratory 
susceptibility to a bacterial pathogen, an infectivity study was conducted to assess the 
clearance of L. monocytogenes from the lung over a 14 day time course 1 week 
following exposure to particles. Despite lung inflammation and phagocytic cell activity 
observed in the absence of infection in co-exposed groups (Figure 3), overall clearance 
of the pathogen was not significantly altered between these treatment groups (Figure 
4A). The data suggest that, for the doses of DPM used in this study, which were not 
found to induce toxicity by themselves, combination with moderately toxic doses of SIL 
did not alter susceptibility to an infection with Listeria monocytogenes. Influx of cells into 
the lungs was significantly increased for SIL 233 exposed groups at day 1 post-infection 
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(Figure 4). This influx appeared to be comprised mostly of neutrophils (Figure 4D) and 
lymphocytes. By day 3 post-infection, the influx of cells in SIL 233-exposed groups was 
resolved. Finally, cells from the BAL and MLN were phenotyped as in the time-course 
study to evaluate lymphocyte populations. For the SIL 233-exposed group the influx of 
lymphocytes into the BAL at day 1 post-infection was significantly greater when 
compared with the control group, and again on day 14. DPM exposure caused no 
significant alterations in lymphocyte influx into the lung, while combined exposure to 
particles caused significant increases in total lymphocyte influx at day 14 compared with 
control and DPM exposed groups comprised mostly of CD4+ cells (Table 5).  In the 
MLN, the SIL 233-exposed group had significantly increased lymphocytes, specifically 
CD4+ T Cells, compared with control and overall T cell populations were significantly 
increased when compared to control and DPM 50 at day 1 post-infection. SIL-233 
exposure also increased total lymphocytes in the MLN compared with all other groups 
at day 3 post infection. DPM exposure caused significant decreases compared with SIL- 
exposed group for total T Cells at day 3 post-infection and caused significant decreases 
in the CD8+ subset of T cells compared with SIL-233 and control groups for the same 
time-point. Finally, combined exposure caused increased lymphocytes at Day 1 for total 
cells and total T cells compared with control group and compared with DPM and control 
for the CD4+ T cell subset (Table 6). 
Discussion 
 
The current studies were conducted in order to address a knowledge gap with 
relation to co-exposures representative of those that may occur in mining industry 
occupations, including hydraulic fracturing. It is important to note that the DPM used in 
this study was extracted from DE collected from an industrial forklift in the 1990s, which 
qualifies it as “transitional” in nature (collected between 1988 and 2006). Transitional 
DE samples vary from “traditional” DE or “TDE” (collected prior to 1988) and New 
Technology DE or “NTDE” (collected post-2006) in chemical and physical properties. 
TDE is considered to be more hazardous in nature due to having a larger amount of 
particulate matter, carbon monoxide, and hydrocarbon emissions, while NTDE has 
significantly lower TDE-related emissions, [511]; however, very little information is 
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available on health outcomes related to NTDE exposure. Additionally, the current study 
examined DPM only and not total DE, which contains higher levels of metals and 
hydrocarbons, which in turn may lead to greater toxicity following exposure to DE. The 
silica used in this study was also a surrogate for occupational exposures that occur in 
mining operations and oil and gas extraction. It is not a freshly fractured form of 
crystalline silica, which has been shown to be higher in toxicity than aged silica [487], 
and although sand used at hydraulic fracturing sites contains respirable silica, 
composition of the sand may vary from site to site [512, 513]. 
While most parameters of toxicity evaluated could be attributed to the more 
reactive and toxic crystalline silica particles, DPM, at doses that represent different 
durations of exposure based on field measures taken at mining sites and OELs, did 
exacerbate the effects of silica in the acute exposure model examined, particularly 
between 1 week and 1 month post-exposure. This effect was observed for the 
parameters of pulmonary inflammation, quantified by the influx of neutrophils into the 
lung (Figure 3B) as well as by the oxidant production by phagocytes (Figure 3 C, D) at 
time points up to one month for inflammation and up to three months for oxidant 
production. Furthermore, assessment of pathology in the lung tissue suggested that 
DPM may be contributing to the mild fibrotic response induced by silica in the lung, 
whereby there was an increased incidence of mild fibrosis at 1 month post-exposure in 
the animals that were exposed to the combination of the high doses of particulate. 
Additionally, while silica contributed to an increase in lymphocyte- and immune-related 
cytokines in the lungs (Tables 1-3), DPM reduced the expression of many proteins 
including: MIP-1α, GRO/KC, MIP-2, IL-2, IFN-γ, MMP-2, and MMP-9, in the BALF when 
in combination with silica, especially at early time-points. DPM may exhibit independent 
action on macrophage activity, as well as lymphocyte influx and proliferation thus 
attenuating the effects induced on these cell types by silica alone (Table 1-3).  
Immunological alterations were further examined by evaluating susceptibility to an 
infection following particulate exposure. While some alterations in immune cellular influx 
were observed in silica-exposed groups (Tables 6-7), the exposures did not alter the 
bacterial clearance rate or resolution of infection.  
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The toxicological properties of crystalline silica are well-established. Silica is 
known to cause fibrotic changes in the lung following both acute exposures to bolus 
doses of particles and chronic lower dose exposure to particles [514]. The mechanism 
directing the toxicity of silica particles in the lung still remains ambiguous but is thought 
to stem from multiple attributes relating to the crystalline structure of silica and its 
reactivity based on either surface charge or silicon-containing groups present on the 
surface of silica due to disruptions made to its structure during crushing, grinding, and 
drilling [514]. In conjunction with this, reactive oxygen/nitrogen species (ROS/RNS) 
associated with the particles themselves or as products of the respiratory burst following 
activation of phagocytes have been shown to drive a prolonged state of inflammation in 
the lungs [487, 490, 515, 516]. Studies investigating pulmonary toxicity of diesel 
demonstrate DPM-induced inflammation and oxidative stress as well [467, 473-476]; 
however, unlike silica, DPM exposure does not have the same propensity to cause 
fibrosis. Instead, chronic exposures to DE/DPM have been shown to cause disease 
outcomes including chronic obstructive pulmonary disorder, emphysema, and cancer 
[411, 415, 517, 518]. 
In regards to potential mechanisms in the development of fibrosis, crystalline 
silica particles have been shown to either bind to scavenger receptors on alternatively 
activated macrophages (M2) followed by uptake into the cell in a phagosome, or the 
particles are phagocytosed by a classically activated macrophage (M1) in the 
interstitium once the M2 macrophages become overloaded [128]. M2s are 
phenotypically distinct from M1s, being activated primarily by IL-4 and IL-13 rather than 
IFN-γ and are typically less involved in killing of microbes/clearance and more 
associated with functions of wound healing and collagen development [519]. As 
reviewed by Kawasaki et al. and demonstrated in original work by Joshi et al. [128, 130, 
520], the uptake of these particles triggers a signaling cascade within macrophages that 
leads to: the release of recruitment factors for additional inflammatory/immune cells, 
stimulation of the autocrine and paracrine production of fibrogenic mediators, and, most 
notably, either the successful clearance of particles from the lung to either the GI tract 
or lymphatics or the eventual phagolysosomal destruction and death of the cell that 
engulfed the particles. Directly following the death of a macrophage containing silica, 
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the particles are engulfed by another nearby phagocyte. This repeated cycle of uptake, 
release, and re-uptake continues in the lung until a point when cellular signals lead to 
the formation of a granuloma to sequester particles in an effort to reduce damage to the 
surrounding tissue [521-523]. It is hypothesized that M1 type macrophages may initiate 
this process [128], but other cell types including lymphocytes, epitheliod monocytes and 
macrophages, and giant cells are involved as well [91, 524, 525].  
In relationship to the fibrotic paradigm discussed above, this study showed that 
there were significant increases in neutrophil and lymphocyte recruitment in the high 
dose co-exposed group when compared to the silica-exposed group, along with 
significant increases in cytotoxicity in the lung measured as LDH in BALF, and this was 
accompanied by the increase in incidence of mild fibrosis at 1 month post-exposure in 
the high dose co-exposure group.  While the interaction of silica with receptors was not 
investigated in the present study, downstream mediators of these interactions were 
increased in the BALF. Increases in chemotactic/recruitment proteins associated with 
inflammation (MCP-1 (CCL2), MIP-1α (CCL3), RANTES (CCL5), GRO/KC (CXCL1), 
MIP-2 (CXCL2), IP-10 (CXCL10), and TNF-α) were significantly increased in the groups 
containing the high dose of silica, and the increases tended to progress throughout the 
time-course (Table 1); whereas, the anti-inflammatory protein, IL-10, was significantly 
decreased in silica-exposed groups throughout the time-course. Additionally, OPN, 
MMP-2, and MMP-9, proteins involved in tissue remodeling, were also significantly 
increased in silica-exposed groups, particularly later in the time-course. Though 
differences between the high dose co-exposed group and high dose silica-exposed 
group separately were not statistically significant for this parameter, there was 
approximately a 30% increase in MMP-9 expression, at the latest time-point, suggesting 
a trend for increased tissue remodeling in the co-exposed group over that of silica 
alone.  
In addition to the pro-inflammatory responses discussed above, a significant 
increase in IL-18 at later time-points following silica exposure was measured for both 
the high dose co-exposed and high dose silica only groups. The NLRP3 inflammasome 
is an immune system mediator that detects danger signals produced by damaged cells. 
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The inflammasome is also activated by stimulation with foreign bioreactive particles like 
multi-walled carbon nanotubes, which cause production of oxidants by phagocytic cells 
leading to up-regulation of NLRP3 complex formation, resulting in the cleavage of IL-18 
and IL-1β and prolonged inflammation and fibrotic development in the lung [526-530]. 
Crystalline silica exposure has also been shown to upregulate the activity of the 
NALP3/NLRP3 inflammasome following binding to scavenger receptors on 
macrophages both in vitro [123, 531, 532] and in vivo [532] leading to the cleavage of 
IL-1β and IL-18 to their active forms by caspases leading to apoptosis or pyroptosis in 
cells [123, 131] .  While we did not observe an increase in IL-1β we did observe an 
increase in IL-18 for both the SIL 233 and high dose co-exposed groups. At time-points 
as early as 1 week following exposure, IL-18 was significantly increased in both groups 
compared with DPM 50, but by 3 months both groups were significantly greater than 
both DPM 50 and control (Table 1). Therefore, inflammasome activation may also be 
occurring as an early response in the development of fibrosis.  
In addition to the pro-inflammatory properties of both DPM and crystalline silica, 
both particles have been shown to alter mechanisms of pulmonary immunity, although 
the effects following exposure to these particles differ in this regard. Silica has been 
shown to cause hyper-activation and hyper-responsiveness of both macrophages [92, 
402] and T-cells [52, 91]. This was also demonstrated in the current study in the group 
exposed only to the high dose of silica individually. Conversely, DPM has been shown 
to suppress activation and effector functions of macrophages and T cells, and this 
suppression has been associated with increased susceptibility to infection and reduced 
pulmonary clearance of pathogens [316, 324, 402, 483, 485, 533-535]. Because both 
DPM and silica exposure have been shown to increase lung inflammation and 
phagocytic recruitment in acute exposures, but lead to decreased clearance following 
chronic exposure, it was of interest to determine whether the capacity for clearance of a 
pathogen in an acute model of exposure to the particles in combination would be 
altered. In the present study, a difference in bacterial clearance from the lungs was not 
observed following exposure to DPM, silica, or the DPM and silica co-exposure (Figure 
4A); this may reflect the lower doses delivered here when compared to previous studies 
[59, 62, 316, 324, 481, 497]. Other differences among studies include the degree to 
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which DPM or SIL were freshly collected, thus making them less reactive than particles 
that workers in the field may be exposed to [514, 536, 537], and the engine source of 
the DPM, which would determine the elemental constituents. In addition, the timing of 
the infection may influence clearance of the infection following exposure.  In studies that 
examined a pathogenic response more acutely (within 3 days of particle exposure), 
DPM exposure reduced clearance of the infection [316, 324, 481]. In response to silica 
exposure, clearance of bacteria has been shown to be critically dependent upon 
whether exposure is acute [538], resulting in increased clearance of infection due to 
enhanced inflammatory and essentially a “primed” macrophage response for effective 
uptake and clearance of the bacteria, or chronic, resulting in decreased clearance [59, 
62, 497] suggesting the degree of lung injury present would alter susceptibility to 
infection.  Further investigation is needed to determine the effects that particles might 
have on clearance and susceptibility to infections experienced more subsequently to 
particle exposure. Given that we observed development of fibrosis at later time-points, 
administering bacteria later in the time-course, such as at 1, 2, or 3 months may result 
in more similar effects to what has been observed in chronic silica exposures previously 
[59, 62, 497].  
Conclusion 
 
The data taken together show that DPM exposure at doses that do not elicit 
pulmonary toxicity has the capacity to significantly alter silica-induced pulmonary 
effects, primarily inflammation, oxidant production, and rate of onset of fibrotic changes 
in the lung, as well as exhibit independent action, which mediates some immune cell 
activity when the exposure occurs simultaneously as a mixture.  The current study does 
not delineate the specific interactions between the two particulates in the lung following 
exposure and leading to the observed effects. One possibility is that presence of and/or 
injury induced by crystalline silica alters the clearance rate of the DPM particles from the 
lung, which in turn results in a longer persistence of DPM in the lung in conjunction with 
silica. DPM alone may be cleared at a greater rate resulting in the lack of observed 
toxicity following the individual exposures in this study. This hypothesis is supported by 
the evidence from the histopathology analysis in the observance of brown granules 
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(DPM) in the lungs of only the co-exposed group and by the presence of DPM particles 
in the lymph nodes of only the co-exposed group at the later time points and not the 
DPM-only exposure.  Another possibility for the observed effects may be related to the 
particle load as a result of DPM and crystalline silica delivered to the lung 
simultaneously. Although the delivered doses by intratracheal instillation in these 
studies are lower than many previous studies [324, 481, 497, 538], the co-exposed 
group received a total particle load of 283 µg compared to the individual silica load of 
233 µg and the DPM load of 50 µg, which is an increase in load of ~18 %. Studies are 
underway to address the effects of load and clearance in relationship to the combined 




Table 1: Immunoregulatory Proteins Recovered from BALF of Sprague-Dawley Rats Exposed to DPM, 
SIL, or Combination of DPM and SIL  
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All data are shown as mean fold change over control ± standard error. *Different from control and DPM 50 µg; ^different from 
DPM 50 µg and DS 50/233 µg groups; +different from all other groups; &different from DPM 50 µg; @different from control. 
Results that were below the limit of detection (BLD) were noted; 1/2 of the lowest limit of detection was used for statistical 
analysis of values BLD. Statistical significance is p ≤ 0.05.
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Table 2: Lymphocyte Phenotype Determination by Flow Cytometry in the BALF 




















All data are expressed as mean fold change over control ± standard error. *Different from control 
and DPM 50 µg; & different from DPM 50 µg; + different from all other groups. Statistical 





Table 3: Lymphocyte Phenotype Determination by Flow Cytometry in the 
MLN Excised from Sprague-Dawley Rats Exposed to DPM, SIL, or DPM 
and SIL Combined 
 
All data are shown as mean fold change over control ± standard error. *Different from control and 




Table 4: Severity and Incidence Scores for Left Lung Lobes of Sprague-
Dawley Rats Exposed to DPM, SIL, or DPM and SIL Combined in Varyin g 
Doses 
Lung tissue was analyzed and scored for accumulation of alveolar macrophages as an 
index of inflammation (AM), alveolar epithelial hyperplasia (AEH), bronchus associated 
lymphoid tissue hyperplasia (BH), lymphoid nodules in the interstitium (LNI), brown 
granules in alveolar macrophages (BG; presence of DPM particles), fibrosis in alveolar 
septae (F) (n=5 or 10 per group per time point). Severity was scored as 0 - 5: 0 = 
normal, 1 = minimal/slight, 2 = mild, 3 = moderate, 4 = marked, and 5 = severe. 
Incidence was noted as Focal (F), Multi-focal (M), and Diffuse (D). Data are presented 
as means with incidence (number of animals with a positive score per total animals) in 
parentheses. bDifferent from all other groups; ddifferent from control and DPM 50 µg 
only; hdifferent from control only; idifferent from control, DPM 7.89 µg, and DPM 50 µg 
group; jdifferent from control and SIL 233 µg group;  kdifferent from control and DPM 
7.89 µg group.  Note: all notations indicate a p value <0.05 except where asterisks 




Table 5: Lymphocyte Phenotype Determination by Flow Cytometry in the 
BALF Recovered from Sprague-Dawley Rats Exposed to DPM, SIL, or 
DPM and SIL Combined with LM 
 
All data are shown as mean fold change over control ± standard error. *Different from 




Table 6: Lymphocyte Phenotype Determination by Flow Cytometry in the 
MLN Excised from Sprague-Dawley Rats Exposed to DPM, SIL, or DPM 
and SIL Combined with LM 
 
All data are shown as mean fold change over control ± standard error.  *Different from 
control and DPM 50 µg; @different from control; ^ different from DPM 50 µg and DS 50/233 
µg groups; #different from SIL 233 µg; +different from all other groups. Statistical 




Figure 1: FESEM images of particles. (A) 233 µg SIL and 7.89 µg DPM in combination 
prepared in PBS solution, diluted 1:10 in PBS, then dried onto a filter under 20,000x 
magnification (scale bar = 2 µm with 10 segments of 0.2 µm each) (B) 233 µg SIL
 
and 
50 µg DPM prepared in PBS solution, diluted 1:10 in PBS, then dried onto a filter in PBS 
solution under 20,000x magnification (scale bar = 2 µm with 10 segments of 0.2 µm 
each). Red arrows indicate SIL and yellow arrows indicate DPM. (C) EDX of DPM 
particles pictured in the FESEM above at 20 keV. Labeled spectral peaks for elements 
primarily present in the samples appear in red (carbon). All other labeled peaks are 
elements commonly found in DPM but present only in trace amounts in this sample 
(Chromium, Copper, Iron, Nickel, Oxygen, Silicon, and Zinc). (D) EDX of SIL particles 




















































































Figure 2: LDH activity in BALF after exposure to DPM, SIL, or a combination of DPM 
and SIL (DS) at indicated doses (µg). Data are shown as mean fold change over control 
(y = 0). DPM 7.89 µg was not evaluated at 2 months.  aDifferent from control, DPM 7.89 
µg, DPM 50 µg, SIL 50 µg, DS 50/50 µg groups; bdifferent from all other groups; 
cdifferent from control, DPM 50 µg, SIL 50 µg, and DS 50/50 µg groups. Statistical 




Figure 3: Total AMs (A) and neutrophils (B) in the BALF following exposure to DPM, 
SIL, or DS at doses indicated.  Production of oxidants by total phagocytes stimulated 
with PMA (C)  or by AMs only stimulated by zymosan (D) measured by 
chemiluminescence following exposure to DPM, SIL or DS at doses indicated. DPM 
7.89 µg was not evaluated at 2 months. All data are shown as a mean fold change over 
control (y = 0). aDifferent from control, DPM 7.89 µg, DPM 50 µg, SIL 50 µg, DS 50/50 
µg groups; bdifferent from all other groups; cdifferent from control, DPM 7.89 µg, DPM 
50 µg, SIL 50 µg, and DS 50/50 µg groups; ddifferent from control and DPM 50 µg only; 
edifferent from control , DPM 50 µg, and SIL 50 µg groups; fdifferent from control, DPM 
7.89 µg, DPM 50 µg, SIL 50 µg, and DS 50/50 µg; gdifferent from control, DPM 7.89 µg, 





















Figure 4: (A) Bacterial burden in the left lung over the time-course. Data is shown on a 
Log10 scale. Total cells (B), total AMs (C), and total neutrophils (D) recovered by lavage 
following exposure to DPM, SIL, or DS at doses indicated. (B-D) Data are shown as a 
mean fold change over control (y = 0). *Different from control and DPM 50 µg; @different 
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The effects of acute pulmonary co-exposures to silica and diesel particulate matter 
(DPM), which may occur in various occupations including the mining and construction 
industries, were investigated in vivo. Rats were exposed by intratracheal instillation (IT) to silica 
(SIL) 233 µg, DPM 233 µg, carbon black (CB) 233 µg, DPM and SIL (DPM/SIL) combined, CB 
and SIL (CB/SIL) combined, or to PBS alone (vehicle control). At 1 day, 1 week, 1 month, 2 
months, and 3 months post-exposure, bronchoalveolar lavage and histopathology were 
performed to assess lung injury, inflammation, and immune response. Although SIL caused 
enhanced parameters of inflammation and injury at all times-points, DPM exposure alone 
caused increased lactate dehydrogenase activity only at the early time-points (1 day, 1 week) 
post-exposure when compared to control.  Parameters of increased injury were also observed in 
the CB group compared to control and compared to DPM and control for inflammation at day 1; 
however, these effects were transient and subsided by 1 week. DPM combined with SIL 
increased oxidant production by phagocytes compared with all other groups at all time-points 
post exposure, and increased markers of inflammation, injury, the influx of lymphocytes in the 
lung, the proliferation of lymphocytes in the mediastinal lymph nodes (MLN), and the incidence 
of epithelial hyperplasia in lung tissue, scored as minimal, at later time-points compared to 
exposure to SIL alone. The combination of CB with SIL caused increased macrophage oxidant 
production at 1 day compared with control and DPM groups, and 1 week and 1 month 
compared with all individual particle dose groups, which resolved by 2 months post-exposure. 
Additionally, CB combined with SIL resulted in increased markers of inflammation and injury at 
all time-points following exposure; however, these effects were primarily attributed to the effects 
of SIL, particularly at later time-points following exposure. To assess susceptibility to lung 
infection following co-exposure, rats were exposed to particles, as described above, 1 week 
before intratracheal inoculation with 5x105 Listeria monocytogenes. At 1, 3, 5, 7, and 14 days 
following infection, pulmonary immune response and bacterial clearance from the lung were 
evaluated. Co-exposure to CB and SIL increased bacterial clearance at day 1 compared with 
control and CB only. At day 3, animals exposed to SIL alone or in combination with CB or DPM 
cleared the infection to a greater degree than those exposed to DPM alone. No differences in 
clearance rate occurred beyond day 3 and all groups effectively resolved the infection by day 
14. The study showed that DPM had the capacity to increase SIL-induced lung injury, 
inflammation and oxidant production to a greater degree than equal doses of CB and SIL, 
indicating these effects are due to properties inherent to DPM rather than particle load. 
Alternately, tissue remodeling at later time points, indicated by increased incidence of tissue 
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remodeling proteins in the lung and fibrosis, correlated better with particle load and the 
presence of SIL following co-exposures. Additionally, particle-specific effects were observed in 
the susceptibility model whereby DPM alone transiently reduced innate immune response to a 
pathogen, and SIL appeared to enhance the bacterial clearance at early time points post-
infection; however, effects on susceptibility to infection did not occur during the adaptive phase 
of the response. Overall, the study showed that in co-exposure to SIL and DPM, total particle 
load and the presence of SIL contribute to toxicity in the lung, and in addition, DPM caused 
particle specific effects that significantly altered the toxicological outcomes beyond that of just 




Many workers in industrial occupations may be at risk for exposure to respirable 
particles as a part of their regular duties. This is particularly true in industries that utilize heavy 
machinery powered by diesel engines. Diesel exhaust releases particulates into the air, which 
are respirable in size. Furthermore, occupations that involve the redistribution of earth or the 
extraction of natural resources including construction, excavation, tunneling, agriculture, metal 
and non-metal mining, and the oil and gas industry may not only utilize this equipment during 
operations, but depending on the industry or operation, a co-exposure with quartz or crystalline 
silica (SiO2) that is ubiquitous in nature may also occur.  Field studies performed by researchers 
at the National Institute for Occupational Safety and Health (NIOSH) identified both of these 
particulates as potential concerns for occupational exposure [461].  Furthermore, since diesel-
powered equipment has gained popularity as a mechanical mechanism of extracting mineral 
resources underground, these types of co-exposures are common in many mining 
environments, and have the potential to create particulate exposures that are greater in 
concentration due to the confined working environments encountered underground [403]. While 
the toxicities of these two particulates have been studied in detail as individual exposures, there 
are very few in vivo studies examining the pulmonary effects of these particulates in 
combination or at doses that are comparable to measurements collected during occupational 
activities.  
Previously we have shown that exposure to DPM at doses derived from particulate 
measures collected during different mining operations were minimally toxic as an individual 
exposure; however, when in combination with crystalline silica, the presence of DPM 
significantly enhanced parameters of inflammation, oxidant production, and the onset of fibrotic 
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tissue changes in the lung as compared to silica (SIL) alone. Furthermore, DPM in combination 
with SIL was shown to alter some immunological responses observed individually due to SIL 
exposure [539]. The study however, did not delineate whether specific properties of DPM 
contributed to these responses or whether the presence of additional particle, or overall particle 
load, influenced these effects. The goal of the current study was to evaluate whether those 
effects are particle- or particle load-specific. DPM is a complex mixture of aromatic 
hydrocarbons, metals, nitrates, sulfates, and other chemicals complexed to a carbon core. For 
this purpose, carbon black (Printex® 90; CB) was used as a reference particle to control for load 
effects versus DPM-specific effects, as it represents the core material of DPM without the 
constituents of DPM frequently associated with toxicity [277, 281, 298, 326, 332, 333, 335, 467, 
481]. 
 Doses for the current study were based on field measurements of SiO2 taken during 
active surface-level mining operations [486]. Equivalent doses of DPM and CB were 
administered in an effort to determine the toxicological effects due specifically to a particular 
particle (SIL, DPM, or CB). Further, combinations of CB or DPM with SIL were administered to 
determine load versus particle specific effects that may result in a co-exposure scenario. Similar 
to the previous study [539], a single acute bolus dose of SIL, DPM, CB, a combination of DPM 
and SIL (DPM/SIL), or a combination of CB and SIL (CB/SIL), were administered to Sprague-
Dawley rats by a single intratracheal instillation (IT). Parameters of lung injury, inflammation, 
histopathology, and immune responses were evaluated over a three-month time-course. In 
addition, susceptibility to pulmonary infection following exposure to the particles individually and 
in combination was also evaluated to further assess alterations in immune response following 
particle exposure.  
Methods 
 
Particles. Particles in these studies were used as surrogates to represent work site exposures. 
The surrogate particle used for SiO2 was α-quartz crystalline silica (SIL; MIN-U-SIL® 5, US 
SILICA; Berkeley Springs, WV). DPM was obtained from the National Institute of Standards and 
Technology (NIST) as a commercially available NIST Standard Reference Material (SRM) 2975 
(referred to as DPM in this study). SRM 2975 was originally collected from an industrial forklift in 
the 1990s [540]. Carbon black (CB; Printex®90 from Degussa-Hüls, Parsippany, NJ) was used 
as a reference material and control for effects related to particle load. The particle was selected 
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based on composition, as carbon black comprises the core material of DPM, and size of primary 
particles derived from field emission scanning electron micrographs. 
Dose Determination. Doses were derived from field measurements of SiO2 and applied to the 
equation below (EQ1) to quantify the amount of particle that would deposit in the lungs of an 
average male worker doing moderate work for 12 hours per day for a period of 14 continuous 
days using pulmonary deposition efficacy for each particle. Deposition efficacy was derived from 
a software-based algorithm that considers particle characteristics including shape and density 
[541]. This dose was then normalized to the surface area of both the worker’s and rat’s lungs to 
obtain dose for in vivo studies (EQ2). The SIL dose (233 µg SIL) was derived from the highest 
SiO2 levels measured during hydraulic fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ3). It 
was previously demonstrated that DPM in a co-exposure with SIL induced greater inflammation, 
oxidant production by phagocytes, and onset of pulmonary fibrosis in comparison to either 
particle individually. The goal of this study was to determine whether particle load induced these 
effects or if effects were due to DPM specifically. For this purpose, DPM or CB were 
administered at a dose equivalent to that of SIL to determine which particle, if either, had a 
greater toxic effect in a co-exposure.  
EQ1 - Basic equation for standard worker lung deposition: 
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day, min/d) 
x (total fracking days, d) x (pulmonary deposition efficacy, unitless) 
EQ2 - Equation for normalization to rat lung surface area: 
= (worker’s deposited dose/average male worker lung surface area) x (average rat lung 
surface area) 
EQ3 - Equation for SIL Dose: 
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x (0.118) = 
59,472 μg per worker 
Dose calculated = (59,472 μg/102.2 m2) x (0.4 m2) ≈ 233 μg per rat 
SIL, DPM, and CB Preparation and Characterization.  Particles were prepared in USP-grade 
phosphate-buffered sterile saline without Ca2+ or Mg2+ (PBS: AMERESCO, Solon, OH) for IT. A 
sonication process was used to disperse agglomerated particles. SIL was prepared as a 10 
mg/ml stock solution, DPM and CB were prepared as 2 mg/ml stock solutions. All particles were 
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vortex mixed for 1 min, followed by 1 min of continuous sonication (GE130PB ultrasonic 
processor; General Electric, Boston, MA).  Aliquots of stock solution were then further diluted to 
233 µg SIL, 233 µg DPM, 233 µg CB, 233 µg DPM + 233 µg SIL , or 233 µg CB + 233 µg SIL in 
0.3 ml PBS. Particles were then administered to the rats by IT as a single dose as previously 
described [539]. 
Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals (Scottdale, 
PA), weighing approximately 300 g and free of viral pathogens, parasites, mycoplasmas, 
Helicobacter, and CAR Bacillus, were used for all studies. Rats were housed in the pathogen 
free, environmentally controlled, AAALAC-accredited facility. The rats were housed in ventilated 
polycarbonate cages, two per cage, on Alpha-Dri cellulose chips and hardwood Beta chips as 
bedding; they were provided HEPA-filtered air, irradiated Teklad 2918 diet, and tap water ad 
libitum; and were allowed to acclimate for one week before exposure. Rats were not restricted 
from enrichment activity  
(i.e., chewing/climbing). All animal procedures used during the study were reviewed and 
approved by the IACUC in the Health Effects Laboratory Division (HELD) at NIOSH. 
Time-Course Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0, rats 
were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium methohexital 
(Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 233 µg DPM, 233 µg CB, 
233 µg SIL, 233 µg DPM + 233 µg SIL, 233 µg CB + 233 µg SIL, or vehicle control (PBS). 
Studies were conducted in two blocks with paired PBS and SIL controls. All particles were 
delivered in 0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 week, 1 
month, 2 months, or 3 months following particle exposure (n = 8/group/time point for DPM, CB, 
DPM/SIL, and CB/SIL groups and n = 16 for PBS and SIL groups) with an intraperitoneal 
injection of 100-300 mg/kg sodium pentobarbital, followed by exsanguination. The trachea was 
cannulated, bronchoalveolar lavage (BAL) was performed on the right lung lobes, and BAL cells 
(BALCs) and fluid (BALF) were retained for analysis of parameters indicative of inflammation, 
injury, oxidant production, and immune function. Lung injury and inflammation were evaluated 
as the presence of lactate dehydrogenase (LDH) activity, cytokines, and chemokines in BALF. 
BALCs were differentiated and phenotyped. Lymphocytes from the mediastinal lymph nodes 
(MLN) draining the lung were also differentiated by phenotype. Chemiluminescence assays 
were used to measure oxidant/free radical production by BAL phagocytes to evaluate the 
inflammatory response. The left lung was excised, pressure-inflated with 10% neutral-buffered 
formalin, and weighed with water-displacement to determine fixed lung volume. 
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Histopathological assessment of lung injury, inflammation, and disease was performed, and 
morphometric analysis was performed to assess particulate lung burden. 
Infection Study Design.  Pulmonary Immune Response to Infection Following Particle 
Exposure. In this study, rats were exposed to 233 µg DPM, 233 µg CB, 233 µg SIL, 233 µg 
DPM + 233 µg SIL, or 233 µg CB + 233 µg SIL combined in 0.3 ml PBS, or PBS alone (vehicle 
control) by intratracheal instillation as described above. One week following particle exposure, 
rats were intratracheally instilled with ~ 5 x 105 colony forming units (cfu) of Listeria 
monocytogenes (strain 10403S, serotype 1; LM) in 0.5 ml of sterile PBS. The study was 
conducted with the same block design as the previous study with paired PBS and SIL controls. 
Animals were euthanized at 1, 3, 5, 7, and 14 days following infection (n = 8/dose/time point for 
DPM, CB, DPM/SIL, and CB/SIL groups and n = 16 for PBS and SIL groups). BAL was 
performed on the right lung lobes, and BALC and BALF were retained for analysis of 
parameters indicative of inflammation, injury, and immune alteration as described for the time 
course study. The left lung was clamped during lavage and subsequently excised, 
homogenized, and cultured to evaluate bacterial clearance from the lung.  
BAL. BAL was performed at each time point after exposure as previously described [539]. The 
acellular first fraction of fluid was retained for analysis of LDH, cytokines and chemokines. The 
BALC were counted, differentiated, and assess for oxidative potential as described previously. 
BALF Analysis: LDH activity in the BALF of all treatment groups was measured 
spectrophotometrically at each time point after exposure to evaluate cytotoxicity as a measure 
of lung injury as previously described [539].Cytokines and chemokines involved in inflammatory 
and immune responses were measured in the BALF at each time-point after exposure using 
commercially-available enzyme-linked immunosorbent assay (ELISA) kits or by multiplex array. 
The following cytokines and chemokines were quantified by ELISA: monocyte chemotactic 
protein (MCP)-1, macrophage inflammatory protein (MIP)-2 (Novex, Life Technologies; Grand 
Island, New York); and osteopontin (OPN, Enzo Life Sciences; Farmingdale, New York). 
Additionally, two matrix metalloproteinases (MMP), MMP-2 and MMP-9, and tissue inhibitor of 
metalloproteinases (TIMP)-1 were quantified by ELISA (R&D Systems) as indices of tissue 
remodeling due to injury. Interleukin (IL)-1α, IL-1β, IL-5, IL-13, IL-17A, IL-18, granulocyte colony 
stimulating factor (G-CSF), granulocyte and macrophage colony stimulating factor (GM-CSF), 
eotaxin, fractalkine, leptin, MIP-1α, epidermal growth factor (EGF), IFN-γ inducible protein (IP)-
10, growth-regulated oncogene/keratinocyte chemoattractant (GRO/KC), vascular endothelial 
growth factor (VEGF), tumor necrosis factor-α (TNF-α), transforming growth factor-β2 (TGF-β2), 
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IL-2, IL-4, IL-6, IL-10, IL-12p70, interferon (IFN)-γ, lipopolysaccharide (LPS)-induced CXC 
chemokine (LIX) and regulated on activation, normal T-cell expressed and secreted (RANTES) 
were assessed by multiplex array (Eve Technologies; Alberta, CA).  
BALC and Mediastinal Lymph Node (MLN) Cell Differentiation and Phenotyping. Total 
BALC collected from rats were counted using a Coulter Multisizer II (Coulter Electronics; 
Hialeah, FL), followed by differentiation into alveolar macrophages (AMs) and neutrophils as 
previously described [539]. Flow cytometry was performed to enumerate and phenotype BALC. 
The total number of lymphocytes, B cells (CD45R), and T cells (CD3+), as well as T cell subsets 
(CD4+/CD8+) cells were quantified. 
Chemiluminescence (CL). To measure the production of reactive oxidant species by BALC, 
CL was measured according to the method of Antonini et al. [507] as previously described [539]. 
Briefly, extracellular oxidant production was measured as light emitted as a reaction of oxidants 
with luminol following stimulation of BAL AMs by zymosan or total BAL phagocytes (AMs and 
neutrophils) by phorbal myristate acetate (PMA).  
Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by airway 
pressure fixation under 30 cm-water pressure to total lung capacity for 15 min. Lung volumes 
were assessed by weight of water displacement. The left lungs were embedded in paraffin, 
sectioned onto slides, and stained with hematoxylin and eosin (H&E) or trichrome. An n = 5 
stained slides per treatment group per time-point per study block were assessed; blocks were 
designed with paired controls resulting in n = 10 for saline and SIL groups from each of the 
blocks when combined. Stained slides were analyzed for indications of inflammation, injury, and 
fibrosis by a certified veterinary pathologist at Charles River Laboratories (Wilmington, MA) who 
was blinded to the treatment groups. Indices of pathology were scored on scale of 0 – 5, where 
0 = no observed effect, 1 = minimal response, 2 = mild response, 3= moderate response, 4 = 
marked response, and 5 = severe response.  
Determination of Particle Clearance – Clearance of particles from the lungs was evaluated 
both qualitatively by examining representative images of particle loaded phagocytes from 
cytospins using light field microscopy on an Olympus BX63 using CellSens Dimensions 
Software version 1.15 (Olympus, Tokyo, Japan) and quantitatively by morphometrical analysis 
of tissue section. Tissue sections from left lung were deparaffinized and stained lightly with 
Sirius Red. Slides were immersed in 0.1% picrosirius solution (100 mg of Sirius Red F3BA in 
100 ml of saturated aqueous picric acid) for 2 h followed by washing for 1 min in 0.01 N HCl. 
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Slides were then counterstained with hematoxylin for 2 min, dehydrated, and mounted with a 
coverslip for imaging. Quantitative morphometric methods were used to measure the volume (% 
of the alveolar wall) and enumerate particles present by standard morphometric analyses 
(Underwood 1970; Mercer et al. 1994). This consisted of basic point counting. An eyepiece 
counting overlay consisting of 11 by 11 lines (121 total points for each throw of the overlay) was 
used with a 40X objective. A grid pattern for throws of the counting overlay was used in order to 
ensure a uniform sampling of the section, which did not overweigh interior points. An n = 5 
slides was evaluated for each group at time-points of 1 day, 1 week, 1 month, and 3 months 
following exposure. Briefly, clearance was calculated by finding the total volume of particle, 
normalizing data to 1 at day 1 and deriving a natural log curve from latter time-points. Tissue 
stained lightly with Sirius red was examined by dark-field microscopy on an Olympus BX41 
using CellSens Dimensions Software version 1.15 (Olympus, Tokyo, Japan) at a magnification 
of 20x. Representative images of total particle load were captured using darkfield microscopy at 
1 day, 1 month, and 3 months to illustrate the morphometric findings. 
Bacterial Clearance from the Lung. To measure the clearance of bacteria from the lung, left 
lungs were excised and placed in 10 ml of sterile deionized water. Lungs were homogenized 
using a Polytron®PT-2100 homogenizer with PT-DA 2112/EC aggregate attachment 
(Kinematica; Bohemia, NY). Homogenates were diluted and cultured on prepared Brain Heart 
Infusion Agar plates (Becton, Dickinson and Company). Cultures were incubated at 37 °C for 24 
h. Cfu were counted and multiplied according to culture dilution factors.  
Statistical Analyses. Results for all BAL parameters and bacterial clearance were expressed 
as mean ± standard error. For BAL proteins that were below the limit of detection, 1/2 of the 
lowest limit of detection was used for statistical analysis of values. Lymphocyte phenotype 
derived from flow cytometry was expressed as fold change from control ± standard error 
calculated as  
∆?̅?
𝑐𝑜𝑛𝑡𝑟𝑜𝑙?̅?
  and a one-way analysis of variance (ANOVA) was performed between all 
treatments groups at each time point. Significant differences among groups were determined 
using the Student-Newman-Keuls post-hoc test. Data were analyzed using SigmaPlot for 
Windows Version 12.5 (Systat Software, Inc, Ekrath, Germany).  For all analyses, significance 
was set at p < 0.05. Because data from histopathology studies are inherently categorical, 
nonparametric analysis of variance was assessed using SAS/STAT software, Version 9.1, of the 
SAS System for Windows statistical programs (SAS Institute, Inc.; Cary, NC). In this instance, 





Particle Characterization. One ml aliquots of 233 µg dose DPM, 233 µg dose CB, 233 µg dose 
of SIL, 233 µg DPM in combination with SIL 233 µg (DPM/SIL), and 233 µg CB in combination 
with SIL 233 µg (CB/SIL) in PBS solution, were dried on carbon filters and examined using 
FESEM in order to characterize size of the primary particles and their degree of agglomeration. 
The primary particles of SIL were approximately 2 µm in size and were evenly distributed in 
suspension (Figure 1A, 1B). DPM and CB were found to agglomerate in the vehicle to a size of 
approximately 1-2 µm in diameter. The primary particle size of DPM was found to be smaller in 
size than SIL, < 200 nm (Figure 1A). The form of CB selected (Printex 90) had a primary particle 
size of ~20 nm (Figure 1B). This form of CB was selected over fine or coarse mode CB as their 
primary particles were larger than the DPM agglomerates and the surface area and particle 
number per mass did not correlate well to the DPM represented. The FESEM images show 
similar agglomerates and primary particle size of the DPM and CB. Additionally, the association 
between DPM and SIL or CB and SIL in solution was minimal.  
Time-Course Study. Lung injury was evaluated by examining LDH in the BALF collected from 
rats at 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure to particles (Figure 2). A 
significant increase in LDH activity resulting from exposure to DPM alone occurred at 1 day and 
1 week post-exposure, and at 1 day post-exposure for CB-exposed animals. SIL caused a 
significant increase beginning at 1 week post-exposure that persisted throughout the time 
course. LDH activity was significantly increased in both the DPM/SIL and CB/SIL groups at all 
time-points when compared to control, DPM, and CB. In the DPM/SIL group the increase was 
greater than all other groups at 1, 2, and 3 months post-exposure, whereas the CB/SIL and SIL 
group were comparable to each other at these time-points. 
Cell differentials were performed on BALC to further assess inflammation (Figure 3A&B). DPM 
alone caused an increase in AMs in the lungs at 1 day post-exposure when compared to 
controls. CB alone did not increase AM number at any time point. SIL alone caused increased 
AM influx into the lungs at the later time-points (1 month and following). Increased AMs 
following exposure to CB/SIL did not differ greatly from that of SIL at the later time-points. 
However, DPM/SIL caused a significantly greater increase in AMs when compared to all groups 
at 1, 2, and 3 months post-exposure. DPM exposure alone did not cause an increase in BAL 
neutrophils at any time-point. CB exposure alone caused an increase in neutrophil recruitment 
at day 1 post-exposure only. SIL, DPM/SIL and CB/SIL caused a significant increase in 
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neutrophils at all time-points following exposure. At the later timepoints, SIL and CB/SIL did not 
differ from each other; however, exposure to DPM/SIL caused a significant increase when 
compared to all groups.  
Oxidant production by BALC was evaluated ex vivo (Figure 3C&D). DPM alone did not cause a 
significant increase in oxidant production by total phagocytes (Figure 3C) nor AMs (Figure 3D) 
as measured by CL at any of the time points. CB and SIL alone caused increased AM oxidant 
production at 1 day following exposure compared to control and DPM, although there was a 
trend for an increase in the SIL group at the later time points when compared to control. The 
CB/SIL group caused a significant increase in AM oxidant production up to 1 month post-
exposure when compared to control and at 1 week and 1 month when compared to all individual 
particle groups. Although not significantly different from control, the increase persisted at 2 and 
3 months post-exposure and was comparable to that of SIL. Interestingly, exposure to DPM 
combined with SIL resulted in significantly increased and synergistic production of oxidants 
beyond that of exposure to any single particle alone at all time-points post-exposure for total 
phagocytes and at all time-points post-exposure with the exception of 1 week for AM oxidant 
production.  
BAL and MLN lymphocytes were phenotyped by flow cytometry (Table 1&2). Exposure to DPM 
alone caused only mild increases in lymphocyte populations in BAL with the exception of a trend 
for increased T cells observed at 1 month becoming significant at 2 months. DPM caused 
increased B cells at 1 week and 1 month post-exposure (Table 1). However, at the early time 
points DPM alone did increase all MLN lymphocyte proliferation (Table 2), and though these 
populations remained elevated compared to control throughout the time-course, this result was 
not significant after 1 week. CB alone did not cause any increases in lymphocyte populations 
when compared to control. In addition to phagocytic influx described in Figure 3, exposure to 
SIL alone caused significantly increased lymphocyte influx into the lung (Table 1) and increased 
proliferation in the MLN (Table 2) as early as 1 week following exposure. When SIL was 
combined with DPM, proliferation of MLN lymphocytes were observed as early as 1 day post-
exposure (Table 2). Influx of lymphocytes was primarily attributed T cell population subsets, 
specifically CD4+ cells, though all subsets were increased for the DPM/SIL co-exposure group.  
CB in combination with SIL did increase the influx of lymphocytes in the BAL between 1 week 
and 3 months for T lymphocytes, primarily due to increased CD4+ cells. Interestingly, there were 
no significant increases in lymphocytes in the MLN following CB/SIL exposure.  
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Protein mediators were evaluated in BALF as a measure of inflammation and immune response 
(Table 3-5). CB caused some transient changes, particularly for inflammatory proteins including 
MCP-1, MIP-1α, and TNF-α, at the earliest time-point when compared to control (Table 3). 
There is a trend for increased MIP-2 by CB but this is only significant when compared with DPM 
groups, which demonstrated decreased expression of this chemokine compared to control. IP-
10 expression was also increased by CB at 1 day following exposure (Table 4). Similar to 
inflammatory proteins, CB increased expression of tissue remodeling proteins in the BALF at 
the earliest time-point (Table 5). DPM alone elicited only an increase in MIP-1 α, TNF- α, IL-18, 
IP-10, and TGFβ-2. However, these changes were not consistent throughout the time course 
(Table 3-5). Conversely, DPM exhibited a trend for reduced expression of some proteins 
including MIP-2, IL-6, IL-10, IL-12p70, and OPN, throughout the time course (Tables 3-5), and 
IL-2, IL-4, and IFN-γ at the latest time-points (Table 4). SIL alone caused increases in proteins 
associated with inflammation including LIX, MCP-1, MIP-1α, MIP-2, and TNF-α, at most time-
points compared with the control and/or groups exposed to DPM or CB only. SIL alone also 
caused an increase in IL-18, a protein associated with upregulation of the NLRP3/NALP3 
inflammasome (Table 3). Further, proteins associated with tissue remodeling, OPN and MMP-9, 
which have implications in the development of fibrotic changes in the lung, were increased by 
treatment with SIL particularly at time points after 1 week (Table 5). DPM, when in combination 
with SIL, increased expression of MIP-1α, IL-18, and TNF- α at some time-points (Table 3), and 
tissue remodeling proteins including MMP-9, TGFβ2, and TIMP-1 throughout the time course, 
as well as, OPN at time points as early as 1 month (Table 5).  CB in combination with SIL 
showed effects very similar to SIL for most inflammatory proteins including LIX, MCP-1, MIP1-α, 
MIP-2, IL-18, and TNF-α (Table 3), though at some early time-points CB/SIL increased 
expression of MCP-1 and MIP-2 over that of SIL alone. Similarly to CB alone, CB combined with 
SIL increased expression of IP-10, particularly at earlier time-points. This was also observed for 
DPM/SIL at 1 week and 1 month.  CB/SIL also enhanced the expression of tissue remodeling 
proteins MMP-9, OPN, and TGFβ2 throughout the time course, similar to that of DPM/SIL 
suggesting that these proteins may be most responsive to overall load of particles. Lastly, in the 
co-exposure with SIL, DPM exhibited independent action, reducing the expression of LIX, MIP-
2, IL-2, IL-4, and IL-12p70 at some time-points compared to SIL (Table 3&4). Interestingly, this 
was not the case for CB/SIL, suggesting specific properties of DPM may be responsible for this 
effect. There were no significant changes in the following cytokines in any group: IL-1α, IL-1β, 
IL-5, IL-13, IL-17A, EGF, eotaxin, fractalkine, GRO/KC, G-CSF, GM-CSF, leptin, IFN-γ, MMP-2, 
and VEGF (data not shown).  
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H&E and trichrome-stained tissue sections were evaluated by a board-certified veterinarian 
pathologist (Table 6). DPM caused only mild influx of AMs, as a measure of inflammation; 
however, this did not differ significantly from control. SIL alone and in combination with DPM or 
CB, significantly increased influx of AMs at all time-points following exposure. Alveolar epithelial 
hyperplasia (AEH) was also observed following co-exposures with both particles beginning at 1 
month and persisting up to 3 months. SIL alone also increased AEH at 2 and 3 months post-
exposure. In general, the degree of significance was greater for the DPM/SIL group when 
compared to control versus the SIL and CB/SIL group when compared to control. Beginning at 1 
month following exposure to particles, minimal to mild septal fibrosis was observed in groups 
that contained SIL. At 1 month, the incidence of fibrosis was greatest in the DPM/SIL co-
exposure group (60% of animals), whereas 20% of animals had fibrosis in the SIL and CB/SIL 
groups. At 2 months post-exposure, the DPM/SIL and CB/SIL group had a similar degree of 
fibrosis, which was greater than that of SIL alone. By 3 months post-exposure, the degree of 
fibrosis in all groups containing SIL were similar to each other, with a trend toward the co-
exposures having a slightly greater incidence.  Mild hyperplasia of the bronchiolar/alveolar 
epithelium was observed near the terminal bronchioles as early at 1 month following exposure 
to groups containing SIL and was found to be associated with the presence of macrophages 
loaded with high particle content, suggesting a correlation between tissue damage and the 
presence of particles. Overall, most histopathological changes were attributable to exposure to 
233 µg of SIL; however, the presence of DPM or CB increased the severity and/or incidence of 
some of these changes in the co-exposure groups, suggesting particle load as an additional 
factor in toxicity. DPM increased the onset of fibrosis, but not the degree of fibrosis, which was 
attributable primarily to particle load.    
Lung particle burden and clearance were evaluated both qualitatively in tissue and 
macrophages (Figures 5-10) and quantitatively in tissue by morphometric analysis (Figure 4A). 
Between day 1 and week 1 approximately 2% of DPM was cleared with an increase in the rate 
of clearance following the first week (Figure 4A). By 1 month, 55% of DPM had been cleared; 
after 1 month there was a steady decline in particle burden with only 15% overall DPM 
remaining at 3 months post-exposure. CB was cleared at a faster rate initially, with only 60% of 
particle remaining at 1 week following exposure, and this is evident by the macrophage burden 
of particle observed at 1 day as compared with that of DPM (Figure 5).  By 1 month, the 
clearance of CB had slowed to nearly that of DPM with 16% of particles remaining at 3 months 
post-exposure. Initial clearance of SIL between the time-points of 1 day and 1 week was similar 
to CB, and faster than DPM, with nearly 30% of particle cleared; the rate of clearance slowed 
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after 1 week and by 1 month only 45% SIL particle had been cleared (Figure 4A). Following this, 
there was only approximately an additional 10% clearance of particle by 3 months, suggesting 
that the rate of clearance for SIL slows significantly after 1 month. Clearance in the co-exposure 
groups was significantly slower than any individual particle at time-points following 1 week as 
expected by increase in overall particle load as can be seen in figures 7-10. By 1 week, 
between 2-3% of particle was cleared for the CB/SIL or DPM/SIL groups and the rate of 
clearance remains very slow compared with individual particles up to 1 month following 
exposure where only measurable clearance was observed for the CB/SIL group since 1 week 
following exposure (Figure 4A). By 3 months post-exposure approximately 35% of particle 
burden had been cleared.  
 Infection Study. Respiratory susceptibility to a bacterial pathogen was determined following 
particle exposure in an infectivity study assessing the clearance of LM from the lung over a 14-
day time course, 1 week following exposure to particles. Despite lung inflammation and 
phagocytic cell activity observed in the absence of infection in co-exposed groups (Figure 3), 
overall clearance of the pathogen was not significantly altered for most time-points (Figure 11). 
Clearance in the CB/SIL co-exposure was enhanced at 1 day compared with control and CB 
alone. At 3 days following infection the slowest degree of bacterial clearance was associated 
with the DPM group; whereas, all groups that contained SIL were comparable to control or 
cleared the bacteria faster than DPM alone.  However, by 5 days post-exposure there were no 
differences in bacterial clearance among groups. Neutrophil influx into the lung was significantly 
increased for SIL-containing groups at day 1 post-infection (Figure 12B). By day 3 post-
infection, the influx of cells in SIL- exposed groups was similar to control with the exception of 
neutrophils, which were enhanced beyond that of CB or DPM alone groups at day 14. Influx of 
lymphocytes into the BAL at day 14 was also significantly increased in co-exposed groups 
(Figure 13A). Similarly, proliferation of lymphocytes in the MLN was elevated in groups that 
contained SIL as early as 1-day post-infection, and significantly elevated again by day 14 in the 
co-exposed groups (Figure 13B). BAL and MLN lymphocytes were phenotyped as in the time-
course study to evaluate lymphocyte populations. Neither DPM nor CB exposure caused 
notable lymphocytic influx into the lung when compared to infected controls, while combined 
exposure to particles caused significant increases in total lymphocyte influx at day 14 compared 
with other groups, attributed primarily to an increase in T lymphocytes (Table 7).  In the MLN, 
combined exposure followed by infection caused increased lymphocytes at day 1 compared 
with all other non-SIL-containing groups. For co-exposure groups, proliferation of all MLN cells 
was greater than SIL for all subsets (Table 8). At 14 days post-infection T cell-subsets were 
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increased in both co-exposed groups, attributed mainly to an increase in CD4+ and CD8+ T 
lymphocytes. Overall, the results suggest that DPM may have impaired the innate response to 
infection to a degree; whereas, the presence of SIL may have enhanced the response at the 
early time-points to a degree. By day 14, the infection had resolved and the observed increased 
inflammation and immune cell proliferation may be largely attributable to particle effect. 
Discussion 
 
Our previous study had shown that low- to no-toxicity doses of DPM in combination with 
SIL caused increased inflammation and lung injury when compared to SIL alone [539]. The goal 
of the present study was to determine if those effects were particle-specific or if the effects were 
due to an increased particle load as a result of the co-exposure. It is well-established that 
overall particle load contributes to the development of disease in the lung. Particles with known 
low cytotoxicity or particles not otherwise classified/regulated (PNOC/R) due to low toxicity have 
been shown in animals to contribute to inflammation, fibrosis, and tumor development if the 
number/mass of particles administered exceeds the capabilities of alveolar macrophages to 
adequately clear them [542-546]. In order to address these questions, the current study was 
designed examining an equivalent dose of DPM particles as SIL alone, DPM in combination 
with SIL, and CB at an equivalent dose to DPM alone and in combination with SIL as a 
reference particle for load control.  
In the present study, DPM and CB alone produced inflammation and lung injury only at 
early time-points post-exposure and resolved by 1 week to 1 month. SIL alone increased 
parameters of inflammation and lung injury throughout the time course. In several instances, the 
co-exposures to DPM or CB and SIL further enhanced these effects, which may be attributed to 
particle-specific effect or to load effects depending on the parameter. In general, DPM/SIL had a 
greater effect than CB/SIL on  parameters including lung injury (cytotoxicity), cellular influx into 
the lung, and ex vivo oxidant production by phagocytes in the lung, indicating a particle-specific 
effect relating to a constituent other than the carbon core of DPM; whereas particle load and the 
presence of SIL appeared to affect tissue remodeling and fibrosis to a greater degree, although 
DPM co-exposed with SIL did increase the incidence of pathology at 1 month following 
exposure when compared to SIL or CB/SIL groups .  
In the case of cytotoxicity, while both combined exposures caused significant toxicity 
compared with control at all time-points following exposure, DPM combined with SIL increased 
cytotoxicity examined at all time-points following 1 week (Figure 2). Though CB in combination 
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with SIL also increased cytotoxicity after 1 month, this effect was similar to the level caused by 
SIL alone suggesting that for the DPM/SIL combo group, DPM characteristics and not simply 
the carbon core of DPM enhanced cytotoxicity. Further, this suggests that it is not simply the 
overall load of nearly 500 µg of particles contributing to cell injury. DPM also had particle-
specific effects on the influx of phagocytes into the lung and their oxidant producing activities 
(Figure 3). Though DPM alone had little effect on the influx of phagocytes into the lung, when 
combined with SIL, the presence of macrophages and neutrophils were significantly increased 
compared to all groups and therefore exacerbated the inflammation observed for SIL alone or 
CB/SIL. These effects were observed beginning at one month following exposure for both 
macrophages and neutrophils. In the case of oxidants produced by either total phagocytes or 
macrophages alone, DPM when combined with SIL, synergistically enhanced this effect (Figure 
3 C&D). The same effect was not observed in the CB/SIL co-exposure. Though CB/SIL 
enhanced oxidant production by macrophages alone above that of SIL, the effect was 
diminished after 1 month. Because the rate of particle clearance in the combined exposures is 
similar after 1 month, it is unlikely that these effects are driven entirely by particle burden. Taken 
together, these results suggest that DPM in combination with SIL not only enhanced the influx of 
phagocytic cells into the lung but also increased their function with regard to the production of 
oxidants. Moreover, these results suggest that though particle load may play a role in these 
findings, DPM specific properties also contribute to the overall effect, particularly in the case of 
total oxidant burden that reached as high as 100-fold change from control at some time-points 
for total phagocytes (Figure 3C).  
With regard to the influx of lymphocytes into the lung, CB alone had no effect (Table 1). 
DPM caused slightly enhanced influx of all immune cells examined when compared to control, 
particularly at the earlier time-points. SIL resulted in significantly increased influx of cells at most 
time-points following exposure, attributable primarily to T lymphocytes. When DPM was 
combined with SIL these results were further exacerbated. Though combination of CB with SIL 
did enhance the influx of lymphocytes at some time-points this effect was significantly greater 
for DPM/SIL and therefore suggests that while particle load may contribute to stimulation of 
lymphocyte influx into the lung, DPM-specific properties further enhance this response. Similar 
findings were observed for the proliferation of lymphocytes in the MLN (Table 2). Interestingly, 
there was a trend of increased MLN proliferation for DPM in a co-exposure with SIL as 
compared with control that was not observed for the CB/SIL co-exposure. This finding would 
suggest that although SIL plays a significant role in many facets of pulmonary toxicity relating to 
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this co-exposure, DPM is also contributing significantly, particularly in the context of immune 
alteration.  
Similarly, SIL exposure resulted in increases in several inflammatory, immunoregulatory, 
and tissue remodeling proteins in the lungs (Tables 3-5). Although both DPM/SIL and CB/SIL 
led to equal or enhanced expression of some of these proteins including: MCP-1, MIP-1α, IP-10, 
and MMP-9. DPM reduced the expression of others including: LIX, MIP-2, IL-2, IL-4, and IL-6 in 
the BALF when in combination with SIL. DPM appeared to be exhibiting independent action on 
the expression of these proteins possibly stemming from the suppression of macrophage 
function. Monocytes or macrophages secrete these proteins in order to recruit additional 
phagocytes to the site of acute inflammation, as well as to cause autocrine and paracrine 
activation of cells, and to differentiate lymphocytes (Table 3-5). Furthermore, these results were 
not reflected in the CB/SIL co-exposure suggesting that, despite increased cellular recruitment 
to the lung, potential suppression of macrophage function may be occurring and may be due to 
specific properties related to DPM and not simply an effect of overall particle load. These 
findings are in agreement with conclusions made by Yin et al. that organic fractions of DPM 
result in the reduced expression of cytokines from AMs [316, 535]. This is effect is also evident 
in the innate response to LM infection whereby pulmonary clearance of the bacteria was slowest 
in the DPM only group at day 3.  
Pathological tissue analysis showed that either DPM or CB alone had little influence on 
the histological changes evaluated, with the exception of the incidence of AM influx into the lung 
(Table 6), and the presence of dark granules noted within macrophages throughout the time 
course, representative of particles that had been phagocytosed. Further, brown granules 
observed by the pathologist were scored as more severe in groups exposed to combinations of 
particles when compared to single particle groups, particularly at later time-points, which agrees 
with the morphometrical finding of reduced clearance of particles in these groups (data not 
shown). Tissue from animals exposed to SIL alone or groups containing SIL were characterized 
by enhanced inflammation, alveolar (AEH) and bronchial epithelial hyperplasia (BEH), and 
alveolar septal thickening or fibrosis. Though these parameters were enhanced over that of SIL 
at times in the co-exposure groups, as in the case of BEH and AEH at 1 month post-exposure, 
these effects were correlated better with overall particle load at the later time-points, as there 
were no observed differences between the two co-exposure groups. Furthermore, these 
findings are supported by the observed increases in tissue remodeling proteins expressed in the 
BALF at these time-points. Increases in MMP-9 and OPN were observed throughout the time 
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course with significant differences observed at 1 month post-exposure in the combined groups 
compared with single dose groups. These findings correlate with the earlier incidence of 
hyperplasia developing for these groups compared with SIL alone. Also at 1 month post-
exposure, there are particle specific effects of DPM evident in the incidence of fibrosis and AEH 
that may have related to increases in the expression of tissue remodeling proteins TGFβ and 
TIMP-1 in the DPM/SIL groups at this time-point. This finding was also apparent when 
qualitatively assessing tissue by dark field microscopy (Figure 7). Interestingly, particle 
clearance rate for the CB/SIL group was slightly increased compared with the DPM/SIL group 
between the time-points of 1 week and 1 month, which may also account for the increase in 
injury in the DPM/SIL group observed at this time-point (Figure 10).   
Susceptibility to an infection following particulate exposure was also examined to further 
assess alterations in immune function following particle exposure. Neutrophilic influx, and 
proliferation of lymphocytes in the MLN (Figure 11, Table 8) were increased at 1 day following 
infection for all groups exposed to SIL. Differences between SIL exposure groups were not 
significant with the exception of lymphocyte proliferation in MLN at day 1 following infection in 
the CB/SIL group. This result correlates to increased clearance of bacteria from the lung at 1 
day following infection observed for this group, although this result was only significant when 
compared with control and CB exposures.  Clearance of bacteria was significantly enhanced for 
all groups except CB when compared to the DPM only group at day 3 following infection, 
suggesting further that DPM may lead to a degree of inhibition in the innate immune response 
early after infection. This effect is similar to other studies examining diesel exposure and 
infection. In a study examining inhalation exposure to total DE, Harrod et al. determined that 
exposure resulted in reduced clearance of Pseudomonas aeruginosa infection [313]. Similarly, 
Yin et al. demonstrated reduced clearance of bacteria from the lung of rats following DPM 
exposure, citing reduced phagocytic function and reduction in cytokine expression by 
macrophages as possible DPM-related effects resulting in increased susceptibility [316]. In a 
follow-up study, Yin et al. demonstrated increased bacterial burden at day 3 following co-
exposure of rats to DPM and LM. However, similar to the present study, despite reduced 
expression of cytokines by macrophages, rats were able to ultimately clear infection suggesting 
that the adaptive cell-mediated response was still sufficiently initiated despite the reduction in 
response of the innate immune system [317]. 
Our previous study examining a lower dose of DPM (50 μg) indicated that DPM 
increased parameters of toxicity such as inflammation, oxidant production, and the onset of 
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initiation of fibrosis in the co-exposure compared to SIL, particularly at 1 month following 
exposure. Though these effects were still comparable to SIL at 3 months post-exposure, they no 
longer exceeded that of SIL. Therefore, the present study examined whether the exacerbated 
effects of the combined exposure were no longer apparent compared to silica at 3 months time 
due to clearance of DPM or if the progression of effects due to SIL alone or particle load were 
the primary factor in toxicity. This study showed that combination of DPM and SIL at equivalent 
doses resulted in not only enhanced inflammation and oxidant production as previously 
observed, but increases in cytotoxicity as well. DPM also increased the incidence of fibrosis at 1 
month post-exposure, similar to the previous study; however severity of fibrosis was similar 
between SIL and co-exposure groups. Further, by the later time-points, the incidence and 
severity were more similar in the co-exposure groups. This is in combination with the slower 
particle clearance rate of the co-exposure groups suggests that tissue remodeling initiated by 
SIL exposure and total particle load were the primary factors in progression of fibrosis (Table 6). 
Although SIL is the more toxic particle in the study as compared to DPM alone, when given at a 
dose equal to SIL, effects of DPM co-exposed with SIL were still apparent at 3 months following 
exposure, particularly for cytotoxicity, inflammation, and the production of oxidants. This was not 
the case for the CB/SIL exposure at equivalent loads, suggesting these effects were particle 
specific for both the previous study, as well as this study.  
Overall, this study indicated that both load and particle type, SIL and DPM, contribute to 
toxicity in a co-exposure scenario depending on the effect. The toxicological properties of 
crystalline silica and DPM are well-established individually. Both acute exposures to large doses 
of particles and chronic low-level exposure to silica are known to contribute to the development 
of fibrotic lung diseases related to oxidant-induced lung injury [4, 487, 490, 515, 516]. DPM is 
also known to induce inflammation resulting in oxidative stress [467, 473-476]. Although DPM is 
not typically associated with the restrictive fibrotic disease outcomes that are associated with 
silica exposure at doses below overload, these particles are known to result in obstructive lung 
diseases such as chronic obstructive pulmonary disease and emphysema, as well as cancer 
[411, 415, 517, 518]. While specific mechanisms governing the progression of these diseases 
have been elucidated, many remain unknown. Delineating the mechanisms of action in a co-
exposure is further complicated by potential synergistic or antagonist actions of the materials. 
This study, however does show that SIL-induced inflammation and oxidant production are 
further enhanced by particle specific effects of DPM, but that particle load may also be a 




It should be noted that the particles used for this study and Farris et al. (2017) were 
selected as surrogates for measuring toxicity of particles encountered in the workplace, which 
may be more complex in chemical nature and reactivity. Factors contributing to the workplace 
exposures would include freshly fractured silica, which is more reactive than the aged silica in 
this study. In addition, NIST SRM 2975 only represents the particulate component of diesel 
exhaust (DE). Whole DE, depending on the engine type, contains higher fractions of 
hydrocarbons, as well as metals, and these components may contribute to increased toxicity as 
compared to that observed in this study. These factors are important considerations in the 
interpretation of the data as it pertains to exposure in the workplace. 
Conclusion 
 
In the present study, DPM or CB alone caused a transient inflammation and lung injury, 
whereas SIL alone caused an increase in inflammation characterized by cellular influx into the 
lung, increased inflammatory mediator production in the lung, and alterations in lung histology. 
In general, co-exposure to DPM or CB and SIL followed a similar pattern as SIL alone, and, in 
some instances, the effects were increased relative to SIL alone suggesting particle-specific 
effects or effects due to load.  SIL and particle load appear better correlated with tissue 
remodeling (fibrosis and tissue remodeling proteins in the lung) and some inflammatory proteins 
in the lung, including MCP-1, MIP-1α, and MIP-2. DPM combined with SIL increased production 
of oxidants by phagocytes compared with all other groups at all time-points post exposure. In 
addition, DPM/SIL co-exposure enhanced AMs and neutrophil influx into the lung, lung injury 
(LDH), the influx of lymphocytes in the lung, the proliferation of lymphocytes in the MLN, and the 
incidence of epithelial hyperplasia in lung tissue at later time-points compared to exposure to 
SIL alone. Although CB/SIL co-exposure increased lung injury and cellular influx into the lung, 
as well as epithelial hyperplasia, the increase was comparable to that of SIL alone. The data 
taken together show that DPM exposure at doses that elicit only minimal pulmonary toxicity has 
the capacity to significantly alter SIL-induced pulmonary effects, primarily cytotoxicity, 
inflammation, oxidant production, lymphocytic proliferation, as well as exhibit independent action 
on the expression of immune protein mediators of inflammation.  Furthermore, comparison of 
these effects to a reference particle for size and particle load comparison revealed that many of 
these findings relate directly to unique characteristics of DPM rather than being related only to 
dose administered.   
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Table 1: Lymphocyte Phenotype of BALC  
 
All data are shown as mean fold change over control ± standard error: b different from control 
only; c different from control and all single dose groups; d different from control and CB; e 
different from all other groups; g different from CB only; j different from control and both CB 
groups; k different from control, DPM, and both CB groups; and l different from control, SIL, and 




Table 2: Lymphocyte Phenotype in the MLN  
 
All data are shown as mean fold change over control ± standard error: d different from control and CB; 
e different from all other groups; g different from CB only; j different from control and both CB groups; 





Table 3: Inflammatory Proteins in BALF  
 
All data are shown as mean ± standard error: a different than control and SIL groups; b different from 
control only;  c different from control and all single dose groups; d different from control and CB; e 
different from all other groups; f different from control, DPM and CB; g different from CB only; i different 
from control and DPM groups; m different from control, SIL, and both DPM groups; n different from 
control both DPM groups; o different from both DPM groups only; p different from control, SIL, and 




Table 4: Immuno-regulatory Proteins in BALF  
 
All data are shown as mean ± standard error:c different from control and all single dose groups; 
d different from control and CB; e different from all other groups; h different from control, DPM, 
and SIL groups; n different from control and both DPM groups; r different from control, SIL, and 




Table 5: Tissue Remodeling/Wound Healing Proteins in BALF  
 
All data are shown as mean ± standard error: a different than control and SIL groups; b different 
from control only;  c different from control and all single dose groups; d different from control and 
CB; e different from all other groups; f different from control, DPM and CB; g different from CB 






Table 6: Severity and Incidence Scores for Lung Pathology  
 
Lung tissue was analyzed and scored for accumulation of alveolar macrophages as an index of 
inflammation (AM), alveolar epithelial hyperplasia (AEH), bronchial epithelial hyperplasia (BEH), 
and fibrosis in alveolar septae (F) (n=5 for CB, DPM, DPM/SIL, and CB/SIL groups and  n=10 
per PBS and SIL per time point). Severity was scored as 0 - 5: 0 = normal, 1 = minimal/slight, 2 
= mild, 3 = moderate, 4 = marked, and 5 = severe. Incidence was noted as Focal (F), Multi-focal 
(M), and Diffuse (D). Data are presented as means with incidence (number of animals with a 
positive score per total animals) in parentheses. a different than control and SIL groups; b 
different from control only;  c different from control and all single dose groups; d different from 
control and CB; f different from control, DPM and CB; and g different from CB only; Note: all 
letter symbol notations indicate a p value <0.05 except where a single asterisk indicates p < 
0.05 for all groups except control < 0.01, a double asterisk indicates p < 0.01 for all groups. A 
single cross indicates p < 0.05 for all groups except control and SIL where p < 0.01, and a 





Table 7: Lymphocyte Phenotype of BALC Following LM Infection 
 
All data are shown as mean fold change over control ± standard error: C different than control, 
DPM, and CB groups; D different from control and CB groups; E different from control only; G 
different from all other groups; I different from CB and SIL groups; J different from control, CB, 
and SIL groups; and K different from CB only. Statistical significance is p ≤ 0.05. 
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Table 8: Lymphocyte Phenotype in the MLN Following LM Infection 
 
All data are shown as mean fold change over control ± standard error: A different from control 
and DPM groups; B different from DPM only; E different from control only; F different from control 
and all single dose groups; G different from all other groups; and H different from control and SIL 
groups. Statistical significance is p ≤ 0.05. 
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Figure 1:  
 
Figure 1: Field emission scanning electron microscopy (FESEM) images of particles. (A) 233 
µg SIL and 233 µg DPM in combination prepared in PBS solution, diluted 1:10 in PBS, then 
dried onto a filter under 25,000x magnification (micron bar = 2 µm with 10 segments of 0.2 µm 
each) (B) 233 µg SIL
 
and 233 µg CB prepared in PBS solution, diluted 1:10 in PBS, then dried 
onto a filter in PBS solution under 25,000x magnification (micron bar = 2 µm with 10 segments 
of 0.2 µm each). White arrows indicate SIL particles and black arrows indicate DPM or CB 








Figure 2:  
 
Figure 2: Lactate dehydrogenase activity (LDH) in BALF after exposure to DPM, CB, SIL, a 
combination of DPM and SIL (DPM/SIL), or a combination of CB and SIL (CB/SIL):  a different 
from control and SIL groups;  b different from control only;  c different from control and all single 
dose groups; d different from control and CB; e different from all other groups; and f different from 




Figure 3:  
 
Figure 3: Total AMs (A) and neutrophils (B) in the BALF following exposure to DPM, CB, SIL, 
DPM/SIL, or CB/SIL.  Production of oxidants by total phagocytes stimulated with PMA (C)  or by 
AMs only stimulated by zymosan (D) measured by chemiluminescence following exposure to 
DPM, CB, SIL, DPM/SIL, or CB/SIL: b different from control only;  c different from control and all 
single dose groups; d different from control and CB; e different from all other groups; f different 
from control, DPM, and CB; g different from CB only; h different from control, DPM and SIL 






Figure 4:  
 
 
Figure 4: Particle clearance curve for each treatment group as quantitatively evaluated by 
morphometric analysis of tissue For each group an n = 5 tissue sections per time-point were 
morphometrically assessed: c different from all single dose groups; e different from all other 






Figure 5:  
 
Figure 5: Light field microscopy images of cytospins used to qualitatively assess particulate 
clearance by BAL AMs at 1 day following instillation. Images were taken at 40x magnification 
and scale bar represents 20µm in length. Green arrows indicate the presence of silica 







Figure 6: Dark field microscopy images of Sirius red stained tissue representing injury and 
particulate load in cells at 1 day following instillation. Images were taken at 20x magnification 
and scale bar represents 20µm in length. White arrows indicate the presence of particulate 






Figure 7: Light field microscopy images of cytospins used to qualitatively assess particulate 
clearance by BAL AMs at 1 month following instillation. Images were taken at 40x magnification 
and scale bar represents 20µm in length. Green arrows indicate the presence of silica 





Figure 8: Dark field microscopy images of Sirius red stained tissue representing tissue injury 
and particulate load in cells at 1 month following instillation. Images were taken at 20x 
magnification and scale bar represents 20µm in length. White arrows indicate the presence of 
particulate within macrophages.  
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Figure 9:  
 
Figure 9: Light field microscopy images of cytospins used to qualitatively assess particulate 
clearance by BAL AMs at 3 months following instillation. Images were taken at 40x 
magnification and scale bar represents 20µm in length. Green arrows indicate the presence of 




Figure 10:  
Figure 10: Dark field microscopy images of Sirius red stained tissue representing tissue injury 
and particulate load in cells at 3 months following instillation. Images were taken at 20x 
magnification and scale bar represents 20µm in length. White arrows indicate the presence of 





Figure 11:  
 
Figure 11: Lung clearance of bacteria from the left lung over the time-course recovered by 
lavage following exposure to DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection. 
*CB/SIL lower than control and CB only. +DPM greater than control, SIL, and both combo 




Figure 12:  
 
Figure 12: Total AMs (A), and total neutrophils (B) recovered by lavage following exposure to 
DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection. All data are shown as mean ± 
standard error: A different from control and DPM groups; B different from DPM only; C different 
than control, DPM, and CB groups; D different from control and CB groups; E different from 






Figure 13:  
 
Figure 13: Total Lymphocytes recovered from BALF (A), and mediastinal lymph nodes (B) 
following exposure to DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection. All data are 
shown as mean ± standard error: A different from control and DPM groups; C different than 
control, DPM, and CB groups; D different from control and CB groups; E different from control 
only; F different from control and all single dose groups; G different from all other groups; and H 
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Pulmonary Toxicity following Repeated Co-exposure to Diesel Emission Particulates and 
α-Quartz Crystalline Silica in the Sprague-Dawley Rat 
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The effects of repeated pulmonary co-exposures to silica and diesel particulate matter 
(DPM) that may occur in various occupational settings were investigated in vivo. Previous acute 
single dose co-exposures revealed that DPM increased the inflammatory effects of silica in the 
lung at time-points of up to three months. The goal of this study was to investigate the effects of 
subacute repeated pulmonary co-exposures to silica and DPM. Rats were exposed by 
intratracheal instillation (IT) to 116 µg of silica (SIL), 25 µg of DPM, SIL and DPM combined in 
phosphate-buffered saline (PBS), or to PBS alone (control) once per week for 4 weeks. At one 
day, one month, and three months following the last exposure bronchoalveolar lavage (BAL) 
and histopathology were performed, and lymphocytes from local lymph nodes were phenotyped 
to assess lung injury, inflammation, and immune response. SIL alone caused inflammation, 
oxidant production, lung injury, increased populations of immune proteins and cells in the lung, 
and increased lymphocyte populations in the local lymph nodes; whereas, DPM alone caused a 
lesser degree of injury primarily at one day post-exposure, enhanced proliferation of local lymph 
node cells at one month, but did not increase inflammatory cells and proteins in the lung and 
suppressed levels of some immunoregulatory proteins. Co-exposure to DPM and SIL resulted in 
neutrophilic influx and lung injury comparable to that of SIL alone. Oxidant production by 
stimulated macrophages in the co-exposure group was significantly elevated at all time points 
compared to DPM and control and at 1 day and 1 month when compared to all groups. Co-
exposure also significantly increased lung and local lymph node lymphocytes at all times points 
compared to DPM and control, but further increased T cells in the lung at one month and 
proliferation of total lymphocytes in the local lymph node at 3 months over SIL alone. Overall, 
while DPM co-exposure with SIL exhibited the capability to exacerbate oxidant production and 
increase lymphocyte populations to a greater degree than SIL in the lung, most parameters of 
toxicity were comparable to that of SIL, indicating SIL as the primary factor in toxicity. However, 
alteration in immune cell populations and immune proteins secreted in the lung by the presence 




Due to the vast number of industrial occupations that involve the disruption of terrain 
including surface and below-ground mining, tunneling, construction, road construction, and 
excavation, the health risks of exposure to silica have been recognized and well-characterized 
[4, 23]. Furthermore, with the advent of diesel engine powered equipment in the late 1800s [5] 
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and the expanding utilization in these industries for enhanced productivity, exposure of workers 
to respirable particulate mixtures including silica and diesel particulate matter (DPM) is a 
concern [279, 461]. Though toxicity of DPM and silica as individual exposures has been well-
investigated, there is a possibility that health effects observed following a co-exposure to the 
particulates may be exacerbated or altered following exposure to the mixture versus the 
individual exposures alone.  
Previously, a single acute exposure to either particle individually or as a co-exposure 
were investigated at various doses derived to represent acute, short duration exposures of 
varying degrees in industrial operations [547]. The findings from these studies demonstrated 
that doses of DPM that were not found to be significantly toxic individually, had the potential to 
exacerbate inflammation, oxidant production, alterations of innate immune response, and the 
incidence of the onset of fibrotic changes in the lung in a co-exposure with silica over that of 
silica alone. Alterations in inflammation, injury, oxidant production, and immunological response 
were determined to be due in part to specific characteristics of DPM, rather than an increase in 
overall particle load, as these changes were not observed for similar doses of carbon black, the 
core material of DPM, in combination with silica (Chapter 3). However, some indications of 
pathology, including alveolar or bronchiolar epithelial hyperplasia and fibrosis, were determined 
to be mainly initiated by silica and enhanced by the presence of increased particle load, as 
effects were similar between combinations of either DPM or CB in equal doses with silica.   
Fibrotic and toxic characteristics of crystalline silica have been determined, and both 
acute high doses, as well as longer exposures to reduced doses, lead to progressive fibrosis, 
and in chronic exposure, cancer [4]. Mechanisms that govern the development of pathology are 
not clearly delineated; however, oxidative stress and continuous lung injury due to persistence 
of silica in the lung are involved. Inflammation and oxidative stress in response to exposure to 
DPM are also well-studied [467, 473-476]; DPM exposure is classically associated with 
obstructive changes including emphysema and COPD, rather than fibrosis [411, 415, 517, 518]. 
Our previous studies examined single exposures at doses of DPM and silica that represented 
various concentrations in a model of a two-week industrial exposure. This study investigated a 
lower but more-prolonged exposure to particles employing a sub-chronic repeated dosing 
schedule.  The goal of this study was to determine if sub-chronic exposure to DPM further 
enhanced the effects of silica, or if this longer, lower dose exposure caused effects that differ 
from the previous studies. To address this, particles were administered to rats, individually and 
in a co-exposure one time per week for 4 weeks. Parameters of lung injury, inflammation, 
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oxidant production, and immune response were assessed at 1 day, 1 month, and 3 months 
following the last exposure. The endpoints selected were similar to studies 1 and 2 for 
comparative purposes.  
Methods 
 
Particles. Particles in these studies are used as surrogates to represent work site exposures. 
DPM was obtained from the National Institute of Standards and Technology (NIST) as a 
commercially available NIST Standard Reference Material (SRM) 2975 (referred to as DPM in 
the study). SRM 2975 was originally collected from an industrial forklift in the 1990s [540]. The 
surrogate particle used for SiO2 was α-quartz crystalline silica (SIL; MIN-U-SIL® 5, US SILICA; 
Berkeley Springs, WV).  
Dose Determination. Doses were derived from field measurements of particles and applied to 
the equation below (EQ1) to quantify the amount of particle that would deposit in the lung of an 
average male worker doing moderate work for 12 hours per day for a period of 7 continuous 
days using a pulmonary deposition efficacy for each particle derived from a software-based 
algorithm that considers particle characteristics including shape and density [505]. These doses 
were then normalized from the surface area of human lung to the rat lung to obtain doses for in 
vivo studies (EQ2). There are very few studies reporting carbon levels representative of diesel 
emissions at above ground mining operations such as hydraulic fracturing sites. DPM in 
underground mining operations has been measured in excess of 500 µg/m3 as elemental 
carbon (EC) as reviewed by Pronk et al. (2009). In this study, the dose of DPM was derived 
from high EC level measurements taken during underground mining of 637 µg/m3 (0.637 
µg/l)(EQ3) [506].The SIL dose was derived from the highest SiO2 levels measured at hydraulic 
fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ4). These levels are also common or 
exceeded in underground mining operations as well [548, 549].  
EQ1 - Basic equation for standard worker lung deposition: 
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day, min/d) 
x (total fracking days, d) x (pulmonary deposition efficacy, unitless) 
EQ2 - Equation normalizing for species specific lung surface area: 




EQ3 - Equation for DPM dose: 
Worker lung deposition = (0.637 μg /l) x (20 l/min) x (720 min/day) x (7 days) x (0.10) ≈ 
6,421 μg  
Dose calculated = (6,421 μg/102.2 m2) x (0.4 m2) ≈ 25 μg per rat  
EQ4 - Equation for SIL dose: 
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x (0.118) = 
29,736 μg per worker 
Dose calculated = (29,736 μg/102.2 m2) x (0.4 m2) ≈ 116 μg per rat 
DPM and SIL Preparation and Characterization.  Particles were prepared in USP-grade 
phosphate-buffered sterile saline (PBS) without Ca2+ or Mg2+ (AMERESCO; Solon, OH) for 
intratracheal instillation. A sonication process was used to disperse agglomerated particles. 
DPM was prepared as a 2 mg/ml stock solution and SIL was prepared as a 10 mg/ml stock 
solution, vortex mixed for one min, followed by 1 min of continuous sonication (GE130PB 
ultrasonic processor; General Electric, Boston, MA).  Aliquots of stock solution were then further 
diluted to 25 µg DPM, 116 µg SIL, or 25 µg DPM + 116 µg SIL in 0.3 ml PBS. Particles were 
then vortex mixed for an additional 30 secs, followed by 15 secs of sonication prior to 
intratracheal instillation.  
Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals (Scottdale, 
PA), weighing approximately 300 g and free of viral pathogens, parasites, mycoplasmas, 
Helicobacter, and CAR Bacillus, were used for all studies. Rats were housed in the pathogen 
free, environmentally controlled, AAALAC-accredited facility. The rats were housed in ventilated 
polycarbonate cages, two per cage, on Alpha-Dri cellulose chips and hardwood Beta chips as 
bedding; they were provided HEPA-filtered air, irradiated Teklad 2918 diet, and tap water ad 
libitum; and were allowed to acclimate for one week before exposure. Rats were not restricted 
from enrichment activity (i.e., chewing/climbing). All animal procedures used during the study 
were reviewed and approved by the IACUC at NIOSH. 
Repeated Dose Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0, 7, 
14, and 21 rats were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium 
methohexital (Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 25 µg DPM, 
116 µg SIL, 25 µg DPM + 116 µg SIL (DS), or vehicle control (PBS). All particles were delivered 
in 0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 month, or 3 
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months following final particle exposure (n = 8/group/time point) with an intraperitoneal injection 
of 100-300 mg/kg sodium pentobarbital followed by exsanguination. The trachea was 
cannulated, bronchoalveolar lavage (BAL) was performed on the right lung lobes, and BAL cells 
(BALCs) and fluid (BALF) were retained for analysis of parameters indicative of inflammation, 
injury, oxidant production, and immune function as described below. Lymphocytes from local 
lymph nodes draining the lung were also differentiated by phenotype. The left lung was excised, 
pressure-inflated with 10% neutral-buffered formalin, and weighed with water-displacement to 
determine fixed lung volume. Histopathological assessment of lung injury, inflammation, and 
disease were performed and morphometric analysis of particle clearance was conducted.  
BAL. BAL was performed at 1 day, 1 month, and 3 months following the last exposure. The 
trachea was cannulated, the chest cavity was opened, the left lung bronchus was clamped off, 
and BAL was performed on the right lung lobes. BAL was recovered in two fractions As 
described previously [547]. For each animal, both fractions of BAL were centrifuged, the 
acellular fluid (supernatant) from the first fraction was retained for further analysis described for 
BALF below, the supernatant from the second fraction was discarded, and the cell pellets 
(BALC) from both fractions were combined and re-suspended in 1 ml of PBS.  
BALF Analysis: LDH Activity and Proteins: The level of LDH activity in the BALF of all 
treatment groups was measured at 1 day, 1 month, and 3 months following the final exposure to 
evaluate cytotoxicity as a measure of lung injury. Measurement of LDH activity in the acellular 
fluid was obtained using a Cobas Mira chemistry analyzer (Roche Diagnostic Systems; 
Montclair, IN). LDH activity was quantified by detection of the oxidation of lactate coupled to the 
reduction of NAD+ at a spectrophotometric setting of 340 nm. Cytokines and chemokines 
involved in inflammatory, tissue remodeling, and immune responses were measured at each 
time point after exposure in the BALF of rats treated with PBS, DPM, SIL, or DS combination, 
with commercially-available enzyme-linked immunosorbent assay (ELISA) kits or by multiplex 
array. The following cytokines and chemokines were quantified by ELISA: interleukin (IL)-10, IL-
12p70, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-2 
(Novex, Life Technologies; Grand Island, New York); IL-2, IL-4, IL-6, interferon (IFN)-γ (R&D 
Systems; Minneapolis, Minnesota); and osteopontin (OPN, Enzo Life Sciences; Farmingdale, 
New York). Additionally, two matrix metalloproteinases (MMP), MMP-2 and MMP-9, were 
quantified by ELISA, as well as tissue inhibitor of metalloproteinase (TIMP)-1 (R&D Systems) as 
indices of tissue remodeling due to injury. IL-1α, IL-1β,  
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IL-5, IL-13, IL-17A, IL-18, granulocyte colony stimulating factor (G-CSF), granulocyte and 
macrophage colony stimulating factor (GM-CSF), eotaxin, MIP-1α, IFN-γ inducible protein (IP)-
10, growth-regulated oncogene/keratinocyte chemoattractant (GRO/KC), lipopolysaccharide 
(LPS)-induced CXC chemokine (LIX), regulated on activation normal T-cell expressed and 
secreted (RANTES), tumor necrosis factor-α (TNF-α), and transforming growth factor-β (TGF-β) 
were assessed by multiplex array (Eve Technologies; Alberta, CA).  
BALC Differentials. Total BALC collected from rats intratracheally-instilled with PBS, DPM, 
SIL, or DS were counted using a Coulter Multisizer II (Coulter Electronics; Hialeah, FL). BALC 
differentials were performed to determine the total number of alveolar macrophages (AMs) and 
neutrophils previously described (Farris et al 2017). Briefly, 5 × 104 cells from each rat were 
spun down onto slides with a Cytospin 3 centrifuge (Shandon Life Sciences International; 
Cheshire, England) and labeled with Hema 3® stain (Fisher Scientific; Kalamazoo, MI) to 
differentiate cell types. Two hundred cells per slide were counted, and the percentage of AMs 
and neutrophils was multiplied by the total number of cells to calculate the total number of each 
cell type.  
Chemiluminescence (CL). To measure the production of reactive oxidant species by BALC, 
CL was measured according to the method of Antonini et al. [507] as previously described [547]. 
Briefly, extracellular oxidant production was measured as light emitted as a reaction of oxidants 
with luminol following stimulation of BAL AMs by zymosan or total BAL phagocytes (AMs and 
neutrophils) by phorbal myristate acetate (PMA).  
Phenotypic Quantification of BALC and Mediastinal Lymph Node (MLN) Cells by Flow 
Cytometry.  
Total BALC collected from rats were counted using a Coulter Multisizer II (Coulter Electronics; 
Hialeah, FL), followed by differentiation into alveolar macrophages (AMs) and neutrophils as 
previously described [547]. Flow cytometry was performed to enumerate and phenotype BALC. 
The total number of lymphocytes, B cells (CD45R), and T cells (CD3+), as well as T cell subsets 
(CD4+/CD8+) cells were quantified. 
Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by airway 
pressure fixation under 30 cm-water pressure to total lung capacity for 15 min. Lung volumes for 
morphometric analyses were assessed by weight of water displacement. The left lungs were 
embedded in paraffin, sectioned onto slides, and stained with hematoxylin and eosin (H&E) or 
trichrome. An n = 5 stained slides per treatment group per time-point were assessed; stained 
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slides were analyzed for indications of inflammation, injury, and fibrosis by a certified veterinary 
pathologist at Charles River Laboratories (Wilmington, MA) who was blinded to the treatment 
groups. Indices of pathology were scored on scale of 0 – 5, where 0 = no observed effect, 1 = 
minimal response, 2 = mild response, 3= moderate response, 4 = marked response, and 5 = 
severe response. Tissue stained lightly with Sirius red was also qualitatively examined by dark-
field microscopy on an Olympus BX41 using CellSens Dimensions Software version 1.15 
(Olympus, Tokyo, Japan) at a magnification of 20x in order to observe particle-loaded cells 
within alveolar regions and injury to alveolar septae. 
Determination of Particle Clearance – Clearance was evaluated both qualitatively by 
examining representative images of particle loaded phagocytes from cytospins using light field 
microscopy on an Olympus BX63 using CellSens Dimensions Software version 1.15 (Olympus, 
Tokyo, Japan) and quantitatively by morphometrical analysis. Tissue sections from left lung 
were deparaffinized and stained lightly with Sirius Red. Slides were immersed in 0.1% 
picrosirius solution (100 mg of Sirius Red F3BA in 100 ml of saturated aqueous picric acid) for 2 
h followed by washing for 1 min in 0.01 N HCl. Slides were then counterstained with 
hematoxylin for 2 min, dehydrated, and mounted with a coverslip for imaging. Quantitative 
morphometric methods were used to measure the volume (% of the alveolar wall) and 
enumerate particles present by standard morphometric analyses (Underwood 1970; Mercer et 
al. 1994). This consisted of basic point counting. An eyepiece counting overlay consisting of 11 
by 11 lines (121 total points for each throw of the overlay) was used with a 40X objective. A grid 
pattern for throws of the counting overlay was used in order to ensure a uniform sampling of the 
section, which did not overweigh interior points. An n = 5 slides was evaluated for each group at 
time-points of 1 day, 1 month, and 3 months following exposure. Briefly, clearance was 
calculated by finding the total volume of particle, normalizing data to 1 at day 1 and deriving a 
natural log curve from latter time-points. 
Statistical Analyses. Results for all BAL parameters, and cellular phenotype were expressed 
as mean ± standard error and a one-way analysis of variance (ANOVA) was performed between 
all treatments groups at each time point. For BAL proteins that were below the limit of detection, 
1/2 of the lowest limit of detection was used for statistical analysis of values. Significant 
differences among groups were determined using the Student-Newman-Keuls (SNK) post-hoc 
test using SigmaPlot for Windows Version 12.5 (Systat Software, Inc, Ekrath, Germany). For 
those groups failing normality or variance in the software analysis, ANOVA was run on log 
transformed data followed by SNK post-hoc test. For all analyses, significance was set at p < 
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0.05. Because data from histopathology studies are inherently categorical, nonparametric 
analysis of variance was assessed using SAS/STAT software, Version 9.1, of the SAS System 
for Windows statistical programs (SAS Institute, Inc.; Cary, NC). In this instance, groups were 
compared using the Wilcoxon rank sum test. 
Results 
 
 Lung injury was evaluated as LDH activity in the BALF collected from rats at 1 day, 1 month, 
and 3 months post-final exposure to particles. LDH activity was significantly increased in all 
groups that contained SIL when compared to control and DPM only group (Figure 1). DPM 
alone also increased LDH activity compared with control at 1 day and 3 months following the 
last exposure. Although LDH activity was increased in the groups co-exposed to DPM and SIL, 
this effect was not different from SIL only at any time-point. 
Protein mediators were evaluated in BALF as a measure of inflammation and immune response 
(Tables 1-2). DPM did not cause significant increases in the majority of the inflammatory BALF 
proteins that were measured when compared to control (Table 1).  Only eoxtaxin was elevated 
at 3 months. Exposure to SIL alone caused persistent increases in the following inflammatory 
proteins: LIX, MIP-1α, MIP-2, MCP-1, IL-18, and TNF-α. For several of the cytokines, the 
elevation not only persisted but increased with time.  Additionally, Il-1β and RANTES were also 
elevated at 3 months when compared to control. Co-exposure to DPM and SIL resulted in 
increased MCP-1, MIP-1α, MIP-2, IL-18, TNF-α, and a trend for an increase in LIX at various 
time-points when compared with control and DPM. Further, combined exposure did not increase 
inflammatory protein expression significantly above that of SIL, and for 3 months post-exposure, 
there were a number of inflammatory proteins that were significantly greater in the SIL group 
compared to the DS group. SIL and DS co-exposure also caused a significant increase in MMP-
9, a protein associated with tissue remodeling that has implications in the development of 
fibrotic changes in the lung, at all time-points following exposure (Table 2). Additionally, SIL 
exposure and DS co-exposure increased OPN at 1 day with a trend for an increase at the later 
time-points, and TGFβ2 at 1 and 3 months. These proteins are also integral in tissue 
remodeling, wound healing, and development of fibrosis. DPM alone increased OPN only at 1 
day post-exposure.  SIL alone caused an increase in immunoregulatory protein IL-2 at the later 
time points and IP-10 at all time-points (Table 2). IP-10 was also increased at the later time 
points in the co-exposure group. DPM alone and in the co-exposure with SIL caused a 
downregulation of IFN-. Interestingly, this effect in combination with an attenuation of several 
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inflammatory cytokines relative to SIL alone indicated that DPM in a co-exposure with SIL may 
be exerting independent action on the immune and inflammatory response. These observations 
may indicate altered macrophage and lymphocyte activity in response to treatment with DPM. 
There were no significant changes in the following cytokines in any group: GRO/KC, G-CSF, 
GM-CSF, IL-1α, IL-4, IL-5, IL-10, IL-12p70, IL-13, IL-17A, MMP-2, and TIMP-1 (data not 
shown).  
Cell differentials were performed on BALC to further assess inflammation (Figure 2A&B). DPM 
alone did not cause an increase in the influx of AMs (Figure 2A) or neutrophils (Figure 2B). DPM 
did suppress macrophage influx at the one month time-point compared with control (Figure 2A). 
Macrophage influx was increased in all groups that contained SIL beginning at one month post-
exposure. Neutrophil influx significantly increased as early as one-day post-exposure in all 
groups containing SIL (Figure 2B), and the pattern of inflammation persisted and increased 
throughout the time course. There were no significant differences when comparing influx of cells 
between SIL and co-exposure group, which were also increased throughout the time course. 
BALC activation was also evaluated as oxidant production ex vivo (Figure 2 C&D). DPM alone 
did not cause an increase in oxidant production by AMs and neutrophils as measured by CL. 
Oxidant production in the SIL group significantly increased for total phagocytes at all times post-
final exposure (Figure 2C), and oxidant production by macrophages increased at later time-
points (Figure 2D). Co-exposure to DPM and SIL caused an increase in oxidant production at all 
time-points. Interestingly, exposure to DPM combined with SIL resulted in significantly increased 
oxidant production over exposure to SIL alone at one-day and one-month, suggesting a 
potentially higher oxidant burden in the lung of rats in the co-exposure group at these times.  
Total BAL and MLN lymphocytes are shown in Figure 3 and phenotype determined by flow 
cytometry is shown in Tables 3 and 4.  In addition to phagocytic influx described in Figure 2, 
exposure to SIL alone or in combination with DPM caused significantly increased lymphocyte 
influx into the lung as early as 1 day following exposure (Figure 3A) and proliferation in the MLN 
(Figure 3B) as early as one month following the last exposure. This effect was attributed 
primarily to CD4+ and CD8+ T cell population subsets (Tables 3 & 4). Exposure to DPM alone 
caused a decrease in CD4+ and CD8+ subsets in the lung at the one-month time-point compared 
with control (Table 3).  In the MLN, proliferation of total lymphocytes and all subsets measured 
were increased for DPM exposure at the same time-point. Additionally, it was noted that for the 
co-exposed group, DPM enhanced the influx of T cells into the lung compared with all groups, 
though this was only significantly different from SIL at one-month following the final exposure. 
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However, in the MLN, DS exposure resulted in increased lymphocyte proliferation, particularly at 
later time-points compare with all groups. These results were significantly different from SIL only 
exposure for T cells as early as one-day after final exposure, and for total lymphocytes 
comprised primarily by increased T and B cell lymphocyte populations at three-months following 
exposure (Table 4).  
H&E and trichrome-stained tissue sections were evaluated by a board-certified 
veterinarian pathologist (Table 5). Influx of AMs, as a measure of inflammation, was increased 
in SIL and DS groups at later time points of one and three months following exposure when 
compared to control and DPM, but there was no significant change between SIL and DS.  Mixed 
cell infiltration (MI) was initiated by SIL as there were no changes for DPM alone, and the DS 
group was similar to SIL for later time-points. Significant alveolar epithelial hyperplasia (AEH) 
and minimal to mild septal fibrosis were observed in only the combined exposure group at the 
later time-points, which is reflected in the sirius red stained tissue as evaluated qualitatively by 
dark field microscopy (Figure 5). The presence of brown granules was significantly apparent for 
both DPM only and DS groups as compared to control and SIL groups, indicating the presence 
of diesel (SIL would not appear unless examined under polarized light); interestingly, for the 
DPM group, brown granules were not increased at three months compared with DS group, 
which was still significantly elevated, indicating increased clearance in the DPM group.  
Macrophage particle load was qualitatively observed using images of cytospins collected from 
BAL that  reflect particle load evaluated quantitatively by morphometry (Figure 4).  This 
suggests that clearance of DPM in the co-exposure group may be decreased over time 
compared to DPM alone. Morphometrical analysis of particle clearance showed that clearance 
for the SIL and DS group was significantly slower than that of DPM alone at 1 day following the 
final exposure, and particle burden in the lung was greater for DS and SIL groups at all time 
points with the greatest load in the DS group (Figure 6A). Cumulative doses for each particle 
were also estimated based on morphometrical clearance data analyzed in study 2. Though a 
degree of  particle clearance may have occurred between each dosing week, assuming a 
constant rate of clearance throughout the repeated exposure time course of 21 days, total 
burden of particle at day 1 post final-exposure is still estimated to be 80% of cumulative DPM 
dose; whereas, 90% of either SIL or 95% of DS total dose remained at day 1 following final 
exposure. Additionally, rate of clearance slowed for the co-exposure group by 1 month 
becoming significantly slower than both SIL and DPM. At 1 day post-final exposure, DPM 
comprised 30% of overall remaining DS dose; however, by 3 months following exposure, 
approximately 90% of DS dose remaining was comprised of silica and only 10% remaining was 
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comprised of DPM (Figure 6B). By three-months only 33% of particle had been cleared in the 
co-exposure as compared with SIL or DPM, where 56 % and 74 % had been cleared, 
respectively (Figure 6A). Although clearance of DPM in the co-exposure is slower than DPM 
alone, clearance of this particle in a co-exposure is still occurring at a steady rate.  
Discussion 
 
The toxicological and fibrotic properties of crystalline silica are well-established, and both 
acute bolus doses of silica and more chronic lower dose exposure lead to fibrotic conditions and 
in the latter case, cancer [4], though the overall mechanisms of action are not fully elucidated. 
DPM-induced inflammation and oxidative stress are also well-investigated [467, 473-476]; 
though, DPM exposure is more closely associated with obstructive respiratory conditions and 
cancer, rather than restrictive fibrosis [411, 415, 517, 518]. The current study was conducted in 
order to investigate a model of repeated administrations of DPM and crystalline silica, which 
have been previously shown to cause respiratory health effects individually, and that may be 
encountered in a co-exposure during different mining operations. Previous studies in our lab 
established that combinations of these particles, given in one bolus dose, exacerbated or 
altered toxicological effects observed for either particle alone. These results were particularly 
significant for inflammation, production of oxidants by phagocytes, initiation of fibrotic changes 
in the lung, and differential alteration of immune protein secretion (Farris et al 2017). Further, it 
was established that particle load and SIL particle exposure were the primary determinants for 
histopathological effects related to tissue remodeling; whereas, DPM itself caused particle 
specific effects related to inflammation and oxidant production when in combination with SIL in a 
single dose scenario (Study 2). In both studies, irrespective of the DPM doses, SIL was the 
primary particle by which toxic outcomes were determined, and DPM produced particle specific 
effects that modified or enhanced the toxicity of SIL alone, even at non-toxic doses of DPM. In 
this study, particles were administered in repeated lower doses in order to characterize toxicity 
of SIL and DPM in combination in a sub-chronic exposure scenario. 
In the present study, most of the effects observed in the co-exposure correlated closely 
to effects that were initiated by the presence of SIL, as the SIL and DS groups did not differ 
significantly from each other in many instances. For the parameters of cellular injury and 
pulmonary inflammation, measured by the activity of LDH in the BALF and influx of 
macrophages and neutrophils into the lung, respectively, there were no significant differences 
between the SIL exposed group and the group exposed to the combination of DPM and SIL 
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(Figure 1 and 2 A,B). However, when assessing the potential contribution of inflammation 
caused by production of oxidants by phagocytes, there was an increase in the macrophage 
oxidant production in the co-exposed group compared to SIL alone at one month following the 
final exposure. By the three-month time-point, although still increased, there were no significant 
differences between the two groups. Interestingly, at one-month following exposure, not only did 
DPM alone not cause any change in production of oxidants from that of the control group, DPM 
exposure alone caused a significant decrease in the influx of macrophages into the lung (Figure 
2A). This effect demonstrates a distinct alteration in the toxicological responses in the lung to a 
combination of particles compared to single particle exposure to either DPM or SIL.  
Other studies examining longer duration or higher doses of silica and DPM have also 
shown differential effects on the function of alveolar macrophages, which may play a role in 
differences in effect overall on the immune system and have been reviewed in depth [5, 115, 
127, 128, 511, 550-552]. While crystalline silica characteristically causes acute increases in 
activity of macrophages, inducing production of oxidants and triggering a cascade of 
inflammatory signaling events, it has also been shown to cause eventual cytotoxicity to 
macrophages as reviewed by Fubini and Hubbard [130]. The exact biochemical mechanism(s) 
that govern this event are not fully understood but apoptosis is likely triggered by the 
involvement of scavenger receptors and recognition of damage signals, production of oxidants, 
or some combination of the two events [553]. DPM, similarly, is associated with variable effects 
on alveolar macrophages in some instances triggering inflammatory responses by increased 
oxidant and cytokine production, classically associated with the development of allergic 
hypersensitivity; however, DPM has also been shown by several studies to suppress the 
activities of macrophages particularly associated with effective clearance of pathogens from the 
lung. Dose of DPM administered, as well as, composition of DPM are suspected to be major 
factors in effects upon macrophages as reviewed by Lawal [554]. With regard to effects on the 
immune system, silica has been shown to have variable effects dependent upon length of 
exposure. Acutely, silica increases inflammation and production of oxidants by phagocytes that 
contribute to enhanced clearance of infection acutely [113]. However, when silica exposure 
occurs subchronically and chronically, cytotoxicity, oxidant injury, and a possible shift in resident 
AM population, contribute to reduction of clearance of infection [59, 62, 110]. DPM has been 
shown to suppress activation and effector functions of macrophages and T cells, and these 
alterations are associated with increased susceptibility to infection and reduced pulmonary 
clearance of pathogens [316, 324, 535, 555, 556].  
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In the current study, when evaluating the immunological proteins that were secreted into 
the BALF, SIL increased the expression of many inflammatory chemokines and cytokines 
associated with the recruitment of immune cells to the lung including LIX, MIP-1α, MIP-2, and 
MCP-1 (Table 1). At day 1, expression of several of these proteins was slightly reduced in the 
DPM exposed group compared to control, although not to a statistically significant degree. This 
trend may contribute to the reduction of macrophage recruitment observed in the lung at one 
month following the last exposure (Figure 2A). Interestingly, these same proteins in the DS 
group, although increased overall, were lower when compared to SIL in some instances, and 
more significantly at later time-points. This suggests that DPM may have differentially altered 
the response to SIL in a co-exposure. At some time-points, SIL also enhanced the expression of 
inflammatory proteins such as TNF-α and IL-18 or IL-1β involved in the activation of 
inflammatory cascades including NF-κB and the inflammasome, respectively, and that are also 
involved in apoptotic pathways. These effects, while often mirrored in the co-exposure, were not 
altered by the presence of DPM suggesting that for the expression of these proteins, SIL 
appeared to be the initiating factor, and that DPM did not alter or further enhance the response.  
Proteins involved in immunoregulation and the activation/differentiation of lymphocytes and 
macrophages were also increased in the SIL group: IL-2, IFN-γ, and IP-10 (Table 2). Similar to 
chemotactic factors that were down-regulated by DPM, immunoregulatory proteins were also 
lower than control, particularly at early time-points. These proteins were also reduced in 
expression in the co-exposure group as compared with SIL alone at various time-points. IP-10 
expression is dependent upon the increased levels of IFN-γ, and IFN-γ in turn activates 
macrophages. Therefore, it is plausible that the reduction in IFN-γ in the DPM group at one day 
following exposure may contribute to reduction in macrophage recruitment and a decrease in 
expression of IP-10.  Though expression of IFN-γ is reduced for the co-exposure group 
throughout the time-course, IP-10 expression is only reduced at 1 day following the final 
exposure, and macrophage recruitment was not altered in the co-exposure group when 
compared to SIL alone.  
The lack of the DPM-specific enhancement of various inflammatory responses, as 
observed in the first two studies, and a decrease in differences observed between SIL and DS 
groups may also be partly due to differential clearance of SIL versus DPM over time in the co-
exposure group. Clearance analysis in the DS group revealed that DPM accounted for only 20% 
of the total particle remaining at the 1 month and only approximately 10% by the 3 month time-
point. Therefore, it is likely that the persistence of SIL in the co-exposure group is the primary 
particle contributing to the response at the later time points; whereas in study 2, an acute bolus 
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dose higher than that in the present study may be contributing to a greater degree of particle 
specific effects by DPM in that study. 
Another difference between the present study and studies 1 and 2 occurred in regard to 
lymphocyte proliferation. SIL exposure caused an increased influx of lymphocytes into the lung 
(Table 3). This was followed by enhanced proliferation of lymphocytes in local lymph nodes by 
one month following the last exposure (Table 4).  These lymphocytes were found to be 
comprised primarily of T cells, and more specifically, the CD4+ subset of T lymphocytes. DPM 
caused a transient decrease in the subsets of T cells present in the lungs at one month 
following exposure (Table 3), which may reflect the reduction in protein expression and 
macrophage activity observed at this time point as discussed above (Table 1,2 and Figure 2A). 
For most lung lymphocyte parameters, there were no significant differences between the SIL 
and DS groups. However, for T cells, and more specifically CD4+ and CD8+ subsets, there were 
elevations in the co-exposure group as compared with SIL suggesting an increase, albeit 
transient, in the immunological response for this combined exposure (Table 3). Interestingly, at 
the same time-point, DPM alone reduced overall influx of these subsets into the lung. It is 
possible that load of particle is a contributing factor for this effect in the DS group accounting for 
the increase versus the suppressive effects of DPM alone. Similarly, Yin et al. reported that 
though DPM suppressed some parameters of innate immune function, recruitment of T cells 
following an LM infection, specifically in CD4+ and CD8+ subsets, was sufficient for clearing 
bacteria despite hindered innate immunity [317].  
Similar to the previous studies (study 1 and 2), the toxic properties of SIL and particle 
load are also the primary factors in the tissue remodeling and fibrotic effects following exposure. 
SIL increased the expression of tissue remodeling proteins involved in would healing and 
fibrosis: MMP-9, OPN, and TGFβ2 (Table 2). Changes for OPN were more significant at the 
earliest time-point. MMP-9 was significantly increased throughout the time course, and TGFβ2 
levels continued to increase over time being significantly different from DPM and control at 3 
months. A similar pattern was observed for the DS group with the exception of a significant 
increase in TGF2 at 1 month in the DS group when compared to all groups. The data suggest 
that SIL was the primary particle causing alterations in the signaling for tissue remodeling. 
Interestingly, the most persistent histopathological changes related to inflammation, epithelial 
hyperplasia, and fibrosis occurred in the DS group. In this group, total particle, and SIL 
specifically, was cleared at a slower rate from the lung when compared to the individual 
particles, resulting in a greater total particle load over time as compared to all other groups 
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(Figure 6A).  Therefore, a combination of these effects may account for the increase in fibrosis 
observed in the DS group only.  
Overall, in the previous study (Study 2), effects of the single bolus dose related to 
inflammatory influx of cells, increased inflammatory proteins, altered immune regulatory 
proteins, and increased oxidant production were particle specific responses to DPM, whereas 
tissue remodeling correlated better to total load of particle and the presence of SIL in the 
exposure. There are some differences and similarities between the acute dose and repeated 
subacute dose studies. The DPM specific effect of enhanced oxidant production by 
macrophages in the lung was conserved. However, exacerbation of lung injury indicated by LDH 
in BALF was not observed in the co-exposure group in the current study, where SIL and DS did 
not differ from each other. This could be due to a greater burden of SIL in the lungs following the 
repeated exposure, whereby total SIL is the primary factor for this parameter. Additionally, 
alterations in immunoregulatory proteins in the DPM group and in the co-exposure were more 
pronounced than the previous study, and a decrease in T cells in the lung was also present in 
the DPM group, possibly reflecting a greater effect of exposure to DPM over time versus a 
higher single dose exposure to DPM. In the DS group, although SIL was the primary factor 
causing an increase in all parameters, the effect of the subacute exposure to DPM may have 
contributed to some trends in slight reductions in certain parameters of inflammation and 
immune response in the co-exposure group relative to SIL alone.  
Conclusion 
 
The data taken together show that DPM exposure at doses in the sub-chronic exposure 
do not elicit significant pulmonary toxicity; however, in combination with silica, the co-exposure 
had the capability to alter some silica-induced pulmonary effects, primarily oxidant production, 
and initiation of fibrotic changes in the lung. When administered in combination with SIL, DPM 
had the capacity to exhibit independent action on the expression of some proteins that may alter 
the inflammatory/immunological response in the lung, as demonstrated by a reduction in 
macrophage recruitment at 1 month post-exposure and reductions in immune regulatory 
proteins, particularly IFN-. While it was not examined in this study, these results may have 
implications for adverse outcomes involving the immune system such as susceptibility to 
infection or regulation of auto-immune responses following a sub-acute or even chronic 
exposure to low doses of particles. Overall, the data suggest that there is an increased risk of 
adverse outcomes when there is a co-exposure to SIL and DPM, even at relatively non-toxic 
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doses of DPM. Since clearance of particles in the co-exposure is significantly reduced, more 
chronic exposure may lead to an increase in severity of effects when compared to exposure to 
either particle alone, particularly if accumulation of particles were to exceed rate of clearance. 
Furthermore, the intratracheal bolus doses of particles administered in this and the previous 
studies (Studies 1 and 2) are much lower than what have been previously investigated in similar 
models [271, 325, 498, 557, 558], and better reflect deposition that would occur overtime in 
inhalation models. This suggests that chronic lower-level exposures to a mixture of silica and 
diesel exhaust in the work place may still be sufficient for the development of adverse 
pulmonary health effects.  
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Table 1: BALF Inflammatory Proteins 
All data are shown as mean ± standard error: a different from control and DPM; b different from control; c different from all other 
groups; d different from DPM; and e different from SIL; p ≤ 0.05.  
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Table 2: BALF Immunoregulatory Proteins and Tissue Remodeling Proteins 
All data are shown as mean ± standard error: adifferent from control and DPM; b different from control; 








Table 3: Lymphocyte Phenotype of the BALC  
 
All data are shown as mean ± standard error:  a different from control and DPM; b different from 
control; c different from all other groups; and d different from DPM; p ≤ 0.05. Red text indicates a 
value significantly less than control. 
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Table 4: Lymphocyte Phenotype in the MLN  
 
All data are shown as mean ± standard error: a different from control and DPM; b different from 





Table 5: Lung Histopathology Severity and Incidence Scores  
Lung tissue was analyzed and scored for accumulation of alveolar macrophages (AM), alveolar 
epithelial hyperplasia (AEH), brown granules in alveolar macrophages (BG; presence of DPM 
particles), mixed cellular infiltration (MI), and fibrosis in alveolar septae (F) (n=5 per group per 
time point). Severity was scored as 0 - 5: 0 = normal, 1 = minimal/slight, 2 = mild, 3 = moderate, 
4 = marked, and 5 = severe. Incidence was noted as focal (F), multi-focal (M), and diffuse (D). 
Data are presented as means with incidence (number of animals with a positive score per total 
animals) in parentheses. aDifferent from control and DPM groups; cdifferent from all other 
groups; ddifferent from DPM only; and fdifferent from control and SIL groups; p value <0.05. 
Additional symbols indicate * p <0.01; ** p <0.01 compared with control and DPM; †p <0.01 
compared with DPM; and ††p <0.01 compared with control. 
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Figure 1:  
Figure 1: Lactate dehydrogenase activity (LDH) in BALF after exposure to PBS, DPM, SIL, or a 
combination of DPM and SIL (DS).  All data are shown as mean ± standard error: adifferent from 






Figure 2: Total macrophages (A) and neutrophils (B) in the BALF following exposure to PBS, DPM, 
SIL, or DS.  Production of oxidants by total phagocytes stimulated with PMA (C) or by macrophages 
only stimulated by zymosan (D) measured by chemiluminescence following exposure to PBS, DPM, 
SIL, or DS. All data are shown as mean ± standard error: adifferent from control and DPM; bdifferent 







Figure 3: Total BAL Lymphocytes (A) and MLN Lymphocytes (B) following exposure to PBS, DPM, 
SIL, or DS. For individual cell phenotypes see Tables 3 and 4. aDifferent from control and DPM; 








Light field microscopy images of cytospins used to qualitatively assess particulate clearance by 
BAL AMs at 1 day, 1 month, and 3 months following instillation. Images were taken at 40x 
magnification and scale bar represents 20µm in length. Green arrows indicate the presence of 







Figure 5: Dark field microscopy images of Sirius red stained tissue used to qualitatively assess 
tissue injury and particulate loaded cells at 1 day, 1 month, and 3 months following instillation. 
Images were taken at 20x magnification and scale bar represents 20µm in length. White arrows 







Figure 6: Particle clearance for each dosing group as quantitatively evaluated by morphometry; 
data was normalized to 1.0 for day one following the last instillation in order to compare groups 
that received variable particle masses of initial dose; data shown is Ln of normalized data. For 
each group an n = 5 tissue slides per time-point were morphometrically assessed (A). Relative 






















Industrial operations such as above and below-ground mining may result in occupational 
respiratory exposure to complex mixtures of particulates including crystalline silica and diesel 
exhaust. Toxicity following pulmonary exposure to either crystalline silica or diesel exhaust have 
been studied in detail as individual exposures, as extensively reviewed by several investigators 
[4, 5, 21, 128, 306, 465, 511, 550-552, 559-561]. Silica has been shown to cause oxidative 
stress, prolonged inflammation, development of restrictive fibrotic lung disease, 
hyperresponsiveness of some T cell subsets, upregulation of the inflammasome, incidence of 
autoimmune developments, increased susceptibility to infections, and cancers. Diesel exposure 
may result in oxidative stress, inflammation, suppression of macrophage function, reduced T 
cell activity, increased susceptibility to infection, allergic sensitization, development of 
obstructive lung diseases, and cancer. The hazards associated with these exposures are well-
recognized and regulatory organizations have recommended exposure limits (RELs) [30, 184], 
permissible exposure limits (PELs) [7, 31, 182], or occupational exposure limits (OELs) [179-
181, 183] for crystalline silica and in some instances for underground levels of diesel (regulated 
as total carbon). However, there are very few studies that investigate the health effects of these 
two materials in a co-exposure scenario that may occur in occupational setting, such as surface 
or below-ground mining operations, including hydraulic fracturing, a fast-expanding form of oil 
and gas extraction that utilizes diesel-powered engines as the motive force in moving proppant 
and sand containing crystalline silica. 
The current series of investigations was designed to address these main knowledge 
gaps in the literature. The overall goal of these studies was to characterize pulmonary toxicity 
following a co-exposure to diesel particulate matter (DPM) and crystalline silica (SIL) at doses 
derived from current occupational measures, and determine if these effects were variable 
compared with exposure to the particles individually. The project had three major aims: (1a) 
Characterize the pulmonary response to an acute co-exposure to DPM and SIL at varying 
doses; (1b) characterize the pulmonary response to a repeated co-exposure to DPM and SIL in 
order to determine if subacute exposure vs. acute exposure altered the effects observed for 1a; 
(2) establish if susceptibility to an acute respiratory infection was altered following a co-
exposure of DPM and SIL; and (3) determine whether clearance of particulate in a co-exposure 
to DPM and SIL was altered compared with the clearance rate of either particle individually to 
assess the effect of particle load in toxicity  
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 In Study 1, two doses of DPM were employed, which were derived from field measures 
of elemental carbon (EC) collected either above or below-ground during mining operations 
[547]. Particulates were administered to rats by intratracheal instillation in one bolus dose to 
model an acute exposure. The study showed that these doses of DPM, ~7 or 50 g, produced 
low to no effect on pulmonary toxicity individually. The high dose of SIL (233 g), which was 
greater than that of the DPM by mass, but not the lower dose (50 g), did result in acute injury, 
inflammation, alterations in immune response, and the induction of pathological changes in the 
lung associated with fibrosis. When the higher of the two DPM doses was combined with the 
high dose of SIL, inflammation, and oxidant production by phagocytes were enhanced at early 
time-points. By 3 months post-exposure, effects of the co-exposure were similar to that of SIL 
alone, which persisted or progressed depending on the parameter of toxicity. This led to the 
goal of determining whether the increase in toxic effects elicited by DPM at earlier time-points 
were not enhanced beyond that of SIL at 3 months following exposure due to clearance of DPM, 
or a masking of any additional effect of DPM due to the progression of toxicity caused by SIL. 
Additionally, there was a need to address whether the effects observed were due to increased 
particle load administered to the co-exposure group, or rather, due to specific properties of DPM 
in the co-exposure.  
This concept was addressed in Study 2, where equal doses of SIL, and DPM or CB were 
administered to determine if the effects observed in Study 1 were particle-specific to DPM or if 
total particle load was a factor in toxicity. CB was employed as a particle load control for 
comparison to DPM as it is comprised of the primary core component of DPM, but does not 
have the metal and PAH components, and it is relatively low in pulmonary toxicity at non-
overload doses [267, 277, 281]. It was determined from this investigation that DPM given at a 
dose equivalent to that of silica, also enhanced inflammation, injury, oxidant production, and 
induction of pathological changes observed for silica alone. Further, CB did not contribute to 
enhanced inflammation, injury, and oxidant production beyond that of silica alone suggesting 
that for DPM and silica combined, these responses were due to specific characteristics of DPM 
and not due specifically to an increase in overall particle load. However, pathological changes 
were closely correlated to SIL exposure, but were enhanced by particle load as these changes 
were slightly increased beyond that of SIL for both DPM and CB co-exposed groups. Further, it 
was established that overall clearance of particles was reduced in the co-exposures compared 




Study 3 investigated toxicological changes that occur during a sub-chronic, repeated co-
exposure to lower concentrations of particles representing a longer period of working conditions 
from mining sites. Rats were exposed intratracheally to DPM (25 g), SIL (116 g), or DPM (25 
g) and SIL (116 g) combined once per week for four consecutive weeks. Effects observed in 
the co-exposure  group in this study were primarily due to silica, as this group did not differ from 
SIL alone as had been observed in the acute dose study; however, relatively low doses of DPM 
were sufficient to enhance the production of oxidants by phagocytes at 1 month following final 
exposure, and increase the incidence of fibrotic pathological changes in the lung tissue 
beginning at 1 month following exposure that increased further at 3 months following final 
exposure.  Additionally, it was observed that DPM both alone, and in co-exposure with SIL was 
capable of eliciting independent action on the expression of some proteins in the lung 
associated with chemotaxis of innate immune cells and the differentiation of lymphocytes.  
Based on the findings related to immune response in the characterization studies, further 
studies examining the susceptibility to infection were designed to determine if alterations of 
inflammation, oxidant production, and protein expression might alter pulmonary response to a 
pathogen using the acute exposure models in studies 1 and 2. Although bacterial clearance was 
reduced for the highest dose of DPM at day 3 following infection when compared to all groups 
that contained SIL, all exposed groups were able to clear infection in the adaptive phase of the 
immune response following exposure to bacteria. The high dose DPM group showed a degree 
of increased T cell response to infection at days 5 and 7 (Study 2, Table 7), although not to the 
level of significance, which may have been compensatory to the initial suppression in innate 
immune response and increased bacterial load at day 3. Therefore, the differential effects on 
immune parameters of DPM in the co-exposure groups observed in studies 1 and 2 in the 
absence of infection were not significant enough to disrupt immune function in the response to a 
pathogen.  
Taken together, these results suggest that acute exposure to DPM and SIL in 
combination showed that relatively low toxicity doses of DPM could exacerbate the effects of 
lung injury and inflammation and alter immune responses when compared to that of SIL 
exposure alone, while total particle load in the presence of SIL contributed to fibrotic response 
and tissue remodeling. Further, the finding that combined exposure to DPM and SIL results in 
reduced clearance rate of particles when compared to individual exposures may have 
implications in development of adverse pulmonary outcomes following chronic exposures, 
where persistent particle load could further exacerbate lung pathology. It is well-accepted that 
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particle clearance and load are critical factors in toxicity, and that particle overload can be a 
mechanism of toxicity for particles that are considered relatively non-toxic or “nuisance dusts.” 
Overload is described as a particle load that overwhelms the capability of natural clearance 
mechanisms by way of mucociliary escalation or uptake by macrophages, and is dependent on 
a number of particle properties including size, shape, and density, occurring when a 
macrophage reaches a particle burden of ~ 60 % of its volume [75, 562].   
Although combined exposure to DPM and SIL led to reduced rate of particle clearance, 
continued particle clearance was observed throughout the time course suggesting that the 
doses of particles administered did not reach overload. Also, although there were macrophages 
that were in particle overload conditions at the highest doses of DPM administered in study 2, 
the vast majority of macrophages recovered by BAL did not have greater than 60% volume in 
particles. It is important to note that the instillation doses used in these studies better reflect 
doses delivered by inhalation as calculated based on worksite measurements and pulmonary 
deposition models; whereas, historically, intratracheal instillation studies of silica and diesel 
individually have used much higher acute bolus doses of the materials to represent longer, more 
chronic exposures or to determine maximal effect of toxicity [291, 468, 521, 563-567]. 
Therefore, bolus dose delivery often reflect amounts of particulate that far-exceed exposure 
levels that are likely to occur routinely in the workplace, and may reflect to some degree the 
state of particle overload, which may not adequately reflect workplace exposures where particle 
concentrations are kept within the limitations outlined by governing agencies [31, 180-183]. The 
reduced rate of particle clearance observed in the co-exposures in the present studies are not a 
product of particle overload in the lung, which allows the investigators to be able to determine 
effects that are correlated to particle specific toxicity or general particle load effects under non-
overload conditions.  
Reduced clearance of a highly toxic material, such as silica, following exposure is of 
significant concern. As silica is known to be directly cytotoxic and reactive, is it not surprising 
that parameters of toxicity associated with silica, such as inflammation and cytotoxicity, are 
dose and exposure duration dependent [568-570]. It has been shown that once a given 
threshold of silica exposure has been reached and exposure has ceased, progression of 
pathology may still occur [74, 80, 81, 570]. This was also observed in the SIL group in the 
current studies; whereas, the dose-dependent effects for DPM alone resolved over time [547].  
In study 1 and study 2, the total particle load increased in the co-exposure groups over the 
individual exposures on a mass basis, and although several parameters measured showed a 
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particle-specific effect due to DPM, other parameters were influenced more by particle load and 
the presence of SIL. Tissue remodeling and fibrosis, although dependent upon the presence of 
SIL, were increased due to overall particle load, as the DPM or CB co-exposures did not differ 
from each other and  resulted in increased tissue injury over that of SIL alone. This suggests 
that particulate combined with a toxic dose of SIL may be sufficient to elicit these effects, 
regardless of the specific particle.  
Overall, these studies show particle specific effects of DPM as well as particle load 
effects in the co-exposure; however the majority of the underlying toxicity during this 
investigation was initiated by SIL. As mentioned, inflammation, cytotoxic injury, migration of 
immune cells into the lung, proliferation of lymphocytes in MLN, production of oxidants by 
phagocytes, and expression of inflammatory and tissue remodeling proteins in the lung were 
increased in response to silica at the high dose (233 g) throughout the time course. These 
results are in agreement with numerous studies examining the pulmonary toxicity of silica [80, 
81, 571]. In sharp contrast to the effects of silica, the doses of DPM used in our studies (~7, 50, 
or 233 g) did not elicit persistent inflammatory effects beyond 1 day or 1 week for most 
parameters when administered as an individual exposure, although DPM did appear to alter 
effects related to immune function differentially from that of SIL. The transient inflammatory 
responses are in contrast to other investigations of DPM toxicity [268-272], and this may be due 
to several factors including dose, whereby the doses used in the present study are lower than 
those employed in other installation studies, as well as duration of exposure (an acute or 
subacute dose versus subchronic or chronic studies), and/or composition of diesel depending 
on source, engine type, whole exhaust, or particulate fraction [278, 280, 308, 572].  
Immune effects related to DPM are most often associated with suppression of certain 
parameters of innate immunity related to macrophage effector functions [248, 316, 318, 324, 
325, 387, 573, 574]. In the current studies, we did observe decreased influx of macrophages 
following subacute exposure and the expression of inflammatory cytokines associated with 
macrophage effector functions for both acute and subacute exposure, specifically signaling 
chemotaxis of additional immune cells and auto-activation. Furthermore, DPM exposure 
resulted in the decreased influx of some sets of T cells into the lung corresponding with a 
decrease in IP-10 at 1 month following final exposure in our subacute model. Interestingly, 
some suppression of macrophage related proteins was also observed in the DPM and SIL 
combined exposure as compared with SIL exposure alone, suggesting that DPM has the 
capability to attenuate the effects observed for SIL depending on the time point and parameter 
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examined, which may play a role in susceptibility to infection during a chronic model of exposure 
and infection. Though an alteration in bacterial clearance following infection was not observed 
for the lower dose of DPM (50 µg), the higher dose exposure group (233 µg) had significantly 
decreased clearance at day 3 following infection, which was not observed for the same particle 
load of CB (Study 2).  Moreover, clearance of bacteria in the DPM/SIL group was not different 
from that of SIL.  
Overall, the suppressive effects of DPM in the present studies were transient and, 
although there were clear trends in the suppression of macrophage response, not all 
parameters were statistically significant from control, as has been observed in other studies of 
diesel reviewed in Chapter 1 [387, 573, 574]. As mentioned above, the differences in the degree 
of immune suppression observed in other investigations versus the current studies described 
here may be attributable to the form of diesel used in this study.  Investigators have 
demonstrated that the immunoregulatory effects of DPM are more closely related to the organic 
fraction of the material adsorbed to the carbon core of DPM [268, 296, 298, 324, 325, 330, 335, 
337, 339], and not to the carbon core itself, which is similar to the CB control used in study 2. 
Relative to other studies, the diesel exposure in this study used only the particulate form diesel 
collected from a forklift (NIST SRM 2975) representing a “tranisitional” form of diesel exhaust. 
This particle is relatively low in organic material relative to freshly generated diesel exhaust. The 
studies did show, however, a degree of suppression in macrophage- and immune-related 
responses over that of the carbon core control group (CB), suggesting that the levels of 
components adsorbed to the core of the DPM in this study may contribute to the particle specific 
effects related to immune parameters in the co-exposure group. 
Taken together, the data indicate that toxicity in the co-exposure group was attributable 
to SIL, and although there was a degree of independent action due to DPM in the co-exposure 
group in regard to immune function, DPM did have particle-specific effects in the co-exposure 
group related to exacerbation of inflammation and oxidant production; whereas, 
histopathological changes were primarily attributable to particle load and the presence of SIL. 
These studies are the first to characterize effects that are specific to the interaction of DPM with 
SIL in a co-exposure and are important for the continued understanding of workplace 




Model for Overall Progression of Lung Toxicity 
 
 
1) A worker is exposed to silica particles. 2) Silica particles may cause direct damage to 
bronchiolar or alveolar epithelial cells in the form of reactive oxidants leading to oxidative stress 
(2a), or may be phagocytosed by cells such as alveolar macrophages when deposited deeply 
within the lung (2b). 3) Particles that are phagocytosed will result in cellular damage in the form 
of reactive oxidants that may cause cellular damage (oxidative stress) or cell death. 4) Cells, 
either bronchial or alveolar epithelial, or cells that have phagocytosed particles will express 
inflammatory mediators and/or fibrogenic mediators. 5) Inflammatory mediators signal the 
infiltration of additional immune cells such as monocytes, macrophages, and neutrophils. 6) Cell 
damage/death leads to the re-release of silica particles into the alveolar spaces, which must be 
phagocytosed by newly recruited cells. This process is reinitiated again at 2b. 7) Fibrogenic 
mediators recruit fibroblasts to the site of prolonged inflammation in order to secrete 
extracellular matrix proteins such as collagen in an effort to sequester silica particles to a 
particular area. 8) Collagen deposition results in the development of fibrosis. This study also 
showed that exposure to DPM in addition to silica resulted in more prolonged and increased 
parameters of inflammation, cellular injury, and oxidative stress. Furthermore, the increase in 
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